Intel (INTC) 10-K 13 Feb 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
In Billions, except Share data in Millions, unless otherwise specified	Dec. 27, 2014	Feb. 06, 2015	Jun. 27, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	Intel Corporation
Entity Central Index Key	50863
Company Fiscal Year End Date	-15
Entity Filer Category	Large Accelerated Filer
Document Type	10-K
Document Period End Date	27-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Amendment Flag	FALSE
Entity Common Stock Shares Outstanding		4,736
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$153

Consolidated_Statements_of_Inc

Consolidated Statements of Income (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Net revenue	$55,870	$52,708	$53,341
Cost of sales	20,261	21,187	20,190
Gross margin	35,609	31,521	33,151
Research and development	11,537	10,611	10,148
Marketing, general and administrative	8,136	8,088	8,057
Restructuring and asset impairment charges	295	240	0
Amortization of acquisition-related intangibles	1,169	1,242	1,165
Operating expenses	20,262	19,230	18,513
Operating income	15,347	12,291	14,638
Gains (losses) on equity investments, net	411	471	141
Interest and other, net	43	-151	94
Income before taxes	15,801	12,611	14,873
Provision for taxes	4,097	2,991	3,868
Net income	11,704	9,620	11,005
Basic earnings per share of common stock	$2.39	$1.94	$2.20
Diluted earnings per share of common stock	$2.31	$1.89	$2.13
Weighted average shares of common stock outstanding:
Basic (shares)	4,901	4,970	4,996
Diluted (shares)	5,056	5,097	5,160
Operating Expense [Member]
Amortization of acquisition-related intangibles	$294	$291	$308

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Statement of Comprehensive Income [Abstract]
Net income	$11,704	$9,620	$11,005
Other comprehensive income, net of tax:
Change in net unrealized holding gains (losses) on available-for-sale investments	577	1,181	470
Change in deferred tax asset valuation allowance	-41	-26	-11
Change in net unrealized holding gains (losses) on derivatives	-427	-89	85
Change in net prior service costs (credits)	-33	18	0
Change in actuarial valuation	-402	520	-172
Change in net foreign currency translation adjustment	-251	38	10
Other comprehensive income (loss)	-577	1,642	382
Total comprehensive income	$11,127	$11,262	$11,387

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 27, 2014	Dec. 28, 2013
In Millions, unless otherwise specified
Current assets:
Cash and cash equivalents	$2,561	$5,674
Short-term investments	2,430	5,972
Trading assets	9,063	8,441
Accounts receivable, net of allowance for doubtful accounts of $38 ($38 in 2013)	4,427	3,582
Inventories	4,273	4,172
Deferred tax assets	1,958	2,594
Other current assets	3,018	1,649
Total current assets	27,730	32,084
Property, plant and equipment, net	33,238	31,428
Marketable equity securities	7,097	6,221
Other long-term investments	2,023	1,473
Goodwill	10,861	10,513
Identified intangible assets, net	4,446	5,150
Other long-term assets	6,561	5,489
Total assets	91,956	92,358
Current liabilities:
Short-term debt	1,604	281
Accounts payable	2,748	2,969
Accrued compensation and benefits	3,475	3,123
Accrued advertising	1,092	1,021
Deferred income	2,205	2,096
Other accrued liabilities	4,895	4,078
Total current liabilities	16,019	13,568
Long-term debt	12,107	13,165
Long-term deferred tax liabilities	3,775	4,397
Other long-term liabilities	3,278	2,972
Commitments and contingencies (Notes 17 and 25)
Temporary equity	912	0
Stockholders' equity:
Preferred stock, $0.001 par value, 50 shares authorized; none issued	0	0
Common stock, $0.001 par value, 10,000 shares authorized; 4,752 shares issued and 4,748 shares outstanding (4,967 issued and outstanding in 2013) and capital in excess of par value	21,781	21,536
Accumulated other comprehensive income (loss)	666	1,243
Retained earnings	33,418	35,477
Total stockholders’ equity	55,865	58,256
Total liabilities, temporary equity, and stockholders’ equity	$91,956	$92,358

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 27, 2014	Dec. 28, 2013
In Millions, except Per Share data, unless otherwise specified
Current assets:
Accounts receivable allowance for doubtful accounts	$38	$38
Stockholders' equity:
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	50	50
Preferred stock, shares issued	0	0
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	10,000	10,000
Common stock, shares issued	4,752	4,967
Common stock, shares outstanding	4,748	4,967

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Cash and cash equivalents, beginning of year	$5,674	$8,478	$5,065
Cash flows provided by (used for) operating activities:
Net income	11,704	9,620	11,005
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	7,380	6,790	6,357
Share-based compensation	1,148	1,118	1,102
Restructuring and asset impairment charges	295	240	0
Excess tax benefit from share-based payment arrangements	-122	-49	-142
Amortization of intangibles	1,169	1,242	1,165
(Gains) losses on equity investments, net	-354	-425	-141
Deferred taxes	-703	-900	-242
Changes in assets and liabilities:
Accounts receivable	-861	271	-176
Inventories	-98	563	-626
Accounts payable	-249	267	67
Accrued compensation and benefits	4	155	192
Income taxes payable and receivable	-286	1,019	229
Other assets and liabilities	1,391	865	94
Total adjustments	8,714	11,156	7,879
Net cash provided by operating activities	20,418	20,776	18,884
Cash flows provided by (used for) investing activities:
Additions to property, plant and equipment	-10,105	-10,711	-11,027
Acquisitions, net of cash acquired	-934	-925	-638
Purchases of available-for-sale investments	-7,007	-12,493	-8,694
Sales of available-for-sale investments	1,227	934	2,282
Maturities of available-for-sale investments	8,944	8,336	5,369
Purchases of trading assets	-14,397	-16,718	-16,892
Maturities and sales of trading assets	13,165	13,677	15,786
Origination of loans receivable	0	-200	-216
Investments in non-marketable equity investments	-1,377	-440	-475
Other investing	671	503	655
Net cash used for investing activities	-9,905	-18,073	-14,060
Cash flows provided by (used for) financing activities:
Increase (decrease) in short-term debt, net	235	-31	65
Proceeds from government grants	104	129	63
Excess tax benefit from share-based payment arrangements	122	49	142
Issuance of long-term debt, net of issuance costs	0	0	6,124
Proceeds from sales of common stock through employee equity incentive plans	1,660	1,588	2,111
Repurchase of common stock	-10,792	-2,147	-4,765
Restricted stock unit withholdings	-332	-293	-345
Payment of dividends to stockholders	-4,409	-4,479	-4,350
Collateral associated with repurchase of common stock	-325	0	0
Increase in liability due to collateral associated with repurchase of common stock	325	0	0
Other financing	-199	-314	-453
Net cash used for financing activities	-13,611	-5,498	-1,408
Effect of exchange rate fluctuations on cash and cash equivalents	-15	-9	-3
Net increase (decrease) in cash and cash equivalents	-3,113	-2,804	3,413
Cash and cash equivalents, end of year	2,561	5,674	8,478
Cash paid during the year for:
Interest, net of capitalized interest	167	204	71
Income taxes, net of refunds	4,639	2,874	3,930
Licensed Technology and Patents [Member]
Cash flows provided by (used for) investing activities:
Purchases of licensed technology and patents	-92	-36	-815
IM Flash Technologies, LLC and IM Flash Singapore, LLP [Member] | Micron Technology, Inc. [Member]
Cash flows provided by (used for) investing activities:
Proceeds from the sale of IM Flash Singapore, LLP assets and certain IM Flash Technologies, LLC assets	$0	$0	$605

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders' Equity (USD $)	Total	Common Stock and Capital in Excess of Par Value [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]
In Millions, unless otherwise specified
Beginning Balance at Dec. 31, 2011	$45,911	$17,036	($781)	$29,656
Beginning Balance, shares at Dec. 31, 2011		5,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Proceeds from sales of shares through employee equity incentive plans, net excess tax benefit/tax deficiency, and other, shares		148
Repurchase of common stock, shares		-191
Restricted stock unit withholdings, shares		-13
Components of comprehensive income, net of tax:
Net income	11,005			11,005
Other comprehensive income (loss)	382		382
Total comprehensive income	11,387
Proceeds from sales of common stock through employee equity incentive plans, net excess tax benefit, and other	2,257	2,257
Share-based compensation	1,108	1,108
Repurchase of common stock	-4,765	-592		-4,173
Restricted stock unit withholdings	-345	-345
Cash dividends declared	-4,350			-4,350
Ending Balance at Dec. 29, 2012	51,203	19,464	-399	32,138
Ending Balance, shares at Dec. 29, 2012		4,944
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Proceeds from sales of shares through employee equity incentive plans, net excess tax benefit/tax deficiency, and other, shares		130
Repurchase of common stock, shares		-94
Restricted stock unit withholdings, shares		-13
Components of comprehensive income, net of tax:
Net income	9,620			9,620
Other comprehensive income (loss)	1,642		1,642
Total comprehensive income	11,262
Proceeds from sales of common stock through employee equity incentive plans, net excess tax benefit, and other	1,593	1,593
Share-based compensation	1,117	1,117
Repurchase of common stock	-2,147	-345		-1,802
Restricted stock unit withholdings	-293	-293
Cash dividends declared	-4,479			-4,479
Ending Balance at Dec. 28, 2013	58,256	21,536	1,243	35,477
Ending Balance, shares at Dec. 28, 2013	4,967	4,967
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Proceeds from sales of shares through employee equity incentive plans, net excess tax benefit/tax deficiency, and other, shares		125
Repurchase of common stock, shares		-332
Restricted stock unit withholdings, shares		-12
Components of comprehensive income, net of tax:
Net income	11,704			11,704
Other comprehensive income (loss)	-577		-577
Total comprehensive income	11,127
Proceeds from sales of common stock through employee equity incentive plans, net excess tax benefit, and other	1,787	1,787
Share-based compensation	1,140	1,140
Temporary equity reclassification	-912	-912
Repurchase of common stock	-10,792	-1,438		-9,354
Restricted stock unit withholdings	-332	-332
Cash dividends declared	-4,409			-4,409
Ending Balance at Dec. 27, 2014	$55,865	$21,781	$666	$33,418
Ending Balance, shares at Dec. 27, 2014	4,748	4,748

Consolidated_Statements_of_Sto1

Consolidated Statements of Stockholders' Equity (Parenthetical) (Retained Earnings [Member], USD $)	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Retained Earnings [Member]
Cash dividends declared per common share (in dollars per share)	$0.90	$0.90	$0.87

Basis_of_Presentation

Basis of Presentation	12 Months Ended
	Dec. 27, 2014
Basis of Presentation [Abstract]
Basis of Presentation [Text Block]	Note 1: Basis of Presentation
	We have a 52- or 53-week fiscal year that ends on the last Saturday in December. Fiscal years 2014, 2013, and 2012 were all 52-week years. The next 53-week year will end on December 31, 2016. Our consolidated financial statements include the accounts of Intel Corporation and our subsidiaries. We have eliminated intercompany accounts and transactions. We use the equity method to account for equity investments in instances in which we own common stock or similar interests and have the ability to exercise significant influence, but not control, over the investee. We have reclassified certain prior period amounts to conform to current period presentation.

Accounting_Policies

Accounting Policies	12 Months Ended
	Dec. 27, 2014
Accounting Policies [Abstract]
Accounting Policies	Note 2: Accounting Policies
	Use of Estimates
	The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and judgments that affect the amounts reported in our consolidated financial statements and the accompanying notes. The accounting estimates that require our most significant, difficult, and subjective judgments include:
	•	the valuation of non-marketable equity investments and the determination of other-than-temporary impairments;
	•	the assessment of recoverability of long-lived assets (property, plant and equipment; goodwill; and identified intangibles);
	•	the recognition and measurement of current and deferred income taxes (including the measurement of uncertain tax positions);
	•	the valuation of inventory; and
	•	the recognition and measurement of loss contingencies.
	The actual results that we experience may differ materially from our estimates.
	Fair Value
	Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, we consider the principal or most advantageous market in which we would transact, and we consider assumptions that market participants would use when pricing the asset or liability. Our financial assets are measured and recorded at fair value, except for cost method investments, cost method loans receivable, equity method investments, grants receivable, and reverse repurchase agreements with original maturities greater than approximately three months. Substantially all of our liabilities are not measured and recorded at fair value.
	Fair Value Hierarchy
	The three levels of inputs that may be used to measure fair value are as follows:
	Level 1. Quoted prices in active markets for identical assets or liabilities.
	Level 2. Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in less active markets, or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities. Level 2 inputs also include non-binding market consensus prices that can be corroborated with observable market data, as well as quoted prices that were adjusted for security-specific restrictions.
	Level 3. Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. Level 3 inputs also include non-binding market consensus prices or non-binding broker quotes that we were unable to corroborate with observable market data.
	For further discussion of fair value, see "Note 4: Fair Value" and "Note 16: Retirement Benefit Plans."
	Cash Equivalents
	We consider all highly liquid debt investments with original maturities from the date of purchase of approximately three months or less as cash equivalents. Cash equivalents can include investments such as corporate debt, financial institution instruments, government debt, and reverse repurchase agreements classified as cash equivalents. See "Note 4: Fair Value" for the instruments held as cash equivalents.
	Trading Assets
	Marketable debt instruments are generally designated as trading assets when a market risk is economically hedged at inception with a related derivative instrument, or when the marketable debt instrument itself is used to economically hedge foreign exchange rate risk from remeasurement. Investments designated as trading assets are reported at fair value. The gains or losses of these investments arising from changes in fair value due to interest rate and currency market fluctuations and credit market volatility, largely offset by losses or gains on the related derivative instruments and balance sheet remeasurement, are recorded in interest and other, net. We also designate certain floating-rate securitized financial instruments, primarily asset-backed securities, as trading assets.
	Available-for-Sale Investments
	We consider all liquid available-for-sale debt instruments with original maturities from the date of purchase of approximately three months or less to be cash and cash equivalents. Available-for-sale debt instruments with original maturities at the date of purchase greater than approximately three months and remaining maturities of less than one year are classified as short-term investments. Available-for-sale debt instruments with remaining maturities beyond one year are classified as other long-term investments.
	Investments that we designate as available-for-sale are reported at fair value, with unrealized gains and losses, net of tax, recorded in accumulated other comprehensive income (loss), except as noted in the "Other-Than-Temporary Impairment" section that follows. We determine the cost of the investment sold based on an average cost basis at the individual security level. Our available-for-sale investments include:
	•	Marketable debt instruments when the interest rate and foreign currency risks are not hedged at the inception of the investment or when our criteria for designation as trading assets are not met. We generally hold these debt instruments to generate a return commensurate with the U.S.-dollar three-month LIBOR. We record the interest income and realized gains and losses on the sale of these instruments in interest and other, net.
	•	Marketable equity securities when there is no plan to sell or hedge the investment at the time of original classification. We acquire these equity investments to promote business and strategic objectives. To the extent that these investments continue to have strategic value, we typically do not attempt to reduce or eliminate the equity market risks through hedging activities. We record the realized gains or losses on the sale or exchange of marketable equity securities in gains (losses) on equity investments, net.
	Non-Marketable and Other Equity Investments
	Our non-marketable equity and other equity investments are included in other long-term assets. We account for non-marketable equity and other equity investments for which we do not have control over the investee as:
	•	Equity method investments when we have the ability to exercise significant influence, but not control, over the investee. Equity method investments include marketable and non-marketable investments. Our proportionate share of the income or loss is recognized on a one-quarter lag and is recorded in gains (losses) on equity investments, net.
	•	Non-marketable cost method investments when the equity method does not apply.
	We record the realized gains or losses on the sale of equity method and non-marketable cost method investments in gains (losses) on equity investments, net.
	Other-Than-Temporary Impairment
	Our available-for-sale investments and non-marketable and other equity investments are subject to a periodic impairment review. Investments are considered impaired when the fair value is below the investment’s adjusted cost basis. Impairments affect earnings as follows:
	•	Marketable debt instruments when the fair value is below amortized cost and we intend to sell the instrument, or when it is more likely than not that we will be required to sell the instrument before recovery of its amortized cost basis, or when we do not expect to recover the entire amortized cost basis of the instrument (that is, a credit loss exists). When we do not expect to recover the entire amortized cost basis of the instrument, we separate other-than-temporary impairments into amounts representing credit losses, which are recognized in interest and other, net, and amounts related to all other factors, which are recognized in other comprehensive income (loss).
	•	Marketable equity securities based on the specific facts and circumstances present at the time of assessment, which include the consideration of general market conditions, the duration and extent to which the fair value is below cost, and our ability and intent to hold the investment for a sufficient period of time to allow for recovery of value in the foreseeable future. We also consider specific adverse conditions related to the financial health of, and the business outlook for, the investee, which may include industry and sector performance, changes in technology, operational and financing cash flow factors, and changes in the investee’s credit rating. We record other-than-temporary impairments on marketable equity securities and marketable equity method investments in gains (losses) on equity investments, net.
	•	Non-marketable equity investments based on our assessment of the severity and duration of the impairment, and qualitative and quantitative analysis, including:
	•	the investee’s revenue and earnings trends relative to pre-defined milestones and overall business prospects;
	•	the technological feasibility of the investee’s products and technologies;
	•	the general market conditions in the investee’s industry or geographic area, including adverse regulatory or economic changes;
	•	the management and governance structure of the investee;
	•	factors related to the investee’s ability to remain in business, such as the investee’s liquidity and debt ratios, and the rate at which the investee is using its cash; and
	•	the investee’s receipt of additional funding at a lower valuation.
	We record other-than-temporary impairments for non-marketable cost method investments and equity method investments in gains (losses) on equity investments, net.
	Derivative Financial Instruments
	Our primary objective for holding derivative financial instruments is to manage currency exchange rate risk and interest rate risk, and, to a lesser extent, equity market risk, commodity price risk, and credit risk. When possible, we enter into master netting arrangements with counterparties to mitigate credit risk in derivative transactions. A master netting arrangement may allow counterparties to net settle amounts owed to each other as a result of multiple, separate derivative transactions. Generally, our master netting agreements allow for net settlement in case of certain triggering events such as bankruptcy or default of one of the counterparties to the transaction. We may also elect to exchange cash collateral with certain of our counterparties on a regular basis. For presentation on our consolidated balance sheets, we do not offset fair value amounts recognized for derivative instruments under master netting arrangements. Our derivative financial instruments are recorded at fair value and are included in other current assets, other long-term assets, other accrued liabilities, or other long-term liabilities.
	Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as a cash flow hedge. A designated hedge with exposure to variability in the functional currency equivalent of the future foreign currency cash flows of a forecasted transaction is one example of a cash flow hedge. The criteria for designating a derivative as a cash flow hedge include the assessment of the instrument’s effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction, and the assessment of the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss) and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedged transaction. Derivatives that we designate as cash flow hedges are classified in the consolidated statements of cash flows in the same section as the underlying item, primarily within cash flows from operating activities.
	We recognize gains and losses from changes in fair value of derivatives that are not designated as hedges for accounting purposes in the line item on the consolidated statements of income most closely associated with the related exposures, primarily in interest and other, net and gains (losses) on equity investments, net. As part of our strategic investment program, we also acquire equity derivative instruments, such as equity conversion rights associated with debt instruments, that we do not designate as hedging instruments. We recognize the gains or losses from changes in fair value of these equity derivative instruments in gains (losses) on equity investments, net. Realized gains and losses from derivatives not designated as hedges are classified in the consolidated statements of cash flows within cash flows from operating activities or investing activities, depending on the activity the exposure is most closely associated with.
	Measurement of Effectiveness
	•	Effectiveness for forwards is generally measured by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the fair value of the forecasted cash flows of the hedged item. For currency forward contracts used in cash flow hedging strategies related to capital purchases, forward points are excluded, and effectiveness is measured using spot rates to value both the hedge contract and the hedged item. For currency forward contracts used in cash flow hedging strategies related to operating expenditures, forward points are included, and effectiveness is measured using forward rates to value both the hedge contract and the hedged item.
	•	Effectiveness for options is generally measured by comparing the cumulative change in the intrinsic value of the hedge contract with the cumulative change in the intrinsic value of an option instrument representing the hedged risks in the hedged item. Time value is excluded and effectiveness is measured using spot rates to value both the hedge contract and the hedged item.
	•	Effectiveness for interest rate swaps and commodity swaps is generally measured by comparing the cumulative change in fair value of the swap with the cumulative change in the fair value of the hedged item.
	If a cash flow hedge is discontinued because it is probable that the original hedged transaction will not occur as previously anticipated, the cumulative unrealized gain or loss on the related derivative is reclassified from accumulated other comprehensive income (loss) into earnings. Subsequent gains or losses on the related derivative instrument are recognized in interest and other, net in each period until the instrument matures, is terminated, is re-designated as a qualified cash flow hedge, or is sold. Ineffective portions of cash flow hedges, as well as amounts excluded from the assessment of effectiveness, are recognized in earnings in interest and other, net. For further discussion of our derivative instruments and risk management programs, see "Note 6: Derivative Financial Instruments."
	Securities Lending
	We may enter into securities lending agreements with financial institutions, generally to facilitate hedging and certain investment and financing transactions. Selected securities may be loaned, secured by collateral in the form of cash or securities. The loaned securities continue to be carried as investment assets on our consolidated balance sheets. For lending agreements collateralized by cash and cash equivalents, collateral is recorded as an asset with a corresponding liability. For lending agreements collateralized by other securities, we do not record the collateral as an asset or a liability, unless the collateral is repledged.
	Loans Receivable
	We make loans to third parties that are classified within other current assets or other long-term assets. We may elect the fair value option for loans when the interest rate or foreign currency exchange rate risk is economically hedged at inception with a related derivative instrument. We record the gains or losses on these loans arising from changes in fair value due to interest rate, currency, and counterparty credit changes, largely offset by losses or gains on the related derivative instruments, in interest and other, net. Loans that are denominated in U.S. dollars and have a floating-rate coupon are carried at amortized cost. We measure interest income for all loans receivable using the interest method, which is based on the effective yield of the loans rather than the stated coupon rate. For further discussion of our loans receivable, see "Note 4: Fair Value."
	Inventories
	We compute inventory cost on a first-in, first-out basis. Costs incurred to manufacture our products are included in the valuation of inventory beginning in the quarter in which a product meets the technical criteria to qualify for sale to customers. Prior to qualification for sale, costs that do not meet the criteria for research and development (R&D) are included in cost of sales in the period incurred. Inventories at the end of each period were as follows:
	(In Millions)		Dec 27,			Dec 28,
			2014			2013
	Raw materials		$	462		$	458
	Work in process		2,375			1,998
	Finished goods		1,436			1,716
	Total inventories		$	4,273		$	4,172
Property, Plant and Equipment
Property, plant and equipment, net at the end of each period were as follows:
(In Millions)		Dec 27,			Dec 28,
		2014			2013
Land and buildings		$	22,989		$	21,098
Machinery and equipment		44,441			40,540
Construction in progress		12,279			11,778
Total property, plant and equipment, gross		79,709			73,416
Less: accumulated depreciation		(46,471		)	(41,988		)
Total property, plant and equipment, net		$	33,238		$	31,428
We compute depreciation for financial reporting purposes using the straight-line method. Substantially all of our depreciable property, plant and equipment assets are depreciated over the following estimated useful lives: machinery and equipment, 2 to 4 years; buildings, 10 to 25 years.
We capitalize a majority of interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and amortized over the estimated useful lives of the assets. We record capital-related government grants earned as a reduction to property, plant and equipment.
Goodwill
We record goodwill when the purchase price of an acquisition exceeds the fair value of the net tangible and identified intangible assets acquired. We assign the goodwill to our reporting units based on the relative expected fair value provided by the acquisition. We perform an annual impairment assessment in the fourth quarter of each year, or more frequently if indicators of potential impairment exist, which includes evaluating qualitative and quantitative factors to assess the likelihood of an impairment of a reporting unit’s goodwill. We perform impairment tests using a fair value approach when necessary. The reporting unit’s carrying value used in an impairment test represents the assignment of various assets and liabilities, excluding certain corporate assets and liabilities, such as cash, investments, and debt. For further discussion of goodwill, see "Note 10: Goodwill."
Identified Intangible Assets
Licensed technology and patents are generally amortized on a straight-line basis over the periods of benefit. We amortize all acquisition-related intangible assets that are subject to amortization over their estimated useful life based on economic benefit. Acquisition-related in-process R&D assets represent the fair value of incomplete R&D projects that had not reached technological feasibility as of the date of acquisition; initially, these are classified as "other intangible assets" that are not subject to amortization. Assets related to projects that have been completed are transferred from "other intangible assets" to "acquisition-related developed technology;" these are subject to amortization, while assets related to projects that have been abandoned are impaired and expensed to R&D. In the quarter following the period in which identified intangible assets become fully amortized, we remove the fully amortized balances from the gross asset and accumulated amortization amounts.
The estimated useful life ranges for substantially all identified intangible assets that are subject to amortization as of December 27, 2014 were as follows:
(In Years)		Estimated
		Useful Life
Acquisition-related developed technology		4	–	9
Acquisition-related customer relationships		6	–	9
Acquisition-related trade names		5	–	8
Licensed technology and patents		5	–	17
We perform a quarterly review of finite-lived identified intangible assets to determine whether facts and circumstances indicate that the useful life is shorter than we had originally estimated or that the carrying amount of assets may not be recoverable. If such facts and circumstances exist, we assess recoverability by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets. If an asset’s useful life is shorter than originally estimated, we accelerate the rate of amortization and amortize the remaining carrying value over the new shorter useful life. We perform an annual impairment assessment in the fourth quarter of each year for indefinite-lived intangible assets, or more frequently if indicators of potential impairment exist, to determine whether it is more likely than not that the carrying value of the assets may not be recoverable. If necessary, a quantitative impairment test is performed to compare the fair value of the indefinite-lived intangible asset with its carrying value. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets.
For further discussion of identified intangible assets, see "Note 11: Identified Intangible Assets."
Product Warranty
The vast majority of our products are sold with a limited warranty on product quality and a limited indemnification for customers against intellectual property rights infringement claims related to our products. The accrual and the related expense for known product warranty issues were not significant during the periods presented. Due to product testing, the short time typically between product shipment and the detection and correction of product failures, and the historical rate of payments on indemnification claims, the accrual and related expense for estimated incurred but unidentified issues were not significant during the periods presented.
Revenue Recognition
We recognize net product revenue when the earnings process is complete, as evidenced by an agreement with the customer, delivery has occurred, and acceptance, if applicable, as well as fixed pricing and probable collectibility. We record pricing allowances, including discounts based on contractual arrangements with customers, when we recognize revenue as a reduction to both accounts receivable and net revenue. Because of frequent sales price reductions and rapid technology obsolescence in the industry, we defer product revenue and related costs of sales from component sales made to distributors under agreements allowing price protection or right of return until the distributors sell the merchandise. The right of return granted generally consists of a stock rotation program in which distributors are able to exchange certain products based on the number of qualified purchases made by the distributor. Under the price protection program, we give distributors credits for the difference between the original price paid and the current price that we offer. We include shipping charges billed to customers in net revenue, and include the related shipping costs in cost of sales.
Revenue from license agreements with our McAfee, Inc. (McAfee) business generally includes service and support agreements for which the related revenue is deferred and recognized ratably over the performance period. Revenue derived from online subscription products is deferred and recognized ratably over the performance period. Professional services revenue is recognized as services are performed or, if required, upon customer acceptance. For arrangements with multiple elements, including software licenses, maintenance, and/or services, revenue is allocated across the separately identified deliverables and may be recognized or deferred. When vendor-specific objective evidence does not exist for undelivered elements such as maintenance and support, the entire arrangement fee is recognized ratably over the performance period. Direct costs, such as costs related to revenue-sharing and royalty arrangements associated with license arrangements, as well as component costs associated with product revenue and sales commissions, are deferred and amortized over the same period that the related revenue is recognized.
We record deferred revenue offset by the related cost of sales on our consolidated balance sheets as deferred income.
Advertising
Cooperative advertising programs reimburse customers for marketing activities for certain of our products, subject to defined criteria. We accrue cooperative advertising obligations and record the costs at the same time that the related revenue is recognized. We record cooperative advertising costs as marketing, general and administrative (MG&A) expenses to the extent that an advertising benefit separate from the revenue transaction can be identified and the fair value of that advertising benefit received is determinable. We record any excess in cash paid to customers over the fair value of the advertising benefit we receive as a reduction in revenue. Advertising costs, including direct marketing costs, recorded within MG&A expenses were $1.8 billion in 2014 ($1.9 billion in 2013 and $2.0 billion in 2012).
Employee Equity Incentive Plans
We have employee equity incentive plans, which are described more fully in "Note 18: Employee Equity Incentive Plans." We use the straight-line attribution method to recognize share-based compensation over the service period of the award. Upon exercise, cancellation, forfeiture, or expiration of stock options, or upon vesting or forfeiture of restricted stock units, we eliminate deferred tax assets for options and restricted stock units with multiple vesting dates for each vesting period on a first-in, first-out basis as if each vesting period were a separate award.
Income Taxes
We compute the provision for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. We measure deferred tax assets and liabilities using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We record a valuation allowance to reduce deferred tax assets to the amount that it is believed more likely than not to be realized.
We recognize tax benefits from uncertain tax positions only if that tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. We then measure the tax benefits recognized in the financial statements from such positions based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. We recognize interest and penalties related to unrecognized tax benefits within the provision for taxes on the consolidated statements of income. For more information about income taxes, see "Note 23: Income Taxes."

Recent_Accounting_Standards

Recent Accounting Standards	12 Months Ended
	Dec. 27, 2014
Recent Accounting Standards [Abstract]
Recent Accounting Standards [Text Block]	Note 3: Recent Accounting Standards
	In May 2014, the Financial Accounting Standards Board issued a new standard to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under U.S. generally accepted accounting principles. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The new standard is effective for us beginning in the first quarter of 2017; early adoption is prohibited. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. We have not yet selected a transition method nor have we determined the impact of the new standard on our consolidated financial statements.

Fair_Value

Fair Value	12 Months Ended
	Dec. 27, 2014
Fair Value Disclosures [Abstract]
Fair Value [Text Block]	Note 4: Fair Value
	Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis
	Assets and liabilities measured and recorded at fair value on a recurring basis at the end of each period were as follows:
		27-Dec-14								28-Dec-13
		Fair Value Measured and						Total		Fair Value Measured and						Total
		Recorded at Reporting Date Using								Recorded at Reporting Date Using
	(In Millions)	Level 1		Level 2		Level 3				Level 1		Level 2		Level 3
	Assets
	Cash equivalents:
	Corporate debt	$	—	$	48	$	—	$	48	$	154	$	1,920	$	—	$	2,074
	Financial institution instruments	321		1,119		—		1,440		887		1,190		—		2,077
	Government debt	—		—		—		—		—		269		—		269
	Reverse repurchase agreements	—		268		—		268		—		400		—		400
	Short-term investments:
	Corporate debt	363		412		31		806		274		1,374		19		1,667
	Financial institution instruments	149		1,050		—		1,199		194		2,895		—		3,089
	Government debt	252		173		—		425		183		1,033		—		1,216
	Trading assets:
	Asset-backed securities	—		766		58		824		—		684		4		688
	Corporate debt	2,625		339		—		2,964		2,161		628		—		2,789
	Financial institution instruments	1,146		613		—		1,759		1,188		418		—		1,606
	Government debt	1,295		2,221		—		3,516		1,625		1,733		—		3,358
	Other current assets:
	Derivative assets	—		559		2		561		48		309		—		357
	Loans receivable	—		505		—		505		—		103		—		103
	Marketable equity securities	7,097		—		—		7,097		6,221		—		—		6,221
	Other long-term investments:
	Asset-backed securities	—		2		4		6		—		—		9		9
	Corporate debt	453		728		13		1,194		228		270		27		525
	Financial institution instruments	189		319		—		508		90		402		—		492
	Government debt	75		240		—		315		259		188		—		447
	Other long-term assets:
	Derivative assets	—		35		22		57		—		7		29		36
	Loans receivable	—		216		—		216		—		702		—		702
	Total assets measured and recorded at fair value	13,965		9,613		130		23,708		13,512		14,525		88		28,125
	Liabilities
	Other accrued liabilities:
	Derivative liabilities	—		563		—		563		—		372		—		372
	Other long-term liabilities:
	Derivative liabilities	—		17		—		17		—		50		—		50
	Total liabilities measured and recorded at fair value	$	—	$	580	$	—	$	580	$	—	$	422	$	—	$	422
	Government debt includes instruments such as non-U.S. government securities and U.S. agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms, such as commercial paper, fixed and floating rate bonds, money market fund deposits, and time deposits.
	For the year ended December 27, 2014 we transferred corporate debt, financial institution instruments, and government debt of approximately $177 million from Level 1 to Level 2 of the fair value hierarchy, and approximately $395 million from Level 2 to Level 1. These transfers were primarily based on changes in market activity for the underlying securities. Our policy is to reflect transfers between the fair value hierarchy levels at the beginning of the quarter in which a change in circumstances resulted in the transfer.
	Investments in Debt Instruments
	Debt instruments reflected in the preceding table include investments such as asset-backed securities, corporate debt, financial institution instruments, government debt, and reverse repurchase agreements classified as cash equivalents. We classify our debt instruments as Level 2 when we use observable market prices for identical securities that are traded in less active markets. When observable market prices for identical securities are not available, we price the debt instruments using our own models, such as a discounted cash flow model, or non-binding market consensus prices based on the proprietary valuation models of pricing providers or brokers. We corroborate non-binding market consensus prices with observable market data using statistical models when observable market data exists, quoted market prices for similar instruments, or pricing models such as a discounted cash flow model. These valuation models incorporate a number of inputs, including non-binding and binding broker quotes; observable market prices for identical or similar instruments; and the internal assumptions of pricing providers or brokers that use observable market inputs and unobservable market inputs that we consider to be not significant. The discounted cash flow model uses observable market inputs, such as LIBOR-based yield curves, currency spot and forward rates, and credit ratings. All significant inputs are derived from or corroborated with observable market data.
	The fair values of debt instruments classified as Level 3 are generally derived from discounted cash flow models, performed either by us or our pricing providers, using inputs that we are unable to corroborate with observable market data. We monitor and review the inputs and results of these valuation models to help ensure the fair value measurements are reasonable and consistent with market experience in similar asset classes.
	Fair Value Option for Loans Receivable
	We elected the fair value option for loans receivable when the interest rate or currency exchange rate risk was hedged at inception with a related derivative instrument. As of December 27, 2014 and December 28, 2013, the fair value of our loans receivable for which we elected the fair value option did not significantly differ from the contractual principal balance based on the contractual currency. Loans receivable are classified within other current assets and other long-term assets. Fair value is determined using a discounted cash flow model, with all significant inputs derived from or corroborated with observable market data. Gains and losses from changes in fair value on the loans receivable and related derivative instruments, as well as interest income, are recorded in interest and other, net. During all periods presented, changes in the fair value of our loans receivable were largely offset by changes in the related derivative instruments, resulting in an insignificant net impact on our consolidated statements of income. Gains and losses attributable to changes in credit risk are determined using observable credit default spreads for the issuer or comparable companies; these gains and losses were insignificant during all periods presented. We did not elect the fair value option for loans receivable when the interest rate or currency exchange rate risk was not hedged at inception with a related derivative instrument. Loans receivable not measured and recorded at fair value are included in the following "Financial Instruments Not Recorded at Fair Value on a Recurring Basis" section.
	Assets Measured and Recorded at Fair Value on a Non-Recurring Basis
	Our non-marketable equity investments, marketable equity method investments, and non-financial assets, such as intangible assets and property, plant and equipment, are recorded at fair value only if an impairment is recognized.
	Some of our non-marketable equity investments have been measured and recorded at fair value due to events or circumstances that significantly impacted the fair value of those investments, resulting in other-than-temporary impairments. We classified these investments as Level 3 because the valuations used unobservable inputs that were significant to the fair value measurements and required management judgment due to the absence of quoted market prices. Impairments recognized on non-marketable equity investments held as of December 27, 2014 were $128 million in 2014 ($106 million in 2013 on non-marketable equity investments held as of December 28, 2013 and $68 million in 2012 on non-marketable equity investments held as of December 29, 2012).
	Financial Instruments Not Recorded at Fair Value on a Recurring Basis
	On a quarterly basis, we measure the fair value of our grants receivable, cost method loans receivable, non-marketable cost method investments, reverse repurchase agreements with original maturities greater than approximately three months, and indebtedness carried at amortized cost; however, the assets are recorded at fair value only when an impairment is recognized. The carrying amounts and fair values of financial instruments not recorded at fair value on a recurring basis at the end of each period were as follows:
		December 27, 2014
		Carrying		Fair Value Measured Using						Fair Value
	(In Millions)	Amount		Level 1		Level 2		Level 3
	Grants receivable	$	676	$	—	$	679	$	—	$	679
	Loans receivable	$	250	$	—	$	250	$	—	$	250
	Non-marketable cost method investments	$	1,769	$	—	$	—	$	2,599	$	2,599
	Reverse repurchase agreements	$	450	$	—	$	450	$	—	$	450
	Short-term debt	$	1,588	$	—	$	2,145	$	—	$	2,145
	Long-term debt	$	12,107	$	11,467	$	1,309	$	—	$	12,776
	NVIDIA Corporation cross-license agreement liability	$	395	$	—	$	399	$	—	$	399
		December 28, 2013
	Carrying		Fair Value Measured Using						Fair Value
(In Millions)	Amount		Level 1		Level 2		Level 3
Grants receivable	$	416	$	—	$	481	$	—	$	481
Loans receivable	$	267	$	—	$	250	$	17	$	267
Non-marketable cost method investments	$	1,270	$	—	$	—	$	2,105	$	2,105
Reverse repurchase agreements	$	400	$	—	$	400	$	—	$	400
Short-term debt	$	24	$	—	$	24	$	—	$	24
Long-term debt	$	13,165	$	10,937	$	2,601	$	—	$	13,538
NVIDIA Corporation cross-license agreement liability	$	587	$	—	$	597	$	—	$	597
The fair value of our grants receivable is determined using a discounted cash flow model, which discounts future cash flows using an appropriate yield curve. As of December 27, 2014 and December 28, 2013, the carrying amount of our grants receivable was classified within other current assets and other long-term assets, as applicable.
The carrying amount and fair value of loans receivable exclude loans measured and recorded at a fair value of $721 million as of December 27, 2014 ($805 million as of December 28, 2013). The fair value of our loans receivable and reverse repurchase agreements, including those held at fair value, is determined using a discounted cash flow model. All significant inputs in the models are derived from or corroborated with observable market data, such as LIBOR-based yield curves, currency spot and forward rates, and credit ratings. The credit quality of these assets remains high, with credit ratings of A+/A1 or better for the substantial majority of our loans receivable and the majority of our reverse repurchase agreements as of December 27, 2014.
As of December 27, 2014, and December 28, 2013, the unrealized loss position of our non-marketable cost method investments was insignificant. Our non-marketable cost method investments are valued using a qualitative and quantitative analysis of events or circumstances that impact the fair value of the investment. Qualitative analysis of our investments involves understanding our investee’s revenue and earnings trends relative to pre-defined milestones and overall business prospects; the technological feasibility of our investee’s products and technologies; the general market conditions in the investee’s industry or geographic area, including adverse regulatory or economic changes; and the management and governance structure of the investee. Quantitative assessments of the fair value of our investments are developed using the market and income approaches. The market approach includes the use of financial metrics and ratios of comparable public companies, such as revenue, earnings, comparable performance multiples, recent financing rounds, the terms of the investees’ issued interests, and the level of marketability of the investments. The selection of comparable companies requires management judgment and is based on a number of factors, including comparable companies’ sizes, growth rates, industries, and development stages. The income approach includes the use of a discounted cash flow model, which requires significant estimates regarding investees’ revenue, costs, and discount rates based on the risk profile of comparable companies. Estimates of revenue and costs are developed using available market, historical, and forecast data.
The carrying amount and fair value of short-term debt exclude drafts payable. Our short-term debt recognized at amortized cost includes our 2009 junior subordinated convertible debentures due 2039 (2009 debentures) and our commercial paper outstanding as of December 27, 2014. During the first quarter of 2015, holders may, at their option, surrender the 2009 debentures for conversion. For further information, see "Note 15: Borrowings." Our long-term debt recognized at amortized cost is comprised of our senior notes and our convertible debentures. The fair value of our senior notes is determined using active market prices, and is therefore classified as Level 1. The fair value of our 2009 and 2005 convertible debentures is determined using discounted cash flow models with observable market inputs, and takes into consideration variables such as interest rate changes, comparable instruments, subordination discount, and credit-rating changes, and is therefore classified as Level 2.
The NVIDIA Corporation (NVIDIA) cross-license agreement liability in the preceding table was incurred as a result of entering into a long-term patent cross-license agreement with NVIDIA in January 2011, pursuant to which we agreed to make payments to NVIDIA over six years. As of December 27, 2014 and December 28, 2013, the carrying amount of the liability arising from the agreement was classified within other accrued liabilities and other long-term liabilities, based on the expected timing of the underlying payments ($200 million in each of January 2015 and 2016 treated as cash used for financing activities). The fair value is determined using a discounted cash flow model, which discounts future cash flows using our incremental borrowing rates.

Cash_and_Investments

Cash and Investments	12 Months Ended
	Dec. 27, 2014
Investments and Cash [Abstract]
Cash And Investments [Text Block]	Note 5: Cash and Investments
	Cash and investments at the end of each period were as follows:
	(In Millions)	Dec 27,		Dec 28,
		2014		2013
	Available-for-sale investments	$	13,038	$	18,086
	Cash	805		854
	Equity method investments	1,446		1,038
	Loans receivable	971		1,072
	Non-marketable cost method investments	1,769		1,270
	Reverse repurchase agreements	718		800
	Trading assets	9,063		8,441
	Total cash and investments	$	27,810	$	31,561
	Available-for-Sale Investments
	Available-for-sale investments at the end of each period were as follows:
		December 27, 2014											December 28, 2013
	(In Millions)	Adjusted		Gross			Gross				Fair		Adjusted		Gross		Gross			Fair
		Cost		Unrealized			Unrealized				Value		Cost		Unrealized		Unrealized			Value
				Gains			Losses								Gains		Losses
	Asset-backed securities	$	8	$	—		$	(2	)		$	6	$	11	$	—	$	(2	)	$	9
	Corporate debt	2,040		13			(5		)		2,048		4,254		15		(3		)	4,266
	Financial institution instruments	3,146		2			(1		)		3,147		5,654		5		(1		)	5,658
	Government debt	741		—			(1		)		740		1,932		1		(1		)	1,932
	Marketable equity securities	3,318		3,779			—				7,097		3,340		2,881		—			6,221
	Total available-for-sale investments	$	9,253	$	3,794		$	(9	)		$	13,038	$	15,191	$	2,902	$	(7	)	$	18,086
	Government debt includes instruments such as non-U.S. government securities and U.S. agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms, such as commercial paper, fixed and floating rate bonds, money market fund deposits, and time deposits. Time deposits were primarily issued by institutions outside the U.S. as of December 27, 2014 and December 28, 2013.
	During 2014, we sold available-for-sale investments for proceeds of $1.7 billion, of which $509 million related to sales of cash and cash equivalents ($1.3 billion in 2013, of which $339 million related to sales of cash and cash equivalents; and $3.4 billion in 2012, of which $1.1 billion related to sales of cash and cash equivalents). The gross realized gains on sales of available-for-sale investments were $136 million in 2014 ($146 million in 2013 and $166 million in 2012). We determine the cost of an investment sold on an average cost basis at the individual security level. Impairments recognized on available-for-sale investments were $5 million in 2014 ($14 million in 2013 and $36 million in 2012).
	During 2012, we purchased ASML Holding N.V. (ASML) equity securities totaling $3.2 billion. This equity interest has been accounted for as an available-for-sale investment and is included as marketable equity securities in the preceding table.
	For information on the unrealized holding gains (losses) on available-for-sale investments reclassified out of accumulated other comprehensive income (loss) into the consolidated statements of income, see "Note 24: Other Comprehensive Income (Loss)."
	The amortized cost and fair value of available-for-sale debt investments, by contractual maturity, as of December 27, 2014 were as follows:
	(In Millions)	Cost		Fair Value
	Due in 1 year or less	$	3,490	$	3,500
	Due in 1–2 years	1,003		1,004
	Due in 2–5 years	964		962
	Instruments not due at a single maturity date	478		475
	Total	$	5,935	$	5,941
	Equity Method Investments
	Equity method investments, classified within other long-term assets, at the end of each period were as follows:
		December 27, 2014				December 28, 2013
	(Dollars In Millions)	Carrying		Ownership		Carrying				Ownership
		Value		Percentage		Value				Percentage
	IM Flash Technologies, LLC	$	713	49	%	$	646			49	%
	Cloudera, Inc.	280		17	%	—				—	%
	Intel-GE Care Innovations, LLC	108		50	%	117				50	%
	Other equity method investments	345				275
	Total	$	1,446			$	1,038
	IM Flash Technologies, LLC and IM Flash Singapore, LLP
	Micron Technology, Inc. (Micron) and Intel formed IM Flash Technologies, LLC (IMFT) in 2006 and IM Flash Singapore, LLP (IMFS) in 2007 to manufacture NAND flash memory products for Micron and Intel. During 2012, we amended the operating agreement for IMFT and entered into agreements with Micron that modified our joint venture relationship, including an agreement to sell our ownership interest in IMFS. We received $605 million in 2012 from the sale of assets of IMFS and certain assets of IMFT to Micron.
	The amended operating agreement for IMFT extended the term of IMFT to 2024, unless earlier terminated under certain terms and conditions, and provides that IMFT may manufacture certain emerging memory technologies in addition to NAND flash memory. The amended agreement also provides for certain rights that, beginning in 2015, will enable us to sell to Micron or enable Micron to purchase from us our interest in IMFT. If we exercise this right, Micron would set the closing date of the transaction within two years following such election and could elect to receive financing from us for one to two years. Additionally, our agreements with Micron include a supply agreement for Micron to supply us with NAND flash memory products. These agreements also extend and expand our NAND joint development program with Micron to include emerging memory technologies.
	IMFT is a variable interest entity. All costs of the IMFT joint venture will be passed on to Micron and Intel pursuant to our purchase agreements. Intel's portion of IMFT costs, primarily related to product purchases and production-related services, was approximately $400 million in 2014 (approximately $380 million in 2013 and approximately $705 million in 2012). Subsequent to the sale of our ownership interest in IMFS in the second quarter of 2012, we no longer incur costs related to IMFS. The amount due to IMFT for product purchases and services provided was approximately $60 million as of December 27, 2014 (approximately $75 million as of December 28, 2013). IMFT returned $6 million to Intel in 2014, which is reflected as a return of equity method investment within investing activities on the consolidated statements of cash flows ($45 million in 2013 and $137 million in 2012).
	IMFT depends on Micron and Intel for any additional cash needs. Our known maximum exposure to loss approximated the carrying value of our investment balance in IMFT, which was $713 million as of December 27, 2014. Except for the amount due to IMFT for product purchases and services, we did not have any additional liabilities recognized on our consolidated balance sheets in connection with our interests in this joint venture as of December 27, 2014. Our potential future losses could be higher than the carrying amount of our investment, as Intel and Micron are liable for other future operating costs or obligations of IMFT. Future cash calls could also increase our investment balance and the related exposure to loss. In addition, because we are currently committed to purchasing 49% of IMFT’s production output and production-related services, we may be required to purchase products at a cost in excess of realizable value.
	We have determined that we do not have the characteristics of a consolidating investor in the variable interest entity and, therefore, we account for our interest in IMFT (and accounted for our prior interest in IMFS) using the equity method of accounting.
	Cloudera, Inc.
	During 2014, we invested in Cloudera, Inc. (Cloudera). Our fully-diluted ownership interest in Cloudera is 17% as of December 27, 2014. Our investment is accounted for under the equity and cost methods of accounting based on the rights associated with different securities we own, and is classified within other long-term assets. As of December 27, 2014, the carrying value of our equity method investment was $280 million and of our cost method investment was $454 million.
	Intel-GE Care Innovations, LLC
	During 2011, Intel and General Electric Company (GE) formed Intel-GE Care Innovations, LLC (Care Innovations), an equally owned joint venture in the healthcare industry, that focuses on independent living and delivery of health-related services by means of telecommunications. The company was formed by combining assets of GE Healthcare’s Home Health division and Intel’s Digital Health Group.
	Care Innovations is a variable interest entity and depends on Intel and GE for any additional cash needs. Our known maximum exposure to loss approximated the carrying value of our investment balance in Care Innovations, which was $108 million as of December 27, 2014.
	Intel and GE equally share the power to direct all of Care Innovations' activities that most significantly impact its economic performance. We have determined that we do not have the characteristics of a consolidating investor in the variable interest entity and, therefore, we account for our interest in Care Innovations using the equity method of accounting.
	Clearwire Communications, LLC
	During 2013, we sold our interest in Clearwire Communications, LLC (Clearwire LLC), which we originally acquired in 2008, for proceeds of $328 million. These proceeds are included in other investing within investing activities on the consolidated statements of cash flows. We recognized a gain on the sale of our interest in Clearwire LLC of $328 million.
	For proceeds received and gains recognized for each investment, see "Note 20: Gains (Losses) on Equity Investments, Net."
	Non-marketable cost method investments
	The carrying value of our non-marketable cost method investments was $1.8 billion as of December 27, 2014 ($1.3 billion as of December 28, 2013), of which $454 million related to our cost method investment in Cloudera. In 2014, we recognized impairments of $130 million on non-marketable cost method investments, which is included within gains (losses) on equity investments, net on the consolidated statements of income ($103 million in 2013 and $104 million in 2012).
	Trading Assets
	As of December 27, 2014, and December 28, 2013, all of our trading assets were marketable debt instruments. Net losses related to trading assets still held at the reporting date were $530 million in 2014 (net losses of $70 million in 2013 and net gains of $16 million in 2012). Net gains on the related derivatives were $525 million in 2014 (net gains of $86 million in 2013 and $11 million in 2012).

Derivative_Financial_Instrumen

Derivative Financial Instruments	12 Months Ended
	Dec. 27, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments [Text Block]	Note 6: Derivative Financial Instruments
	Our primary objective for holding derivative financial instruments is to manage currency exchange rate risk and interest rate risk, and, to a lesser extent, equity market risk, commodity price risk, and credit risk.
	Currency Exchange Rate Risk
	We are exposed to currency exchange rate risk, and generally hedge our exposures with currency forward contracts, currency interest rate swaps, or currency options. Substantially all of our revenue is transacted in U.S. dollars. However, a significant amount of our operating expenditures and capital purchases is incurred in or exposed to other currencies, primarily the euro, the Japanese yen, the Chinese yuan, and the Israeli shekel. We have established balance sheet and forecasted transaction currency risk management programs to protect against fluctuations in the fair value and the volatility of the functional currency equivalent of future cash flows caused by changes in exchange rates. Our non-U.S.-dollar-denominated investments in debt instruments and loans receivable are generally hedged with offsetting currency forward contracts or currency interest rate swaps. We may also hedge currency risk arising from funding foreign currency denominated forecasted investments. These programs reduce, but do not eliminate, the impact of currency exchange movements.
	Our currency risk management programs include:
	•	Currency derivatives with cash flow hedge accounting designation that utilize currency forward contracts and currency options to hedge exposures to the variability in the U.S.-dollar equivalent of anticipated non-U.S.-dollar-denominated cash flows. These instruments generally mature within 12 months. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedged transaction.
	•	Currency derivatives without hedge accounting designation that utilize currency forward contracts or currency interest rate swaps to economically hedge the functional currency equivalent cash flows of recognized monetary assets and liabilities, non-U.S.-dollar-denominated debt instruments classified as trading assets, and hedges of non-U.S.-dollar-denominated loans receivable recognized at fair value. The majority of these instruments mature within 12 months. Changes in the functional currency equivalent cash flows of the underlying assets and liabilities are approximately offset by the changes in fair value of the related derivatives. We record net gains or losses in the line item on the consolidated statements of income most closely associated with the related exposures, primarily in interest and other, net, except for equity-related gains or losses, which we primarily record in gains (losses) on equity investments, net.
	Interest Rate Risk
	Our primary objective for holding investments in debt instruments is to preserve principal while maximizing yields. We generally swap the returns on our investments in fixed-rate debt instruments with remaining maturities longer than six months into U.S. dollar three-month LIBOR-based returns, unless management specifically approves otherwise. These swaps are settled at various interest payment times involving cash payments at each interest and principal payment date, with the majority of the contracts having quarterly payments.
	Our interest rate risk management programs include:
	•	Interest rate derivatives with cash flow hedge accounting designation that utilize interest rate swap agreements to modify the interest characteristics of debt instruments. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedged transaction.
	•	Interest rate derivatives without hedge accounting designation that utilize interest rate swaps and currency interest rate swaps in economic hedging transactions, including hedges of non-U.S.-dollar-denominated debt instruments classified as trading assets and hedges of non-U.S.-dollar-denominated loans receivable recognized at fair value. Floating interest rates on the swaps generally reset on a quarterly basis. Changes in the fair value of the debt instruments classified as trading assets and loans receivable recognized at fair value are generally offset by changes in fair value of the related derivatives, both of which are recorded in interest and other, net.
	Equity Market Risk
	Our investments include marketable equity securities and equity derivative instruments. We typically do not attempt to reduce or eliminate our equity market exposure through hedging activities at the inception of our investments. Before we enter into hedge arrangements, we evaluate legal, market, and economic factors, as well as the expected timing of disposal, to determine whether hedging is appropriate. Our equity market risk management program may include equity derivatives with or without hedge accounting designation that utilize warrants, equity options, or other equity derivatives. We recognize changes in the fair value of such derivatives in gains (losses) on equity investments, net.
	We also utilize total return swaps to offset changes in liabilities related to the equity market risks of certain deferred compensation arrangements. Gains and losses from changes in the fair value of these total return swaps are generally offset by the losses and gains on the related liabilities, both of which are recorded in either cost of sales or operating expenses. Deferred compensation liabilities were $1.2 billion as of December 27, 2014 ($1.1 billion as of December 28, 2013), and are included in other accrued liabilities.
	Commodity Price Risk
	We operate facilities that consume commodities and have established forecasted transaction risk management programs to protect against fluctuations in the fair value and the volatility of future cash flows caused by changes in commodity prices, such as those for natural gas. These programs reduce, but do not always eliminate, the impact of commodity price movements.
	Our commodity price risk management program includes commodity derivatives with cash flow hedge accounting designation that utilize commodity swap contracts to hedge future cash flow exposures to the variability in commodity prices. These instruments generally mature within 12 months. For these derivatives, we report the after-tax gain (loss) from the effective portion of the hedge as a component of accumulated other comprehensive income (loss) and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedged transaction.
	Volume of Derivative Activity
	Total gross notional amounts for outstanding derivatives recorded at fair value at the end of each period were as follows:
	(In Millions)		Dec 27,				Dec 28,				Dec 29,
			2014				2013				2012
	Currency forwards		$	15,578			$	13,404			$	13,117
	Currency interest rate swaps		5,446				4,377				2,711
	Embedded debt derivatives		3,600				3,600				3,600
	Interest rate swaps		1,347				1,377				1,101
	Total return swaps		1,056				914				807
	Other		49				67				127
	Total		$	27,076			$	23,739			$	21,463
	The gross notional amounts for currency forwards and currency interest rate swaps, by currency, at the end of each period were as follows:
	(In Millions)		Dec 27,				Dec 28,				Dec 29,
			2014				2013				2012
	British pound sterling		$	410			$	549			$	308
	Chinese yuan		3,097				1,116				647
	Euro		7,486				6,874				5,994
	Indian rupee		418				303				309
	Israeli shekel		2,489				2,244				2,256
	Japanese yen		3,779				4,116				4,389
	Malaysian ringgit		902				506				442
	Swiss franc		1,289				1,189				657
	Other		1,154				884				826
	Total		$	21,024			$	17,781			$	15,828
	During 2014, we entered into a series of agreements with Tsinghua Unigroup Ltd. (Tsinghua Unigroup), an operating subsidiary of Tsinghua Holdings Co. Ltd., to, among other things, jointly develop Intel architecture- and communications-based solutions for smartphones. Subject to regulatory approvals and other closing conditions, we have also agreed to invest up to RMB 9.0 billion (approximately $1.5 billion as of the date of the agreement) for a minority stake of approximately 20% of the holding company under Tsinghua Unigroup. During the fourth quarter of 2014, we entered into $1.5 billion of forward contracts to hedge our anticipated equity funding of the Tsinghua Unigroup investment. The hedges were designated as cash flow hedges and the related gains and losses attributable to changes in the spot rates will be recognized in accumulated other comprehensive income (loss) until the Tsinghua Unigroup shares are either disposed of or impaired. As the shares are either disposed of or impaired, we will reclassify the gains or losses from accumulated other comprehensive income (loss) to gains (losses) on equity investments, net as an offset to the gain or loss recognized for the share disposal or impairment. Hedge gains and losses attributable to changes in the forward rates will be recognized in interest and other, net.
	Fair Value of Derivative Instruments in the Consolidated Balance Sheets
	The fair value of our derivative instruments at the end of each period were as follows:
			December 27, 2014															December 28, 2013
	(In Millions)		Other				Other				Other				Other			Other			Other		Other		Other
			Current				Long-Term				Accrued				Long-Term			Current			Long-Term		Accrued		Long-Term
			Assets				Assets				Liabilities				Liabilities			Assets			Assets		Liabilities		Liabilities
	Derivatives designated as
	hedging instruments:
	Currency forwards		$	6			$	1			$	497			$	9		$	114		$	1	$	118	$	2
	Total derivatives designated as hedging instruments		6				1				497				9			114			1		118		2
	Derivatives not designated
	as hedging instruments:
	Currency forwards		207				—				44				—			66			—		63		—
	Currency interest rate swaps		344				34				7				—			124			6		163		29
	Embedded debt derivatives		—				—				4				8			—			—		—		19
	Interest rate swaps		3				—				11				—			5			—		28		—
	Total return swaps		—				—				—				—			48			—		—		—
	Other		1				22				—				—			—			29		—		—
	Total derivatives not designated as hedging instruments		555				56				66				8			243			35		254		48
	Total derivatives		$	561			$	57			$	563			$	17		$	357		$	36	$	372	$	50
	Amounts Offset in the Consolidated Balance Sheets
The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows:
		27-Dec-14
														Gross Amounts Not Offset in the Balance Sheet
(In Millions)		Gross Amounts Recognized				Gross Amounts Offset in the Balance Sheet				Net Amounts Presented in the Balance Sheet				Financial Instruments			Cash and Non-Cash Collateral Received or Pledged			Net Amount
Assets:
Derivative assets subject to master netting arrangements		$	559			$	—			$	559			$	(365	)	$	(78	)	$	116
Reverse repurchase agreements		718				—				718				—			(718		)	—
Total assets		1,277				—				1,277				(365		)	(796		)	116
Liabilities:
Derivative liabilities subject to master netting arrangements		559				—				559				(365		)	(80		)	114
Total liabilities		$	559			$	—			$	559			$	(365	)	$	(80	)	$	114
		28-Dec-13
														Gross Amounts Not Offset in the Balance Sheet
(In Millions)		Gross Amounts Recognized				Gross Amounts Offset in the Balance Sheet				Net Amounts Presented in the Balance Sheet				Financial Instruments			Cash and Non-Cash Collateral Received or Pledged			Net Amount
Assets:
Derivative assets subject to master netting arrangements		$	325			$	—			$	325			$	(158	)	$	(3	)	$	164
Reverse repurchase agreements		800				—				800				—			(800		)	—
Total assets		1,125				—				1,125				(158		)	(803		)	164
Liabilities:
Derivative liabilities subject to master netting arrangements		401				—				401				(158		)	(32		)	211
Total liabilities		$	401			$	—			$	401			$	(158	)	$	(32	)	$	211
Derivatives in Cash Flow Hedging Relationships
The before-tax gains (losses) attributed to the effective portion of cash flow hedges that were recognized in other comprehensive income (loss) for each period were as follows:
		Gains (Losses)
		Recognized in OCI on
		Derivatives (Effective Portion)
(In Millions)		2014				2013				2012
Currency forwards		$	(587	)		$	(167	)		$	4
Other		(2		)		1				9
Total		$	(589	)		$	(166	)		$	13
Gains and losses on derivative instruments in cash flow hedging relationships related to hedge ineffectiveness and amounts excluded from effectiveness testing were insignificant during all periods presented in the preceding tables. Additionally, for all periods presented, there was an insignificant impact on results of operations from discontinued cash flow hedges, which arises when forecasted transactions are probable of not occurring.
For information on the unrealized holding gains (losses) on derivatives reclassified out of accumulated other comprehensive income into the consolidated statements of income, see "Note 24: Other Comprehensive Income (Loss)."
Derivatives Not Designated as Hedging Instruments
The effects of derivative instruments not designated as hedging instruments on the consolidated statements of income for each period were as follows:
(In Millions)		Location of Gains (Losses)		2014				2013				2012
		Recognized in Income on Derivatives
Currency forwards		Interest and other, net		$	144			$	44			$	3
Currency interest rate swaps		Interest and other, net		456				29				(71		)
Equity options		Gains (losses) on equity investments, net		—				1				(1		)
Interest rate swaps		Interest and other, net		(3		)		—				31
Total return swaps		Various		68				140				77
Other		Gains (losses) on equity investments, net		(6		)		5				(7		)
Other		Interest and other, net		—				—				3
Total				$	659			$	219			$	35

Concentrations_of_Credit_Risk

Concentrations of Credit Risk	12 Months Ended
	Dec. 27, 2014
Risks and Uncertainties [Abstract]
Concentrations of Credit Risk [Text Block]	Note 7: Concentrations of Credit Risk
	Financial instruments that potentially subject us to concentrations of credit risk consist principally of investments in debt instruments, derivative financial instruments, loans receivable, and trade receivables. When possible, we enter into master netting arrangements with counterparties to mitigate credit risk in derivative transactions. A master netting arrangement may allow counterparties to net settle amounts owed to each other as a result of multiple, separate derivative transactions. For presentation on our consolidated balance sheets, we do not offset fair value amounts recognized for derivative instruments under master netting arrangements.
	We generally place investments with high-credit-quality counterparties and, by policy, we limit the amount of credit exposure to any one counterparty based on our analysis of that counterparty’s relative credit standing. Most of our investments in debt instruments are in A/A2 or better rated issuances, and the majority of the issuances are rated AA-/Aa3 or better. Our investment policy requires substantially all investments with original maturities at the time of investment of up to six months to be rated at least A-2/P-2 by Standard & Poor’s/Moody’s, and specifies a higher minimum rating for investments with longer maturities. For instance, investments with maturities of greater than three years generally require a minimum rating of AA-/Aa3 at the time of investment. Government regulations imposed on investment alternatives of our non-U.S. subsidiaries, or the absence of A-rated counterparties in certain countries, result in some minor exceptions. Credit-rating criteria for derivative instruments are similar to those for other investments. Due to master netting arrangements, the amounts subject to credit risk related to derivative instruments are generally limited to the amounts, if any, by which the counterparty’s obligations exceed our obligations with that counterparty. As of December 27, 2014, our total credit exposure to any single counterparty did not exceed $750 million. We obtain and secure available collateral from counterparties against obligations, including securities lending transactions, when we deem it appropriate.
	A substantial majority of our trade receivables are derived from sales to original equipment manufacturers and original design manufacturers. We also have accounts receivable derived from sales to industrial and communications equipment manufacturers in the computing and communications industries. Our three largest customers accounted for 46% of net revenue for 2014 (44% for 2013 and 43% for 2012). These three customers accounted for 43% of net accounts receivable as of December 27, 2014 (34% as of December 28, 2013). We believe that the net accounts receivable balances from these largest customers do not represent a significant credit risk, based on cash flow forecasts, balance sheet analysis, and past collection experience.
	We have adopted credit policies and standards intended to accommodate industry growth and inherent risk. We believe that credit risks are moderated by the financial stability of our major customers. We assess credit risk through quantitative and qualitative analysis. From this analysis, we establish shipping and credit limits, and determine whether we will seek to use one or more credit support devices, such as obtaining a parent guarantee, standby letter of credit, or credit insurance.

Acquisitions

Acquisitions	12 Months Ended
	Dec. 27, 2014
Acquisitions [Abstract]
Acquisitions [Text Block]	Note 8: Acquisitions
	During 2014, we completed eight acquisitions qualifying as business combinations in exchange for aggregate consideration of $963 million, substantially all cash consideration. A substantial majority of the consideration was allocated to goodwill and acquisition related developed technology. Included in these acquisitions is our acquisition of the Axxia Networking Business (Axxia business) of Avago Technologies Limited, intended to accelerate growth in the mobile wireless base station business. We acquired the Axxia business in the fourth quarter of 2014 for net cash consideration of $650 million, substantially all of which was allocated to goodwill and acquisition-related developed technology intangible assets. The operating results of the Axxia business are included in our Data Center Group (DCG) operating segment.
	During 2013, we completed 12 acquisitions qualifying as business combinations in exchange for aggregate net cash consideration of $925 million. Most of the consideration was allocated to goodwill and acquisition-related developed technology intangible assets. Included in these acquisitions is our acquisition of Stonesoft Oyj (Stonesoft) to expand our network security solutions, specifically addressing next-generation firewall products. We acquired Stonesoft in the third quarter of 2013 for net cash consideration of $381 million, substantially all of which was allocated to goodwill and acquisition-related developed technology intangible assets. Stonesoft's operating results are included in our software and services operating segments.
	During 2012, we completed 15 acquisitions qualifying as business combinations in exchange for aggregate net cash consideration of $638 million. Substantially all of the consideration was allocated to goodwill and acquisition-related developed technology intangible assets.
	Acquisitions completed in 2014, 2013, and 2012, both individually and in the aggregate, were not significant to our results of operations. For information on the assignment of goodwill to our operating segments, see "Note 10: Goodwill" and for information on the classification of intangible assets, see "Note 11: Identified Intangible Assets."

Divestitures

Divestitures	12 Months Ended
	Dec. 27, 2014
Divestitures [Abstract]
Divestitures [Text Block]	Note 9: Divestitures
	During the first quarter of 2014, we completed the divestiture of the assets of Intel Media, a business division dedicated to the development of cloud TV products and services, to Verizon Communications Inc. As a result of the transaction, we received aggregate net cash consideration of $150 million, included within investing activities on the consolidated statements of cash flows, and recognized a gain within interest and other, net on the consolidated statements of income.

Goodwill

Goodwill	12 Months Ended
	Dec. 27, 2014
Goodwill [Abstract]
Goodwill [Text Block]	Note 10: Goodwill
	Goodwill activity for each period was as follows:
	(In Millions)	Dec 28,		Acquisitions		Transfers			Currency Exchange and Other			Dec 27,
		2013										2014
	PC Client Group	$	3,058	$	—	$	—		$	—		$	3,058
	Data Center Group	1,831		407		138			—			2,376
	Internet of Things Group	—		—		428			—			428
	Mobile and Communications Group	—		19		631			—			650
	Other Intel architecture operating segments	1,075		—		(1,075		)	—			—
	Software and services operating segments	4,549		41		(140		)	(214		)	4,236
	All other	—		113		18			(18		)	113
	Total	$	10,513	$	580	$	—		$	(232	)	$	10,861
	(In Millions)	Dec 29,		Acquisitions		Transfers			Currency Exchange and Other			Dec 28,
		2012										2013
	PC Client Group	$	2,962	$	62	$	34		$	—		$	3,058
	Data Center Group	1,839		14		(22		)	—			1,831
	Other Intel architecture operating segments	916		171		(12		)	—			1,075
	Software and services operating segments	3,993		504		—			52			4,549
	Total	$	9,710	$	751	$	—		$	52		$	10,513
	During 2014, we formed the Internet of Things Group (IOTG) and we changed our organizational structure to align with our critical objectives, which included the addition of the Mobile and Communications Group (MCG) as a reportable operating segment. Due to this reorganization, goodwill was allocated from our prior reporting units to our new reporting units, as shown in the preceding table within "transfers." The allocation was based on the fair value of each business group within its original reporting unit relative to the fair value of that reporting unit.
	During 2013, we completed a reorganization that transferred a portion of our wired connectivity business formerly included within the Data Center Group (DCG) to the PC Client Group (PCCG). Due to this reorganization, goodwill was transferred from DCG to PCCG. Also during 2013, we completed a reorganization of Intel Mobile Communications (IMC) into our Multi-Comm and existing Phone Group operating segments. Goodwill related to the former IMC was allocated between Multi-Comm and the Phone Group within the "other Intel architecture" operating segments.
	For further information on these reorganizations, see "Note 26: Operating Segments and Geographic Information."
	During the fourth quarters of 2014, 2013, and 2012, we completed our annual impairment assessments and we concluded that goodwill was not impaired in any of these years. The accumulated impairment losses as of December 27, 2014 were $719 million: $352 million associated with PCCG, $275 million associated with DCG, $79 million associated with IOTG, and $13 million associated with MCG.

Identified_Intangible_Assets

Identified Intangible Assets	12 Months Ended
	Dec. 27, 2014
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Identified Intangible Assets [Text Block]	Note 11: Identified Intangible Assets
	Identified intangible assets at the end of each period were as follows:
		27-Dec-14
	(In Millions)	Gross				Accumulated				Net
		Assets				Amortization
	Acquisition-related developed technology	$	3,009			$	(2,192	)		$	817
	Acquisition-related customer relationships	1,698				(1,001		)		697
	Acquisition-related trade names	61				(49		)		12
	Licensed technology and patents	3,153				(1,224		)		1,929
	Identified intangible assets subject to amortization	7,921				(4,466		)		3,455
	Acquisition-related trade names	788				—				788
	Other intangible assets	203				—				203
	Identified intangible assets not subject to amortization	991				—				991
	Total identified intangible assets	$	8,912			$	(4,466	)		$	4,446
		28-Dec-13
	(In Millions)	Gross				Accumulated				Net
		Assets				Amortization
	Acquisition-related developed technology	$	2,922			$	(1,691	)		$	1,231
	Acquisition-related customer relationships	1,760				(828		)		932
	Acquisition-related trade names	65				(44		)		21
	Licensed technology and patents	3,093				(974		)		2,119
	Identified intangible assets subject to amortization	7,840				(3,537		)		4,303
	Acquisition-related trade names	818				—				818
	Other intangible assets	29				—				29
	Identified intangible assets not subject to amortization	847				—				847
	Total identified intangible assets	$	8,687			$	(3,537	)		$	5,150
	As a result of our acquisitions and purchases of licensed technology and patents, identified intangible assets recorded for each period and their respective estimated weighted average useful life were as follows:
		2014						2013
		Gross				Estimated Useful Life		Gross				Estimated Useful Life
		Assets				(In Years)		Assets				(In Years)
		(In Millions)						(In Millions)
	Acquisition-related developed technology	$	175			6		$	114			5
	Acquisition-related customer relationships	$	79			9		$	60			7
	Licensed technology and patents	$	93			8		$	36			10
	During 2014, we also acquired other intangible assets of $197 million that are not subject to amortization.
	Amortization expenses, with presentation location on the consolidated statements of income, for each period were as follows:
	(In Millions)	Location		2014				2013				2012
	Acquisition-related developed technology	Cost of sales		$	600			$	576			$	557
	Acquisition-related customer relationships	Amortization of acquisition-related intangibles		284				279				296
	Acquisition-related trade names	Amortization of acquisition-related intangibles		10				12				12
	Licensed technology and patents	Cost of sales		275				272				214
	Other intangible assets	Reduction of revenue		—				103				86
	Total amortization expenses			$	1,169			$	1,242			$	1,165
	Based on identified intangible assets that are subject to amortization as of December 27, 2014, we expect future amortization expense for each period to be as follows:
	(In Millions)	2015				2016				2017				2018		2019
	Acquisition-related developed technology	$	330			$	240			$	91			$	69	$	60
	Acquisition-related customer relationships	247				229				141				35		15
	Acquisition-related trade names	9				3				—				—		—
	Licensed technology and patents	263				248				210				168		167
	Total future amortization expenses	$	849			$	720			$	442			$	272	$	242

Other_LongTerm_Assets

Other Long-Term Assets	12 Months Ended
	Dec. 27, 2014
Other Assets, Noncurrent Disclosure [Abstract]
Other Long-Term Assets [Text Block]	Note 12: Other Long-Term Assets
	Other long-term assets at the end of each period were as follows:
	(In Millions)	Dec 27,		Dec 28,
		2014		2013
	Equity method investments	$	1,446	$	1,038
	Non-marketable cost method investments	1,769		1,270
	Non-current deferred tax assets	622		434
	Loans receivable	416		952
	Pre-payments for property, plant and equipment	636		521
	Other	1,672		1,274
	Total other long-term assets	$	6,561	$	5,489
	During 2014, we received and transferred $135 million of equipment from other long-term assets to property, plant and equipment. A substantial majority of the equipment was prepaid in 2010 and 2011. We recognized the pre-payments within operating activities in the consolidated statement of cash flows when we paid for the equipment, and the receipt of the equipment is reflected as a non-cash transaction in the current period.

Restructuring_and_Asset_Impair

Restructuring and Asset Impairment Charges	12 Months Ended
	Dec. 27, 2014
Restructuring Costs and Asset Impairment Charges [Abstract]
Restructuring and Asset Impairment Charges [Text Block]	Note 13: Restructuring and Asset Impairment Charges
	Beginning in the third quarter of 2013, management approved several restructuring actions, including targeted workforce reductions and the exit of certain businesses and facilities. These actions include the wind down of our 200 millimeter wafer fabrication facility in Massachusetts, which we expect to cease production in the first quarter of 2015, and the closure of our assembly and test facility in Costa Rica, which ceased production in the fourth quarter of 2014. These targeted reductions will enable the company to better align our resources in areas providing the greatest benefit in the current business environment. We expect these actions to be substantially complete by the end of 2015.
	Restructuring and asset impairment charges for each period were as follows:
	(In Millions)	2014			2013			2012
	Employee severance and benefit arrangements	$	265		$	201		$	—
	Asset impairments and other restructuring charges	30			39			—
	Total restructuring and asset impairment charges	$	295		$	240		$	—
	Restructuring and asset impairment activity for each period was as follows:
	(In Millions)	Employee Severance and Benefits			Asset Impairments and Other			Total
	Accrued restructuring balance as of December 29, 2012	$	—		$	—		$	—
	Additional accruals	195			39			234
	Adjustments	6			—			6
	Cash payments	(18		)	—			(18		)
	Non-cash settlements	—			(39		)	(39		)
	Accrued restructuring balance as of December 28, 2013	183			—			183
	Additional accruals	252			31			283
	Adjustments	13			(1		)	12
	Cash payments	(327		)	(6		)	(333		)
	Non-cash settlements	—			(13		)	(13		)
	Accrued restructuring balance as of December 27, 2014	$	121		$	11		$	132
	We recorded the additional accruals and adjustments as restructuring and asset impairment charges in the consolidated statements of income and within the "all other" operating segments category. A majority of the accrued restructuring balance as of December 27, 2014 is expected to be paid within the next 12 months and was recorded as a current liability within accrued compensation and benefits on the consolidated balance sheets.
	Restructuring actions that were approved in 2014 impacted approximately 3,700 employees. Since the third quarter of 2013, we have incurred a total of $535 million in restructuring and asset impairment charges. These charges included a total of $466 million related to employee severance and benefit arrangements for approximately 7,600 employees, and $69 million in asset impairment charges and other restructuring charges.

Deferred_Income

Deferred Income	12 Months Ended
	Dec. 27, 2014
Deferred Income [Abstract]
Deferred Income [Text Block]	Note 14: Deferred Income
	Deferred income at the end of each period was as follows:
	(In Millions)	Dec 27,		Dec 28,
		2014		2013
	Deferred income on shipments of components to distributors	$	944	$	852
	Deferred income from software and services	1,261		1,244
	Current deferred income	2,205		2,096
	Non-current deferred income from software and services	483		506
	Total deferred income	$	2,688	$	2,602
	We classify non-current deferred income from software and services within other long-term liabilities on the consolidated balance sheets.

Borrowings

Borrowings	12 Months Ended
	Dec. 27, 2014
Debt Disclosure [Abstract]
Borrowings [Text Block]	Note 15: Borrowings
	Short-Term Debt
	Our short-term debt at the end of each period was as follows:
	(In Millions)	Dec 27,				Dec 28,
		2014				2013
	Drafts payable	$	16			$	257
	Notes payable	—				24
	Commercial paper	500				—
	Current portion of long-term debt	1,088				—
	Short-term debt	$	1,604			$	281
	We have an ongoing authorization from our Board of Directors to borrow up to $3.0 billion. This ongoing authorization includes borrowings under our commercial paper program. Maximum borrowings under our commercial paper program in 2014 were $2.4 billion ($300 million in 2013). We had $500 million of outstanding commercial paper as of December 27, 2014 (zero as of December 28, 2013). Our commercial paper was rated A-1+ by Standard & Poor’s and P-1 by Moody’s as of December 27, 2014.
	Long-Term Debt
	Our long-term debt at the end of each period was as follows:
	(In Millions)	Dec 27,				Dec 28,
		2014				2013
	2012 Senior notes due 2017 at 1.35%	$	2,998			$	2,997
	2012 Senior notes due 2022 at 2.70%	1,495				1,494
	2012 Senior notes due 2032 at 4.00%	744				744
	2012 Senior notes due 2042 at 4.25%	924				924
	2011 Senior notes due 2016 at 1.95%	1,499				1,499
	2011 Senior notes due 2021 at 3.30%	1,997				1,996
	2011 Senior notes due 2041 at 4.80%	1,490				1,490
	2009 Junior subordinated convertible debentures due 2039 at 3.25%	1,088				1,075
	2005 Junior subordinated convertible debentures due 2035 at 2.95%	960				946
	Total long-term debt	13,195				13,165
	Less: current portion of long-term debt	(1,088		)		—
	Long-term debt	$	12,107			$	13,165
	Senior Notes
	In the fourth quarter of 2012, we issued $6.2 billion aggregate principal amount of senior unsecured notes for general corporate purposes and to repurchase shares of our common stock pursuant to our authorized common stock repurchase program. In the third quarter of 2011, we issued $5.0 billion aggregate principal amount of senior unsecured notes, primarily to repurchase shares of our common stock pursuant to our authorized common stock repurchase program, and for general corporate purposes.
	Our senior notes pay a fixed rate of interest semiannually. We may redeem our senior notes, in whole or in part, at any time at our option at specified redemption prices. The senior notes rank equally in right of payment with all of our other existing and future senior unsecured indebtedness and will effectively rank junior to all liabilities of our subsidiaries.
	Convertible Debentures
	In 2009, we issued $2.0 billion of 2009 junior subordinated convertible debentures due 2039 (2009 debentures). In 2005, we issued $1.6 billion of 2005 junior subordinated convertible debentures due 2035 (2005 debentures). Both the 2009 and 2005 debentures pay a fixed rate of interest semiannually.
		2009			2005
		Debentures			Debentures
	Annual stated coupon interest rate	3.25	%		2.95	%
	Annual effective interest rate	7.2	%		6.45	%
	The effective interest rate is based on the rate, at inception, for a similar instrument that does not have a conversion feature.
	2009 Debentures
	The 2009 debentures have a contingent interest component that requires us to pay interest based on certain thresholds or for certain events, commencing on August 1, 2019. After such date, if the 10-day average trading price of $1,000 principal amount of the bond immediately preceding any six-month interest period is less than or equal to $650 or greater than or equal to $1,500, we are required to pay contingent 0.25% or 0.50% annual interest, respectively. The fair value of the related contingent interest embedded derivative was $8 million as of December 27, 2014 ($10 million as of December 28, 2013).
	The 2009 debentures are convertible, subject to certain conditions. Holders can surrender the 2009 debentures for conversion if the closing price of Intel common stock has been at least 130% of the conversion price then in effect for at least 20 trading days during the 30 consecutive trading-day period ending on the last trading day of the preceding fiscal quarter. We will settle any conversion of the 2009 debentures in cash up to the face value, and any amount in excess of face value will be settled in cash or stock at our option. On or after August 5, 2019, we can redeem, for cash, all or part of the 2009 debentures for the principal amount, plus any accrued and unpaid interest, if the closing price of Intel common stock has been at least 150% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading-day period. In addition, if certain events occur in the future, the indentures governing the 2009 debentures provide that each holder of the debentures can, for a pre-defined period of time, require us to repurchase the holder’s debentures for the principal amount plus any accrued and unpaid interest. The 2009 debentures are subordinated in right of payment to any existing and future senior debt and to the other liabilities of our subsidiaries. We have concluded that the 2009 debentures are not conventional convertible debt instruments and that the embedded stock conversion options qualify as derivatives. In addition, we have concluded that the embedded conversion options would be classified in stockholders’ equity if they were freestanding derivative instruments. As such, the embedded conversion options are not accounted for separately as derivative liabilities.
	2005 Debentures
	The 2005 debentures have a contingent interest component that requires us to pay interest based on certain thresholds or for certain events. If the 10-day average trading price of $1,000 principal amount of the bond immediately preceding any six-month interest period is less than or equal to $800 or greater than or equal to $1,300, we are required to pay contingent 0.25% or 0.40% annual interest, respectively. As of December 27, 2014, we met the upside contingent interest threshold. For the six-month interest period beginning December 15, 2014, we will accrue and pay contingent interest in the amount of 0.40% per annum of the average trading price for the 10 trading days immediately preceding the first day of the interest period. The fair value of the related contingent interest embedded derivative was $4 million as of December 27, 2014 ($9 million as of December 28, 2013).
	The 2005 debentures are convertible into shares of our common stock. Holders can surrender the 2005 debentures for conversion at any time. We can settle any conversion of the 2005 debentures in cash or stock at our option. The 2005 debentures will become redeemable if the closing price of Intel common stock has been at least 130% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading-day period. Once this condition has been met, we can redeem, for cash, all or part of the 2005 debentures for the principal amount, plus any accrued and unpaid interest. In addition, if certain events occur in the future, the indentures governing the 2005 debentures provide that each holder of the debentures can, for a pre-defined period of time, require us to repurchase the holder’s debentures for the principal amount plus any accrued and unpaid interest. The 2005 debentures are subordinated in right of payment to any existing and future senior debt and to the other liabilities of our subsidiaries. We have concluded that the 2005 debentures are not conventional convertible debt instruments and that the embedded stock conversion options qualify as derivatives. In addition, we have concluded that the embedded conversion options would be classified in stockholders’ equity if they were freestanding derivative instruments. As such, the embedded conversion options are not accounted for separately as derivative liabilities.
		2009 Debentures						2005 Debentures
	(In Millions, Except Per Share Amounts)	Dec 27,				Dec 28,		Dec 27,		Dec 28,
		2014				2013		2014		2013
	Outstanding principal	$	2,000			$	2,000	$	1,600	$	1,600
	Equity component (including temporary equity) carrying	$	613			$	613	$	466	$	466
	amount
	Unamortized discount	$	912			$	925	$	640	$	654
	Net debt carrying amount	$	1,088			$	1,075	$	960	$	946
	Conversion rate (shares of common stock per $1,000 principal amount of debentures)	46.06				45.57		34.95		34.6
	Effective conversion price (per share of common stock)	$	21.71			$	21.94	$	28.61	$	28.9
	In the preceding table, the remaining amortization periods for the unamortized discounts for the 2009 and 2005 debentures are approximately 25 and 21 years, respectively, as of December 27, 2014.
	The conversion rate adjusts for certain events outlined in the indentures governing the 2009 and 2005 debentures, such as quarterly dividend distributions in excess of $0.14 and $0.10 per share for the 2009 and 2005 debentures, respectively, but it does not adjust for accrued interest. In addition, the conversion rate will increase for a holder of either the 2009 or 2005 debentures who elects to convert the debentures in connection with certain share exchanges, mergers, or consolidations involving Intel.
	During the fourth quarter of 2014, the closing stock price conversion right condition of the 2009 debentures was met and the debentures will be convertible at the option of the holders during the first quarter of 2015. As a result of the conversion period during the first quarter of 2015, the $1.1 billion carrying amount of the 2009 debentures was classified as short-term debt on our consolidated balance sheet as of December 27, 2014. The excess of the amount of cash payable if converted over the carrying amount of the 2009 debentures of $912 million has been classified as temporary equity on our consolidated balance sheet as of December 27, 2014. In future periods, if the closing stock price conversion right condition is no longer met, all outstanding 2009 debentures would be reclassified to long-term debt and the temporary equity would be reclassified to stockholders’ equity on our consolidated balance sheet. The 2009 debentures were not convertible for the first quarter of 2014; therefore the liability and equity components of the 2009 debentures were classified as long-term debt and stockholders’ equity, respectively, as of December 28, 2013.
	Debt Maturities
	Our aggregate debt maturities based on outstanding principal as of December 27, 2014, by year payable, were as follows:
	(In Millions)
	2015	$	—
	2016	1,500
	2017	3,000
	2018	—
	2019	—
2020 and thereafter	10,275
Total	$	14,775
In the preceding table, the 2009 debentures are classified based on their stated maturity date, regardless of their classification on the consolidated balance sheet. Substantially all of the difference between the total aggregate debt maturities in the preceding table and the total carrying amount of our debt is due to the unamortized discount of our convertible debentures and the short-term classification of the 2009 debentures.

Retirement_Benefit_Plans

Retirement Benefit Plans	12 Months Ended
	Dec. 27, 2014
Compensation and Retirement Disclosure [Abstract]
Retirement Benefit Plans [Text Block]	Note 16: Retirement Benefit Plans
	Retirement Contribution Plans
	We provide tax-qualified retirement contribution plans for the benefit of eligible employees, former employees, and retirees in the U.S. and certain other countries. The plans are designed to provide employees with an accumulation of funds for retirement on a tax-deferred basis. Employees hired prior to January 1, 2011 are eligible for and receive discretionary employer contributions in the U.S. Intel Retirement Contribution Plan. Employees hired on or after January 1, 2011 receive discretionary employer contributions in the Intel 401(k) Savings Plan, which are participant-directed. Our Chief Executive Officer (CEO) determines the annual discretionary employer contribution amounts for the U.S. Intel Retirement Contribution Plan and the Intel 401(k) Savings Plan under delegation of authority from our Board of Directors, pursuant to the terms of the plans. As of December 27, 2014, 84% of our U.S. Intel Retirement Contribution Plan assets were invested in equities and 16% were invested in fixed-income instruments. These assets are managed by external investment managers. Effective January 1, 2015, the U.S. Intel Retirement Contribution plan assets and future discretionary employer contributions will be participant-directed.
	For the benefit of eligible U.S. employees, we also provide a non-tax-qualified supplemental deferred compensation plan for certain highly compensated employees. This plan is designed to permit certain discretionary employer contributions and to permit employee deferral of a portion of compensation in addition to their Intel 401(k) Savings Plan deferrals. This plan is unfunded.
	We expensed $286 million for the qualified and non-qualified U.S. retirement contribution plans in 2014 ($298 million in 2013 and $357 million in 2012). In the first quarter of 2015, we funded $277 million for the 2014 contributions to the qualified U.S. retirement contribution plans.
	Pension and Postretirement Benefit Plans
	U.S. Pension Benefits. For employees hired prior to January 1, 2011, we provide a tax-qualified defined-benefit pension plan, the U.S. Intel Minimum Pension Plan, for eligible employees, former employees, and retirees in the U.S. During the second quarter of 2014, we communicated to employees our intent, beginning on January 1, 2015, to freeze future benefit accruals in the U.S. Intel Minimum Pension Plan to all employees at or above a specific grade level, and generally covering all highly compensated employees in the plan. Starting in 2016, the impacted employees will receive discretionary employer contributions in the Intel 401(k) Savings Plan, instead of the Retirement Contribution plan. This change was contingent on receiving a favorable private letter ruling (PLR) from the U.S. Internal Revenue Service (IRS), which we filed for in January 2014. A favorable PLR was received in October 2014 and resulted in a $1.1 billion reduction in our projected benefit obligation, most of which was also included as a change in actuarial valuation on the consolidated statements of comprehensive income.
	The U.S. Intel Minimum Pension Plan benefit is determined by a participant’s years of service and final average compensation as defined by the plan document. The plan generates a minimum pension benefit if the participants’ U.S. Intel Minimum Pension Plan benefit exceeds the annuitized value of their U.S. Intel Retirement Contribution Plan benefit. If participant balances in the U.S. Intel Retirement Contribution Plan do not grow sufficiently, the projected benefit obligation of the U.S. Intel Minimum Pension Plan could increase significantly. Consistent with applicable law, assets of the U.S. Intel Minimum Pension Plan are held in trust, solely for the benefit of plan participants, and are not available for general corporate purposes.
	Non-U.S. Pension Benefits. We also provide defined-benefit pension plans in certain other countries, most significantly Germany, Ireland, and Israel. Consistent with the requirements of local law, we deposit funds for certain plans with insurance companies, with third-party trustees, or into government-managed accounts, and/or accrue for the unfunded portion of the obligation. The Ireland pension plan and one of our Germany pension plans were closed to employees hired on or after June 20, 2012 and January 1, 2014, respectively.
	U.S. Postretirement Medical Benefits. Upon retirement, eligible U.S. employees who were hired prior to January 1, 2014 are credited with a defined dollar amount, based on years of service, into a U.S. Sheltered Employee Retirement Medical Account (SERMA). These credits can be used to pay all or a portion of the cost to purchase coverage in the retiree’s choice of medical plan. If the available credits are not sufficient to pay the entire cost of the coverage, the remaining cost is the retiree’s responsibility. Employees hired on or after January 1, 2014 are not eligible to earn a SERMA benefit.
	Funding Policy. Our practice is to fund the various pension plans and the U.S. postretirement medical benefits plan in amounts sufficient to meet the minimum requirements of applicable local laws and regulations. Additional funding may be provided as deemed appropriate. Depending on the design of the plan, local customs, and market circumstances, the liabilities of a plan may exceed qualified plan assets.
	Benefit Obligation and Plan Assets
	The changes in the projected benefit obligations and plan assets for the plans described above were as follows:
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	2014				2013				2014			2013				2014				2013
	Beginning projected benefit obligation	$	1,137			$	1,742			$	1,695		$	1,412			$	509			$	484
	Service cost	88				119				104			78				26				27
	Interest cost	49				67				66			60				23				20
	Actuarial (gain) loss	760				(746		)		767			121				10				(56		)
	Currency exchange rate changes	—				—				(254		)	46				—				—
	Plan curtailments	(1,083		)		—				—			—				—				—
	Other	(59		)		(45		)		45			(22		)		(22		)		34
	Ending projected benefit obligation	$	892			$	1,137			$	2,423		$	1,695			$	546			$	509
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	2014				2013				2014			2013				2014				2013
	Beginning fair value of plan assets	$	649			$	684			$	1,005		$	838			$	395			$	191
	Actual return on plan assets	30				10				80			81				33				49
	Employer contributions	—				—				73			65				—				162
	Currency exchange rate changes	—				—				(114		)	26				—				—
	Other	(56		)		(45		)		(27		)	(5		)		(1		)		(7		)
	Ending fair value of plan assets	$	623			$	649			$	1,017		$	1,005			$	427			$	395
	The amounts recognized on the consolidated balance sheets at the end of each period were as follows:
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	Dec 27,				Dec 28,				Dec 27,			Dec 28,				Dec 27,				Dec 28,
		2014				2013				2014			2013				2014				2013
	Other long-term assets	$	—			$	—			$	14		$	16			$	—			$	—
	Other long-term liabilities	(269		)		(488		)		(1,420		)	(706		)		(119		)		(114		)
	Accumulated other comprehensive loss (income), before tax	1				255				1,217			520				33				43
	Net amount recognized	$	(268	)		$	(233	)		$	(189	)	$	(170	)		$	(86	)		$	(71	)
	The amounts recorded in accumulated other comprehensive income (loss) before taxes at the end of each period were as follows:
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	Dec 27,				Dec 28,				Dec 27,			Dec 28,				Dec 27,				Dec 28,
		2014				2013				2014			2013				2014				2013
	Net prior service credit (cost)	$	—			$	—			$	(13	)	$	25			$	(48	)		$	(54	)
	Net actuarial gain (loss)	(1		)		(255		)		(1,204		)	(545		)		15				11
	Accumulated other comprehensive income (loss), before tax	$	(1	)		$	(255	)		$	(1,217	)	$	(520	)		$	(33	)		$	(43	)
	We use a corridor approach to amortize actuarial gains and losses. Under this approach, net actuarial gains or losses in excess of ten percent of the larger of the projected benefit obligation or the fair value of plan assets are amortized on a straight-line basis. The period of amortization is the average remaining service of active participants who are expected to receive benefits under the plans.
	As of December 27, 2014, the accumulated benefit obligation was $808 million for the U.S. Intel Minimum Pension Plan ($497 million as of December 28, 2013) and $1.7 billion for the non-U.S. defined-benefit pension plans ($1.3 billion as of December 28, 2013). Included in the aggregate data in the following tables are the amounts applicable to our pension plans with accumulated benefit obligations in excess of plan assets, as well as plans with projected benefit obligations in excess of plan assets. Amounts related to such plans at the end of each period were as follows:
		U.S. Pension Benefits								Non-U.S. Pension
										Benefits
	(In Millions)	Dec 27,				Dec 28,				Dec 27,			Dec 28,
		2014				2013				2014			2013
	Plans with accumulated benefit obligations in excess of plan assets:
	Accumulated benefit obligations	$	808			$	—			$	1,344		$	900
	Plan assets	$	623			$	—			$	616		$	563
	Plans with projected benefit obligations in excess of plan assets:
	Projected benefit obligations	$	892			$	1,137			$	2,361		$	1,295
	Plan assets	$	623			$	649			$	941		$	588
	On a worldwide basis, our pension and postretirement benefit plans were 54% funded as of December 27, 2014. The U.S. Intel Minimum Pension Plan, which accounts for 23% of the worldwide pension and postretirement benefit obligations, was 70% funded. Funded status is not indicative of our ability to pay ongoing pension benefits or of our obligation to fund retirement trusts. Required pension funding for U.S. retirement plans is determined in accordance with the Employee Retirement Income Security Act (ERISA), which sets required minimum contributions. Cumulative company funding to the U.S. Intel Minimum Pension Plan currently exceeds the minimum ERISA funding requirements.
	Assumptions
Weighted average actuarial assumptions used to determine benefit obligations for the plans at the end of each period were as follows:
	U.S. Pension Benefits						Non-U.S. Pension					U.S. Postretirement
							Benefits					Medical Benefits
	Dec 27,			Dec 28,			Dec 27,			Dec 28,		Dec 27,			Dec 28,
	2014			2013			2014			2013		2014			2013
Discount rate	3.8	%		4.8	%		2.7	%		4	%	4.1	%		4.6	%
Rate of compensation increase	3.8	%		3.8	%		4	%		3.9	%	n/a			n/a
Weighted average actuarial assumptions used to determine costs for the plans for each period were as follows:
	U.S. Pension Benefits									Non-U.S. Pension Benefits								U.S. Postretirement
																		Medical Benefits
	2014			2013			2012			2014		2013			2012			2014			2013		2012
Discount rate	4.6	%		3.9	%		4.7	%		4	%	4.2	%		5	%		4.6	%		4.2	%	4.6	%
Expected long-term rate of return on plan assets	5.4	%		4.5	%		5	%		5.7	%	5.2	%		5.9	%		7.4	%		7.7	%	3	%
Rate of compensation increase	3.8	%		4.1	%		4.5	%		4.1	%	4.3	%		4.1	%		n/a			n/a		n/a
For the U.S. plans, we developed the discount rate by calculating the benefit payment streams by year to determine when benefit payments will be due. We then matched the benefit payment streams by year to the AA corporate bond rates to match the timing and amount of the expected benefit payments and discounted back to the measurement date to determine the appropriate discount rate. For the non-U.S. plans, we used two approaches to develop the discount rate. In certain countries, we used a model consisting of a theoretical bond portfolio for which the timing and amount of cash flows approximated the estimated benefit payments of our pension plans. In other countries, we analyzed current market long-term bond rates and matched the bond maturity with the average duration of the pension liabilities.
The expected long-term rate of return on plan assets assumptions takes into consideration both duration and risk of the investment portfolios, and is developed through consensus and building-block methodologies. The consensus methodology includes unadjusted estimates by the fund manager on future market expectations by broad asset classes and geography. The building-block approach determines the rates of return implied by historical risk premiums across asset classes. In addition, we analyze rates of return relevant to the country where each plan is in effect and the investments applicable to the plan, expectations of future returns, local actuarial projections, and the projected long-term rates of return from external investment managers. The expected long-term rate of return on plan assets shown for the non-U.S. plan assets is weighted to reflect each country’s relative portion of the non-U.S. plan assets.
Net Periodic Benefit Cost
In 2014, the net periodic benefit cost for U.S. pension benefits, non-U.S. pension benefits, and U.S. postretirement medical benefits was $36 million ($230 million in 2013 and $210 million in 2012), $165 million ($116 million in 2013 and $88 million in 2012) and $17 million ($77 million in 2013 and $50 million in 2012), respectively.
The decrease in the U.S. net periodic pension benefit cost compared to 2013 is primarily attributed to the one-time curtailment gain related to the freeze of future benefit accruals and lower recognized net actuarial losses.
U.S. Pension Plan Assets
In general, the investment strategy for U.S. Intel Minimum Pension Plan assets is to maximize risk-adjusted returns, taking into consideration the investment horizon and expected volatility, to ensure that there are sufficient assets available to pay pension benefits as they come due. The allocation to each asset class will fluctuate with market conditions, such as volatility and liquidity concerns, and will typically be rebalanced when outside the target ranges, which are 55% for equity investments and 45% for fixed-income investments in 2014. The expected long-term rate of return for the U.S. Intel Minimum Pension Plan assets is 6.1%.
U.S. Intel Minimum Pension Plan assets measured at fair value on a recurring basis consisted of the following investment categories at the end of each period:
	27-Dec-14															Dec 28,
																2013
	Fair Value Measured at Reporting Date Using
(In Millions)	Level 1				Level 2				Level 3			Total				Total
Equity securities	$	56			$	291			$	—		$	347			$	220
Fixed income	39				169				46			254				415
Other investments	20				—				—			20				11
Total assets measured at fair value	$	115			$	460			$	46		$	621			$	646
Cash												2				3
Total U.S. pension plan assets at fair value												$	623			$	649
A substantial majority of the fixed income investments in the preceding table are asset-backed securities, corporate debt, and government debt. Government debt includes instruments such as non-U.S. government securities, U.S. agency securities and U.S. treasury securities.
Non-U.S. Plan Assets
The investments of the non-U.S. plans are managed by insurance companies, pension funds, or third-party trustees, consistent with regulations or market practice of the country where the assets are invested. The investment manager makes investment decisions within the guidelines set by Intel or local regulations. The investment manager evaluates performance by comparing the actual rate of return to the return on similar assets. Investments managed by qualified insurance companies or pension funds under standard contracts follow local regulations, and we are not actively involved in their investment strategies. For the assets that we have discretion to set investment guidelines, the assets are invested in developed country equity investments and fixed-income investments, either through index funds or direct investment. In general, the investment strategy is designed to accumulate a diversified portfolio among markets, asset classes, or individual securities to reduce market risk and to ensure that the pension assets are available to pay benefits as they come due. The target allocation of the non-U.S. plan assets that we have control over is 80% equity investments and 20% fixed-income investments. The average expected long-term rate of return for the non-U.S. plan assets is 5.7%.
Non-U.S. plan assets measured at fair value on a recurring basis consisted of the following investment categories at the end of each period:
	27-Dec-14															Dec 28,
																2013
	Fair Value Measured at Reporting Date Using
(In Millions)	Level 1				Level 2				Level 3			Total				Total
Equity securities	$	447			$	59			$	15		$	521			$	361
Fixed income	—				440				36			476				554
Total assets measured at fair value	$	447			$	499			$	51		$	997			$	915
Cash												20				90
Total non-U.S. plan assets at fair value												$	1,017			$	1,005
Substantially all of the equity investments in the preceding table are invested in a diversified mix of equities of developed countries, including the U.S., and emerging markets throughout the world.
The substantial majority of the fixed income investments in the preceding table are investments held by insurance companies and insurance contracts that are managed by qualified insurance companies. We do not have control over the target allocation or visibility of the investment strategies of those investments. Insurance contracts and investments held by insurance companies made up 35% of total non-U.S. plan assets as of December 27, 2014 (38% as of December 28, 2013).
U.S. Postretirement Medical Plan Assets
In general, the investment strategy for U.S. postretirement medical benefits plan assets is to invest primarily in liquid assets due to the level of expected future benefit payments. The assets are invested solely in a tax-aware global equity portfolio, which is actively managed by an external investment manager. The tax-aware global equity portfolio is comprised of a diversified mix of equities in developed countries, including the U.S., and emerging markets throughout the world. The expected long-term rate of return for the U.S. postretirement medical benefits plan assets is 7.4%. As of December 27, 2014, substantially all of the U.S. postretirement medical benefits plan assets were invested in exchange-traded equity securities and were measured at fair value using Level 1 inputs.
Concentrations of Risk
We manage a variety of risks, including credit, liquidity, and market risks, across our plan assets through our investment managers. We define a concentration of risk as an undiversified exposure to one of the aforementioned risks that unnecessarily increases the exposure to a loss of plan assets. We monitor exposure to such risks in both the U.S. and non-U.S. plans by monitoring the magnitude of the risk in each plan and diversifying our exposure to such risks across a variety of counterparties, instruments, and markets. As of December 27, 2014, we did not have concentrations of risk in any single entity, manager, counterparty, sector, industry, or country.
Funding Expectations
Under applicable law for the U.S. Intel Minimum Pension Plan and the U.S. postretirement medical benefits plan, we are not required to make any contributions during 2015. Our expected required funding for the non-U.S. plans during 2015 is approximately $69 million.
Estimated Future Benefit Payments
Estimated benefit payments over the next 10 fiscal years are as follows:
(In Millions)	U.S. Pension				Non-U.S.				U.S.
	Benefits				Pension				Postretirement
					Benefits				Medical
									Benefits
2015	$	55			$	66			$	14
2016	$	54			$	26			$	16
2017	$	58			$	31			$	19
2018	$	64			$	35			$	21
2019	$	64			$	40			$	24
2020-2024	$	327			$	272			$	163

Commitments

Commitments	12 Months Ended
	Dec. 27, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments [Text Block]	Note 17: Commitments
	A portion of our capital equipment and certain facilities are under operating leases that expire at various dates through 2028. Additionally, portions of our real property are under leases that expire at various dates through 2062. Rental expense was $257 million in 2014 ($270 million in 2013 and $214 million in 2012).
	Minimum rental commitments under all non-cancelable leases with an initial term in excess of one year were as follows as of December 27, 2014:
	(In Millions)
	2015	$	205
	2016	179
	2017	152
	2018	118
	2019	101
	2020 and thereafter	315
	Total	$	1,070
	Commitments for construction or purchase of property, plant and equipment totaled $3.5 billion as of December 27, 2014 ($5.5 billion as of December 28, 2013), substantially all of which will be due within the next 12 months. Other purchase obligations and commitments totaled approximately $2.5 billion as of December 27, 2014 (approximately $1.9 billion as of December 28, 2013). Other purchase obligations and commitments include payments due under various types of licenses and agreements to purchase goods or services, as well as payments due under non-contingent funding obligations. Funding obligations include agreements to fund various projects with other companies. In addition, we have various contractual commitments with Micron and IMFT. For further information on these contractual commitments, see "Note 5: Cash and Investments."
	During 2012, we entered into a series of agreements with ASML intended to accelerate the development of extreme ultraviolet lithography projects and deep ultraviolet immersion lithography projects, including generic developments applicable to both 300mm and 450mm. Certain of these agreements were amended in 2014. Under the amended agreements, Intel agreed to provide R&D funding totaling €829 million over five years and committed to advance purchase orders for a specified number of tools from ASML. Our remaining obligation, contingent upon ASML achieving certain milestones, is approximately €562 million, or $689 million, as of December 27, 2014. As our obligation is contingent upon ASML achieving certain milestones, we have excluded this obligation from other purchase obligations and commitments.

Employee_Equity_Incentive_Plan

Employee Equity Incentive Plans	12 Months Ended
	Dec. 27, 2014
Employee Benefits and Share-based Compensation [Abstract]
Employee Equity Incentive Plans [Text Block]	Note 18: Employee Equity Incentive Plans
	Our equity incentive plans are broad-based, long-term programs intended to attract and retain talented employees and align stockholder and employee interests.
	Under the 2006 Equity Incentive Plan (the 2006 Plan), 719 million shares of common stock are available for issuance as equity awards to employees and non-employee directors through June 2016. A maximum of 517 million of these shares of common stock can be granted as restricted stock or restricted stock units. As of December 27, 2014, 258 million shares of common stock remained available for future grant under the 2006 Plan.
	Going forward, we may assume the equity incentive plans and the outstanding equity awards of certain acquired companies. Once they are assumed, we do not grant additional shares of common stock under those plans. The stock options and restricted stock units issued generally retain similar terms and conditions of the respective plan under which they were originally granted.
	We issue restricted stock units with both a market condition and a service condition (market-based restricted stock units), referred to in our 2014 Proxy Statement as outperformance stock units, to a small group of senior officers and non-employee directors. For market-based restricted stock units issued in 2014, the number of shares of our common stock to be received at vesting will range from 0% to 200% of the target amount, based on total stockholder return (TSR) on our common stock measured against the benchmark TSR of a peer group over a three-year period. TSR is a measure of stock price appreciation plus any dividends paid in this performance period. As of December 27, 2014, 4 million market-based restricted stock units were outstanding. These market-based restricted stock units accrue dividend equivalents and generally vest three years and one month from the grant date.
	Equity awards granted to employees in 2014 under our equity incentive plans generally vest over four years from the date of grant, and options expire seven years from the date of grant, with the exception of market-based restricted stock units, an insignificant portion of restricted stock units granted to senior officers, and replacement awards related to acquisitions.
	The 2006 Stock Purchase Plan allows eligible employees to purchase shares of our common stock at 85% of the value of our common stock on specific dates. Under the 2006 Stock Purchase Plan, 373 million shares of common stock are available for issuance through August 2016. As of December 27, 2014, 197 million shares of common stock were available for issuance under the 2006 Stock Purchase Plan.
	Share-Based Compensation
	Share-based compensation recognized in 2014 was $1.1 billion ($1.1 billion in 2013 and $1.1 billion in 2012).
	On a quarterly basis, we assess changes to our estimate of expected equity award forfeitures based on our review of recent forfeiture activity and expected future employee turnover. We recognize the effect of adjustments made to the forfeiture rates, if any, in the period that we change the forfeiture estimate. The effect of forfeiture rate adjustments in all periods presented was not significant.
	The total share-based compensation cost capitalized as part of inventory as of December 27, 2014 was $39 million ($38 million as of December 28, 2013 and $41 million as of December 29, 2012). During 2014, the tax benefit that we realized for the tax deduction from share-based awards totaled $555 million ($385 million in 2013 and $510 million in 2012).
	We estimate the fair value of restricted stock unit awards with time-based vesting using the value of our common stock on the date of grant, reduced by the present value of dividends expected to be paid on our shares of common stock prior to vesting. We estimate the fair value of market-based restricted stock units using a Monte Carlo simulation model on the date of grant. We based the weighted average estimated value of restricted stock unit grants, as well as the weighted average assumptions that we used in calculating the fair value, on estimates at the date of grant, for each period as follows:
			2014				2013				2012
	Estimated values		$	25.4			$	21.45			$	25.32
	Risk-free interest rate		0.5		%		0.2		%		0.3		%
	Dividend yield		3.3		%		3.8		%		3.3		%
	Volatility		23		%		25		%		26		%
	We use the Black-Scholes option pricing model to estimate the fair value of options granted under our equity incentive plans and rights to acquire shares of common stock granted under our stock purchase plan. We based the weighted average estimated value of employee stock option grants and rights granted under the stock purchase plan, as well as the weighted average assumptions used in calculating the fair value, on estimates at the date of grant, for each period as follows:
			Stock Options											Stock Purchase Plan
			2014				2013				2012			2014			2013				2012
	Estimated values		$	3.61			$	3.11			$	4.22		$	5.87		$	4.52			$	5.47
	Expected life (in years)		5.1				5.2				5.3			0.5			0.5				0.5
	Risk-free interest rate		1.7		%		0.8		%		1		%	0.1		%	0.1		%		0.1		%
	Dividend yield		3.6		%		3.9		%		3.3		%	3.2		%	4		%		3.3		%
	Volatility		23		%		25		%		25		%	22		%	22		%		24		%
	We base the expected volatility on implied volatility because we have determined that implied volatility is more reflective of market conditions and a better indicator of expected volatility than historical volatility. We use historical option exercise data as the basis for determining expected life, as we believe that historical data provides a reasonable basis upon which to estimate the expected life input for valuing options using the Black-Scholes model.
	Restricted Stock Unit Awards
	Restricted stock unit activity for each period was as follows:
			Number of			Weighted
			RSUs			Average
			(In Millions)			Grant-Date
						Fair Value
	December 31, 2011		107			$	19.18
	Granted		49.9			$	25.32
	Vested		(43.2	)		$	18.88
	Forfeited		(4.4	)		$	20.93
	29-Dec-12		109.3			$	22.03
	Granted		53.4			$	21.45
	Vested		(44.5	)		$	20.21
	Forfeited		(4.9	)		$	22.06
	28-Dec-13		113.3			$	22.47
	Granted		57.2			$	25.4
	Vested		(42.5	)		$	22.33
	Forfeited		(8.6	)		$	22.94
	27-Dec-14		119.4			$	23.89
	Expected to vest as of December 27, 2014		112.1			$	23.88
	The aggregate fair value of awards that vested in 2014 was $1.1 billion ($1.0 billion in 2013 and $1.2 billion in 2012), which represents the market value of our common stock on the date that the restricted stock units vested. The grant-date fair value of awards that vested in 2014 was $949 million ($899 million in 2013 and $816 million in 2012). The number of restricted stock units vested includes shares of common stock that we withheld on behalf of employees to satisfy the minimum statutory tax withholding requirements. Restricted stock units that are expected to vest are net of estimated future forfeitures.
	As of December 27, 2014, there was $1.8 billion in unrecognized compensation costs related to restricted stock units granted under our equity incentive plans. We expect to recognize those costs over a weighted average period of 1.3 years.
	Stock Option Awards
	As of December 27, 2014, options outstanding that have vested and are expected to vest were as follows:
			Number of			Weighted				Weighted		Aggregate
			Options			Average				Average		Intrinsic
			(In Millions)			Exercise				Remaining		Value
						Price				Contractual		(In Millions)
										Term
										(In Years)
	Vested		54.7			$	20.29			2.3		$	944
	Expected to vest		21.2			$	23.74			4.8		$	293
	Total		75.9			$	21.25			3		$	1,237
	Aggregate intrinsic value represents the difference between the exercise price and $37.55, the closing price of our common stock on December 26, 2014, as reported on The NASDAQ Global Select Market, for all in-the-money options outstanding. Options outstanding that are expected to vest are net of estimated future option forfeitures.
	Options with a fair value of $68 million completed vesting in 2014 ($186 million in 2013 and $205 million in 2012). As of December 27, 2014, there was $34 million in unrecognized compensation costs related to stock options granted under our equity incentive plans. We expect to recognize those costs over a weighted average period of approximately 11 months.
	Stock option activity for each period was as follows:
			Number of			Weighted
			Options			Average
(In Millions)			Exercise
			Price
31-Dec-11		298.3			$	20.12
Granted		13.5			$	27.01
Exercised		(85.8	)		$	20.45
Cancelled and forfeited		(3.9	)		$	21.17
Expired		(19.3	)		$	22.45
29-Dec-12		202.8			$	20.2
Granted		20.1			$	22.99
Exercised		(65.0	)		$	18.76
Cancelled and forfeited		(3.0	)		$	22.58
Expired		(1.9	)		$	22.56
28-Dec-13		153			$	21.1
Granted		0.6			$	25.34
Exercised		(63.7	)		$	19.87
Cancelled and forfeited		(2.7	)		$	23.7
Expired		(9.9	)		$	27
27-Dec-14		77.3			$	21.3
Options exercisable as of:
29-Dec-12		139.8			$	19.76
28-Dec-13		111.5			$	20.25
27-Dec-14		54.7			$	20.29
The aggregate intrinsic value of stock option exercises in 2014 was $611 million ($265 million in 2013 and $517 million in 2012), which represents the difference between the exercise price and the value of our common stock at the time of exercise.
As of December 27, 2014, outstanding options and exercisable options information, by range of exercises prices, was as follows:
									Outstanding Options							Exercisable Options
Range of Exercise Prices									Number of			Weighted	Weighted			Number of			Weighted
									Shares			Average	Average			Shares			Average
									(In Millions)			Remaining	Exercise			(In Millions)			Exercise
												Contractual	Price						Price
												Life
												(In Years)
$	1.82		-	$	15				0.7			3	$	11.6		0.7			$	11.6
$	15.01		-	$	20				32.9			1.8	$	18.27		32.9			$	18.27
$	20.01		-	$	25				34			3.9	$	22.75		17.2			$	22.89
$	25.01		-	$	27.42				9.7			4.3	$	27.11		3.9			$	27.21
Total									77.3			3	$	21.3		54.7			$	20.29
These options will expire if they are not exercised by specific dates through April 2021. Option exercise prices for options exercised during the three-year period ended December 27, 2014 ranged from $1.12 to $28.15.
Stock Purchase Plan
Approximately 76% of our employees were participating in our 2006 Stock Purchase Plan as of December 27, 2014 (76% in 2013 and 72% in 2012). Employees purchased 19.4 million shares of common stock in 2014 for $393 million under the 2006 Stock Purchase Plan (20.5 million shares of common stock for $369 million in 2013 and 17.4 million shares of common stock for $355 million in 2012). As of December 27, 2014 there was $13 million in unrecognized share-based compensation costs related to rights to acquire shares of common stock under our stock purchase plan. We expect to recognize those costs over a period of approximately one and a half months.

Common_Stock_Repurchases

Common Stock Repurchases	12 Months Ended
	Dec. 27, 2014
Common Stock Repurchases [Abstract]
Common Stock Repurchases [Text Block]	Note 19: Common Stock Repurchases
	Common Stock Repurchase Program
	We have an ongoing authorization, originally approved by our Board of Directors in 2005, and subsequently amended, to repurchase up to $65 billion in shares of our common stock in open market or negotiated transactions. This amount includes an increase of $20 billion in the authorization limit approved by our Board of Directors in July 2014. As of December 27, 2014, $12.4 billion remained available for repurchase under the existing repurchase authorization limit.
	During 2014, we repurchased 332.4 million shares of common stock at a cost of $10.8 billion (94.1 million shares of common stock at a cost of $2.1 billion in 2013 and 191.0 million shares of common stock at a cost of $4.8 billion in 2012). We have repurchased 4.7 billion shares of common stock at a cost of $102 billion since the program began in 1990.
	In the fourth quarter of 2014, we entered into a stock repurchase agreement, a portion of which was executed as a forward contract. We received collateral from the counterparty for the value attributable to the forward portion of this contract and invested the collateral into permitted investments considered restricted from other uses. As of December 27, 2014, $325 million of collateral, which approximates fair value, remains recorded as both a current asset and current liability on the consolidated balance sheet. The $325 million represents the unsettled portion of the contract and will be returned to the counterparty by December 29, 2014, the settlement date.
	Restricted Stock Unit Withholdings
	We issue restricted stock units as part of our equity incentive plans. For the majority of restricted stock units granted, the number of shares of common stock issued on the date the restricted stock units vest is net of the minimum statutory withholding requirements that we pay in cash to the appropriate taxing authorities on behalf of our employees. In our consolidated financial statements, we also treat shares of common stock withheld for tax purposes on behalf of our employees in connection with the vesting of restricted stock units as common stock repurchases because they reduce the number of shares that would have been issued upon vesting. These withheld shares are not considered common stock repurchases under our authorized common stock repurchase plan. During 2014, we withheld 12.0 million shares of common stock to satisfy $332 million (13.1 million shares of common stock to satisfy $293 million in 2013 and 12.6 million shares of common stock to satisfy $345 million in 2012) of employees’ tax obligations.

Gains_Losses_on_Equity_Investm

Gains (Losses) on Equity Investments, Net	12 Months Ended
	Dec. 27, 2014
Equity Method Investments and Joint Ventures [Abstract]
Gains (Losses) on Equity Investments, Net [Text Block]	Note 20: Gains (Losses) on Equity Investments, Net
	The components of gains (losses) on equity investments, net for each period were as follows:
	(In Millions)	2014			2013			2012
	Share of equity method investee losses, net	$	(69	)	$	(69	)	$	(81	)
	Impairments	(146		)	(123		)	(154		)
	Gains on sales, net	422			515			183
	Dividends	57			46			—
	Other, net	147			102			193
	Total gains (losses) on equity investments, net	$	411		$	471		$	141
	The majority of gains on sales, net for 2014 resulted from gains on private equity sales.
	During 2013, we sold our shares in Clearwire Corporation, which had been accounted for as available-for-sale marketable equity securities, and our interest in Clearwire LLC, which had been accounted for as an equity method investment. We received proceeds of $142 million on the sale of our shares in Clearwire Corporation and $328 million on the sale of our interest in Clearwire LLC. The proceeds received on the sale of our shares in Clearwire Corporation and our interest in Clearwire LLC are included in "sales of available-for-sale investments" and "other investing," respectively, within investing activities on the consolidated statements of cash flows. During 2013, we recognized gains of $111 million on the sale of our shares in Clearwire Corporation and $328 million on the sale of our interest in Clearwire LLC. The total gain of $439 million on these transactions is included in "gains (losses) on equity investments, net" on the consolidated statements of income.

Interest_and_Other_Net

Interest and Other, Net	12 Months Ended
	Dec. 27, 2014
Interest and Other, Net [Abstract]
Interest and Other, Net [Text Block]	Note 21: Interest and Other, Net
	The components of interest and other, net for each period were as follows:
	(In Millions)	2014			2013			2012
	Interest income	$	141		$	104		$	97
	Interest expense	(192		)	(244		)	(90		)
	Other, net	94			(11		)	87
	Total interest and other, net	$	43		$	(151	)	$	94
	Interest income increased in 2014 primarily resulting from higher interest rates compared to 2013. Interest expense in the preceding table is net of $276 million of interest capitalized in 2014 ($246 million in 2013 and $240 million in 2012).
	During 2014, we completed the divestiture of our Intel Media assets. As a result of the transaction, we recognized a gain within "other, net" in the preceding table. For further information, see "Note 9: Divestitures" in the Notes to the Consolidated Financial Statements of this Form 10-K.

Earnings_Per_Share

Earnings Per Share	12 Months Ended
	Dec. 27, 2014
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	Note 22: Earnings Per Share
	We computed our basic and diluted earnings per share of common stock for each period as follows:
	(In Millions, Except Per Share Amounts)	2014		2013		2012
	Net income available to common stockholders	$	11,704	$	9,620	$	11,005
	Weighted average shares of common stock outstanding—basic	4,901		4,970		4,996
	Dilutive effect of employee equity incentive plans	75		68		100
	Dilutive effect of convertible debt	80		59		64
	Weighted average shares of common stock outstanding—diluted	5,056		5,097		5,160
	Basic earnings per share of common stock	$	2.39	$	1.94	$	2.2
	Diluted earnings per share of common stock	$	2.31	$	1.89	$	2.13
	We computed basic earnings per share of common stock using net income available to common stockholders and the weighted average number of shares of common stock outstanding during the period. We computed diluted earnings per share of common stock using net income available to common stockholders and the weighted average number of shares of common stock outstanding plus potentially dilutive shares of common stock outstanding during the period. Net income available to participating securities was insignificant for all periods presented.
	Potentially dilutive shares of common stock from employee incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options, the assumed vesting of outstanding restricted stock units, and the assumed issuance of common stock under the stock purchase plan. Potentially dilutive shares of common stock for our 2005 debentures are determined by applying the if-converted method. However, as our 2009 debentures require settlement of the principal amount of the debt in cash upon conversion, with the conversion premium paid in cash or stock at our option, potentially dilutive shares of common stock are determined by applying the treasury stock method. For further discussion on the specific conversion features of our 2005 and 2009 debentures, see "Note 15: Borrowings."
	In 2014, we excluded on average 10 million outstanding stock options and restricted stock units from the computation of diluted earnings per share of common stock because these shares of common stock would have been anti-dilutive (55 million in 2013 and 29 million in 2012). These options could potentially be included in the diluted earnings per share of common stock calculation in the future if the average market value of the shares of common stock increases and is greater than the exercise price of these options.
	In all years presented, we included our 2009 debentures in the calculation of diluted earnings per share of common stock because the average market price was above the conversion price. We could potentially exclude the 2009 debentures in the future if the average market price is below the conversion price.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 27, 2014
Income Tax Disclosure [Abstract]
Income Taxes [Text Block]	Note 23: Income Taxes
	Income Tax Provision
	Income before taxes and the provision for taxes consisted of the following:
	(Dollars in Millions)	2014				2013				2012
	Income before taxes:
	U.S.	$	11,565			$	9,374			$	10,042
	Non-U.S.	4,236				3,237				4,831
	Total income before taxes	15,801				12,611				14,873
	Provision for taxes:
	Current:
	Federal	3,374				2,730				2,539
	State	38				68				52
	Non-U.S.	969				716				1,135
	Total current provision for taxes	4,381				3,514				3,726
	Deferred:
	Federal	(263		)		(412		)		129
	Other	(21		)		(111		)		13
	Total deferred provision for taxes	(284		)		(523		)		142
	Total provision for taxes	$	4,097			$	2,991			$	3,868
	Effective tax rate	25.9		%		23.7		%		26		%
	The difference between the tax provision at the statutory federal income tax rate and the tax provision as a percentage of income before income taxes (effective tax rate) for each period was as follows:
		2014			2013			2012
	Statutory federal income tax rate	35	%		35	%		35	%
	Increase (reduction) in rate resulting from:
	Non-U.S. income taxed at different rates	(6.1	)		(5.8	)		(7.3	)
	Research and development tax credits	(1.7	)		(3.5	)		—
	Domestic manufacturing deduction benefit	(2.1	)		(2.1	)		(2.1	)
	Other	0.8			0.1			0.4
	Effective tax rate	25.9	%		23.7	%		26	%
	The U.S. R&D tax credit was reenacted in the last quarter of 2014, retroactive for the full year. It was also reenacted in the first quarter of 2013, retroactive to the beginning of 2012. A substantial majority of the increase in our effective tax rate between 2014 and 2013 was driven by the reenacted U.S. R&D tax credit in 2013 containing two years' worth of R&D tax credits. The full year 2012 impact of the U.S. R&D tax credit was recognized in the first quarter of 2013.
	Income in certain non-U.S. countries is fully exempt from income taxes for a limited period of time due to eligible activities and certain capital investment actions. These full tax exemptions expire at various dates through 2023; however, the exemptions in certain countries are eligible for renewal.
	In 2014, the tax benefit attributable to tax holidays was $166 million ($213 million for 2013 and $252 million for 2012) with a $0.03 impact on diluted earnings per share ($0.04 for 2013 and $0.05 for 2012).
	During 2014, net income tax benefits attributable to equity-based compensation transactions that were allocated to stockholders’ equity totaled $103 million (net benefits of $3 million in 2013 and net benefits of $137 million in 2012).
	Deferred and Current Income Taxes
	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Significant components of our deferred tax assets and liabilities at the end of each period were as follows:
	(In Millions)	Dec 27,				Dec 28,
		2014				2013
	Deferred tax assets:
	Accrued compensation and other benefits	$	982			$	1,047
	Share-based compensation	438				564
	Deferred income	691				672
	Inventory	339				733
	State credits and net operating losses	519				378
	Other, net	715				654
	Gross deferred tax assets	3,684				4,048
	Valuation allowance	(595		)		(456		)
	Total deferred tax assets	3,089				3,592
	Deferred tax liabilities:
	Property, plant and equipment	(1,171		)		(2,023		)
	Licenses and intangibles	(576		)		(687		)
	Convertible debt	(977		)		(911		)
	Unrealized gains on investments and derivatives	(1,017		)		(815		)
	Investment in non-U.S. subsidiaries	(252		)		(244		)
	Other, net	(291		)		(281		)
	Total deferred tax liabilities	(4,284		)		(4,961		)
	Net deferred tax assets (liabilities)	(1,195		)		(1,369		)
	Reported as:
	Current deferred tax assets	1,958				2,594
	Non-current deferred tax assets	622				434
	Non-current deferred tax liabilities	(3,775		)		(4,397		)
	Net deferred tax assets (liabilities)	$	(1,195	)		$	(1,369	)
	Non-current deferred tax assets are included within other long-term assets on the consolidated balance sheets.
	The valuation allowance is based on our assessment that it is more likely than not that certain deferred tax assets will not be realized in the foreseeable future. The valuation allowance as of December 27, 2014 included allowances related to unrealized state credit carryforwards of $507 million and matters related to our non-U.S. subsidiaries of $88 million.
	As of December 27, 2014, our federal, state, and non-U.S. net operating loss carryforwards for income tax purposes were $219 million, $375 million, and $393 million, respectively. Approximately one third of the non-U.S. net operating loss carryforwards have no expiration date. The remaining non-U.S. as well as the U.S. federal and state net operating loss carryforwards expire at various dates through 2034. A significant amount of the net operating loss carryforwards in the U.S. relates to acquisitions and, as a result, is limited in the amount that can be recognized in any one year. The non-U.S. net operating loss carryforwards include $291 million that is not likely to be recovered and has been reduced by a valuation allowance.
As of December 27, 2014, we had not recognized U.S. deferred income taxes on a cumulative total of $23.3 billion of undistributed earnings for certain non-U.S. subsidiaries and $1.6 billion of other basis differences of our investments in certain non-U.S. subsidiaries primarily related to McAfee. Determining the unrecognized deferred tax liability related to investments in these non-U.S. subsidiaries that are indefinitely reinvested is not practicable. We currently intend to indefinitely reinvest those earnings and other basis differences in operations outside the U.S.
Current income taxes payable of $443 million as of December 27, 2014 ($542 million as of December 28, 2013) is included in other accrued liabilities.
Long-term income taxes payable of $262 million as of December 27, 2014 ($188 million as of December 28, 2013) is included in other long-term liabilities, which includes uncertain tax positions, reduced by the associated federal deduction for state taxes and non-U.S. tax credits, and may also include other long-term tax liabilities that are not uncertain but have not yet been paid.
Uncertain Tax Positions
The aggregate changes in the balance of gross unrecognized tax benefits for each period were as follows:
(In Millions)	2014				2013				2012
Beginning gross unrecognized tax benefits	$	207			$	189			$	212
Settlements and effective settlements with tax authorities and related remeasurements	(220		)		(2		)		(81		)
Lapse of statute of limitations	—				—				(5		)
Increases in balances related to tax positions taken during prior periods	173				21				56
Decreases in balances related to tax positions taken during prior periods	(1		)		(9		)		(6		)
Increases in balances related to tax positions taken during current period	418				8				13
Ending gross unrecognized tax benefits	$	577			$	207			$	189
The related tax benefit for settlements, effective settlements, and remeasurements is insignificant for all periods presented.
If the remaining balance of $577 million of unrecognized tax benefits as of December 27, 2014 ($207 million as of December 28, 2013) was recognized in a future period, it would result in a tax benefit of $485 million ($81 million as of December 28, 2013) and a reduction in the effective tax rate.
During all years presented, we recognized interest and penalties related to unrecognized tax benefits within the provision for taxes on the consolidated statements of income. Interest and penalties related to unrecognized tax benefits were $21 million in 2014 (insignificant in 2013 and 2012). As of December 27, 2014, we had $44 million of accrued interest and penalties related to unrecognized tax benefits ($73 million as of December 28, 2013).
Intel's tax policy is to comply with the laws, regulations, filing requirements of all jurisdictions in which Intel conducts business. We regularly engage in discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. Although the timing of the resolutions and/or closures of audits is highly uncertain, it is reasonably possible that certain U.S. federal and non-U.S. tax audits may be concluded within the next 12 months, which could significantly increase or decrease the balance of our gross unrecognized tax benefits. Positions that may be resolved include issues involving asset tax basis, transfer pricing, and various other matters. We estimate that the unrecognized tax benefits as of December 27, 2014 could decrease by approximately $25 million to $465 million in the next 12 months.
We file federal, state, and non-U.S. tax returns. For state and non-U.S. tax returns, we are generally no longer subject to tax examinations for years prior to 2002. For federal tax returns, we are no longer subject to tax examination for years prior to 2009.

Other_Comprehensive_Income_Los

Other Comprehensive Income (Loss)	12 Months Ended
	Dec. 27, 2014
Equity [Abstract]
Other Comprehensive Income (Loss) [Text Block]	Note 24: Other Comprehensive Income (Loss)
	The components of other comprehensive income (loss) and related tax effects for each period were as follows:
		2014									2013									2012
	(In Millions)	Before			Tax			Net of			Before			Tax			Net of			Before			Tax			Net of
		Tax						Tax			Tax						Tax			Tax						Tax
	Change in unrealized holding gains (losses) on available-for-sale investments	$	1,029		$	(359	)	$	670		$	1,963		$	(687	)	$	1,276		$	909		$	(318	)	$	591
	Less: adjustment for (gains) losses on available-for-sale investments included in net income	(142		)	49			(93		)	(146		)	51			(95		)	(187		)	66			(121		)
	Less: adjustment for (gains) losses on deferred tax asset valuation allowance included in net income	—			(41		)	(41		)	—			(26		)	(26		)	—			(11		)	(11		)
	Change in unrealized holding gains (losses) on derivatives	(589		)	160			(429		)	(166		)	76			(90		)	12			8			20
	Less: adjustment for (gains) losses on derivatives included in net income	13			(11		)	2			30			(29		)	1			78			(13		)	65
	Change in net prior service costs	(42		)	5			(37		)	17			(2		)	15			(4		)	1			(3		)
	Less: adjustment for amortization of net prior service costs	6			(2		)	4			4			(1		)	3			5			(2		)	3
	Change in actuarial valuation	(433		)	3			(430		)	725			(275		)	450			(321		)	91			(230		)
	Less: adjustment for amortization of actuarial (gains) losses	37			(9		)	28			101			(31		)	70			90			(32		)	58
	Change in net foreign currency translation adjustment	(275		)	24			(251		)	45			(7		)	38			12			(2		)	10
	Other comprehensive income (loss)	$	(396	)	$	(181	)	$	(577	)	$	2,573		$	(931	)	$	1,642		$	594		$	(212	)	$	382
	In prior periods, we recorded a reversal of a portion of our deferred tax asset valuation allowance attributed to changes in unrealized holding gains on our available-for-sale investments. This amount is reduced and included in our provision for taxes as these investments mature or are sold, and is included in the preceding table as an adjustment for (gains) losses on deferred tax asset valuation allowance included in net income.
	The change in actuarial valuation in 2014 in the preceding table includes $1.4 billion in actuarial losses arising during the year offset by a $1.0 billion reduction in losses due to a freeze of future benefit accruals in the U.S. Intel Minimum Pension Plan. For further information, see "Note 16: Retirement Benefit Plans."
	The changes in accumulated other comprehensive income (loss) by component and related tax effects for each period were as follows:
	(In Millions)	Unrealized Holding Gains (Losses) on Available-for-Sale Investments			Deferred Tax Asset Valuation Allowance			Unrealized Holding Gains (Losses) on Derivatives			Prior Service Credits (Costs)			Actuarial Gains (Losses)			Foreign Currency Translation Adjustment			Total
	29-Dec-12	$	701		$	93		$	93		$	(32	)	$	(1,122	)	$	(132	)	$	(399	)
	Other comprehensive income before reclassifications	1,963			—			(166		)	17			725			45			2,584
	Amounts reclassified out of accumulated other comprehensive income (loss)	(146		)	—			30			4			101			—			(11		)
	Tax effects	(636		)	(26		)	47			(3		)	(306		)	(7		)	(931		)
	Other comprehensive income (loss)	1,181			(26		)	(89		)	18			520			38			1,642
	28-Dec-13	1,882			67			4			(14		)	(602		)	(94		)	1,243
	Other comprehensive income before reclassifications	1,029			—			(589		)	(42		)	(433		)	(275		)	(310		)
	Amounts reclassified out of accumulated other comprehensive income (loss)	(142		)	—			13			6			37			—			(86		)
	Tax effects	(310		)	(41		)	149			3			(6		)	24			(181		)
	Other comprehensive income (loss)	577			(41		)	(427		)	(33		)	(402		)	(251		)	(577		)
	27-Dec-14	$	2,459		$	26		$	(423	)	$	(47	)	$	(1,004	)	$	(345	)	$	666
	The amounts reclassified out of accumulated other comprehensive income (loss) into the consolidated statements of income, with presentation location, for each period were as follows:
		Income Before Taxes Impact (In Millions)
	Comprehensive Income Components	2014			2013			2012			Location
	Unrealized holding gains (losses) on available-for-sale investments:
		$	10		$	8		$	(8	)	Interest and other, net
		132			138			195			Gains (losses) on equity investments, net
		142			146			187
	Unrealized holding gains (losses) on derivatives:
	Currency forwards	(31		)	(61		)	11			Cost of sales
		18			30			(63		)	Research and development
		2			—			(25		)	Marketing, general and administrative
	Other instruments	(2		)	1			(1		)	Cost of sales
		(13		)	(30		)	(78		)
	Amortization of pension and postretirement benefit components:
	Prior service credits (costs)	(6		)	(4		)	(5		)
	Actuarial gains (losses)	(37		)	(101		)	(90		)
		(43		)	(105		)	(95		)
	Total amounts reclassified out of accumulated other comprehensive income (loss)	$	86		$	11		$	14
	The amortization of pension and postretirement benefit components are included in the computation of net periodic benefit cost. For further information, see "Note 16: Retirement Benefit Plans." The estimated net prior service credits (costs) and net actuarial gains (losses) for the defined-benefit plans that will be amortized from accumulated other comprehensive income (loss) into net periodic benefit cost during 2015 are $8 million and $57 million, respectively.
	We estimate that we will reclassify approximately $336 million (before taxes) of net derivative losses included in accumulated other comprehensive income (loss) into earnings within the next 12 months.

Contingencies

Contingencies	12 Months Ended
	Dec. 27, 2014
Contingencies [Abstract]
Contingencies [Text Block]	Note 25: Contingencies
	Legal Proceedings
	We are a party to various legal proceedings, including those noted in this section. Although management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could include substantial monetary damages. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Except as specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time.
	Government Competition Matters and Related Consumer Class Actions
	A number of proceedings generally have challenged and continue to challenge certain of our competitive practices. The allegations in these proceedings vary and are described in more detail in the following paragraphs. In general, they contend that we improperly conditioned price rebates and other discounts on our microprocessors on exclusive or near-exclusive dealing by some of our customers; and they allege that our software compiler business unfairly preferred Intel® microprocessors over competing microprocessors and that, through the use of our compilers and other means, we have caused the dissemination of inaccurate and misleading benchmark results concerning our microprocessors. Based on the procedural posture of the various remaining competition matters, which we describe in the following paragraphs, our investment of resources to explain and defend our position has declined as compared to the period 2005-2011. Nonetheless, certain of the matters remain active, and these challenges could continue for a number of years, potentially requiring us to invest additional resources. We believe that we compete lawfully and that our marketing, business, intellectual property, and other challenged practices benefit our customers and our stockholders, and we will continue to conduct a vigorous defense in the remaining proceedings.
	In 2001, the European Commission (EC) commenced an investigation regarding claims by Advanced Micro Devices, Inc. (AMD) that we used unfair business practices to persuade customers to buy our microprocessors. We received numerous requests for information and documents from the EC and we responded to each of those requests. The EC issued a Statement of Objections in July 2007 and held a hearing on that Statement in March 2008. The EC issued a Supplemental Statement of Objections in July 2008. In May 2009, the EC issued a decision finding that we had violated Article 82 of the EC Treaty and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 (later renumbered as Article 102 by a new treaty) by offering alleged "conditional rebates and payments" that required our customers to purchase all or most of their x86 microprocessors from us. The EC also found that we violated Article 82 by making alleged "payments to prevent sales of specific rival products." The EC imposed a fine in the amount of €1.06 billion ($1.447 billion as of May 2009), which we subsequently paid during the third quarter of 2009, and ordered us to "immediately bring to an end the infringement referred to in" the EC decision.
	The EC decision contained no specific direction on whether or how we should modify our business practices. Instead, the decision stated that we should "cease and desist" from further conduct that, in the EC's opinion, would violate applicable law. We took steps, which are subject to the EC's ongoing review, to comply with that decision pending appeal. We had discussions with the EC to better understand the decision and to explain changes to our business practices.
	We appealed the EC decision to the Court of First Instance (which has been renamed the General Court) in July 2009. The hearing of our appeal took place in July 2012. In June 2014, the General Court rejected our appeal in its entirety. In August 2014, we filed an appeal with the European Court of Justice. On November 11, 2014, Intervener Association for Competitive Technologies filed comments in support of Intel’s grounds of appeal. The EC and interveners filed briefs in November, after which the Court of Justice is likely to allow the parties to file a final round of briefs by February 2015. The Court of Justice is likely to hold oral argument in late 2015 and issue its decision in 2016.
	At least 82 separate class-action lawsuits have been filed in the U.S. District Courts for the Northern District of California, Southern District of California, District of Idaho, District of Nebraska, District of New Mexico, District of Maine, and District of Delaware, as well as in various California, Kansas, and Tennessee state courts. These actions generally repeat the allegations made in a now-settled lawsuit filed against us by AMD in June 2005 in the U.S. District Court for the District of Delaware (AMD litigation). Like the AMD litigation, these class-action lawsuits allege that we engaged in various actions in violation of the Sherman Act and other laws by, among other things: providing discounts and rebates to our manufacturer and distributor customers conditioned on exclusive or near-exclusive dealing that allegedly unfairly interfered with AMD's ability to sell its microprocessors; interfering with certain AMD product launches; and interfering with AMD's participation in certain industry standards-setting groups. The class actions allege various consumer injuries, including that consumers in various states have been injured by paying higher prices for computers containing our microprocessors. We dispute these class-action claims and intend to defend the lawsuits vigorously.
	All of the federal and state class actions other than the California class actions were transferred by the Multidistrict Litigation Panel to the U.S. District Court in Delaware for all pre-trial proceedings and discovery (MDL proceedings). The Delaware district court appointed a Special Master to address issues in the MDL proceedings, as assigned by the court. In January 2010, the plaintiffs in the Delaware action filed a motion for sanctions for our alleged failure to preserve evidence. This motion largely copies a motion previously filed by AMD in the AMD litigation, which has settled. The plaintiffs in the MDL proceedings also moved for certification of a class of members who purchased certain personal computers containing products sold by us. In July 2010, the Special Master issued a Report and Recommendation (Report) denying the motion to certify a class. The MDL plaintiffs filed objections to the Special Master's Report, and a hearing on those objections was held before the district court in July 2013. In July 2014, the district court affirmed the Special Master's ruling and issued an order denying the MDL plaintiffs' motion for class certification. In August 2014, plaintiffs filed a petition for interlocutory appeal of the district court's decision with the U.S. Court of Appeals for the Third Circuit, which the Third Circuit denied on October 29, 2014. On December 29, 2014, Intel filed a motion for summary judgment on the claims of the remaining individual plaintiffs. The court is likely to rule on this motion in late 2015.
	All California class actions have been consolidated in the Superior Court of California in Santa Clara County. The plaintiffs in the California actions moved for class certification, which we are in the process of opposing. At our request, the court in the California actions agreed to delay ruling on this motion until after the Delaware district court ruled on the similar motion in the MDL proceedings. The plaintiffs asked the court for leave to retain a new expert and to amend their previous motion for class certification. The court granted plaintiffs’ request on February 6, 2015 and set the hearing on plaintiffs’ new motion for class certification for May 29, 2015. Given the procedural posture and the nature of these cases, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from these matters.
	In re High Tech Employee Antitrust Litigation
	Between May and July 2011, former employees of Intel, Adobe Systems Incorporated, Apple Inc., Google Inc., Intuit Inc., Lucasfilm Ltd., and Pixar filed antitrust class-action lawsuits in the California Superior Courts alleging that these companies had entered into a conspiracy to suppress the compensation of their employees. The lawsuits were removed to the United States District Court for the Northern District of California and in September 2011 the plaintiffs filed a consolidated amended complaint, captioned In re High Tech Employee Antitrust Litigation. The plaintiffs’ allegations reference the 2009 and 2010 investigation by the Department of Justice (DOJ) into employment practices in the technology industry, as well as the DOJ’s complaints and subsequent stipulated final judgments with the seven companies named as defendants in the lawsuits. The plaintiffs allege that the defendants entered into certain unlawful agreements not to cold call employees of particular other defendants and that there was an overarching conspiracy among the defendants. Plaintiffs assert one such agreement specific to Intel, namely that Intel and Google entered into an agreement starting in 2005, not to cold call each other's employees. Plaintiffs assert claims under Section 1 of the Sherman Antitrust Act and Section 4 of the Clayton Antitrust Act and seek a declaration that the defendants’ alleged actions violated the antitrust laws, damages trebled as provided for by law under the Sherman Act or Clayton Act, restitution and disgorgement, and attorneys’ fees and costs.
	In October 2013, the district court certified a class consisting of approximately 65,000 current or former employees of the seven defendants and set the matter for trial in late May 2014. The so-called "technical class" consists of a group of current and former technical, creative, and R&D employees at each of the defendants. In January 2014, Intel filed a motion for summary judgment, which the court denied in March 2014.
	In April 2014, Intel, Adobe, Apple, and Google reached an agreement with plaintiffs to settle this lawsuit, but in August 2014, the district court denied preliminary approval of the settlement. In September 2014, defendants filed a petition for writ of mandamus asking the U.S. Court of Appeals for the Ninth Circuit to reverse the district court’s decision. The Ninth Circuit ordered briefing and scheduled a March 2015 hearing date on the writ petition. Defendants have withdrawn the petition for writ of mandamus in light of the settlement agreement discussed below.
	In January 2015, Intel, Adobe, Apple, and Google reached a second agreement with plaintiffs to settle this lawsuit, which is subject to court approval. The court has scheduled a hearing on plaintiffs' motion for preliminary approval for March 2015. We continue to dispute the plaintiffs’ claims, but have agreed to settle this lawsuit to avoid the uncertainties, expenses, and diversion of resources from continued litigation. Our operating expenses for 2014 reflect accruals for this proceeding and we believe reasonably possible losses in excess of the accrued amount are not material to our financial statements.
	In re Intel Corporation Shareholder Derivative Litigation
	In March 2014, the Police Retirement System of St. Louis filed a shareholder derivative action in the Superior Court of California in Santa Clara County against the members of our Board of Directors, certain former Board members, and a current officer. The complaint alleges that the defendants breached their duties to the company by participating in, or allowing, alleged antitrust violations, as described in In re High Tech Employee Antitrust Litigation. In March 2014, a second plaintiff, Barbara Templeton, filed a substantially similar derivative suit in the same court. In May 2014, a third shareholder, Robert Achermann, filed a substantially similar derivative action in the same court. The court consolidated the three actions into one, which is captioned In re Intel Corporation Shareholder Derivative Litigation. Plaintiffs filed a consolidated complaint in July 2014. In September 2014, the court granted our motion to dismiss the consolidated complaint, but granted plaintiffs leave to amend. Plaintiffs are expected to file an amended consolidated complaint in February 2015.
	Lehman Brothers Holdings Inc. and Lehman Brothers OTC Derivatives Inc. v. Intel
	In May 2013, Lehman Brothers OTC Derivatives Inc. (LOTC) and Lehman Brothers Holdings Inc. (LBHI) filed an adversary complaint in the United States Bankruptcy Court in the Southern District of New York asserting claims against us arising from a 2008 contract between Intel and LOTC. Under the terms of the 2008 contract, we prepaid $1.0 billion to LOTC, in exchange for which LOTC was required to deliver to us on or before September 29, 2008, quantities of Intel common stock and cash determined by a formula set forth in the contract. LOTC's performance under the contract was secured by $1.0 billion of cash collateral. Under the terms of the contract, LOTC was obligated to deliver approximately 50 million shares of our common stock to us on September 29, 2008. LOTC failed to deliver any Intel common stock or cash, and we exercised our right of setoff against the $1.0 billion collateral. LOTC and LBHI acknowledge in their complaint that we were entitled to set off our losses against the collateral, but they assert that we withheld collateral in excess of our losses that should have been returned to LOTC. The complaint asserts a claim for breach of contract, a claim for "turnover" under section 542(a) of the Bankruptcy Code, and a claim for violation of the automatic stay under section 362(a)(3) of the Bankruptcy Code. The complaint does not expressly quantify the amount of damages claimed, but does assert multiple theories of damages that impliedly seek up to $312 million of alleged excess collateral, plus interest at LIBOR plus 13.5%, compounded daily. In June 2013, we filed a motion to dismiss plaintiffs' bankruptcy claims and for a determination that the breach of contract claim is "non-core" under the Bankruptcy Code. The bankruptcy court granted our motion in its entirety in December 2013. In May 2014, the United States District Court for the Southern District of New York denied our request that it withdraw its reference of plaintiffs' adversary complaint to the bankruptcy court. In January 2015, Intel and the plaintiffs filed competing motions for summary judgment. Plaintiffs' motion requests judgment against Intel "in the amount of no less than" $129 million, plus interest. We believe that $129 million, plus interest, represents the upper end of the range of reasonably possible loss for this case, although we believe that we acted in a manner consistent with our contractual rights and intend to defend against any claim to the contrary.
	McAfee, Inc. Shareholder Litigation
	On August 19, 2010, we announced that we had agreed to acquire all of the common stock of McAfee, Inc. (McAfee) for $48.00 per share. Four McAfee shareholders filed putative class-action lawsuits in Santa Clara County, California Superior Court challenging the proposed transaction. The cases were ordered consolidated in September 2010. Plaintiffs filed an amended complaint that named former McAfee board members, McAfee, and Intel as defendants, and alleged that the McAfee board members breached their fiduciary duties and that McAfee and Intel aided and abetted those breaches of duty. The complaint requested rescission of the merger agreement, such other equitable relief as the court may deem proper, and an award of damages in an unspecified amount. In June 2012, the plaintiffs’ damages expert asserted that the value of a McAfee share for the purposes of assessing damages should be $62.08.
	In January 2012, the court certified the action as a class action, appointed the Central Pension Laborers’ Fund to act as the class representative, and scheduled trial to begin in January 2013. In March 2012, defendants filed a petition with the California Court of Appeal for a writ of mandate to reverse the class certification order; the petition was denied in June 2012. In March 2012, at defendants’ request, the court held that plaintiffs were not entitled to a jury trial, and ordered a bench trial. In April 2012, plaintiffs filed a petition with the California Court of Appeal for a writ of mandate to reverse that order, which the court of appeal denied in July 2012. In August 2012, defendants filed a motion for summary judgment. The trial court granted that motion in November 2012, and entered final judgment in the case in February 2013. In April 2013, plaintiffs appealed the final judgment. Intel, McAfee, and McAfee’s board of directors filed an opposition to plaintiff’s appeal in December 2014. Because the resolution of the appeal may materially impact the scope and nature of the proceeding, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from this matter. We dispute the class-action claims and intend to continue to defend the lawsuit vigorously.
	X2Y Attenuators, LLC v. Intel et al
	In May 2011, X2Y Attenuators, LLC (X2Y) filed a patent infringement lawsuit in the U.S. District Court for the Western District of Pennsylvania and a complaint with the U.S. International Trade Commission (ITC) pursuant to Section 337 of the Tariff Act of 1930 against us and two of our customers, Apple and Hewlett-Packard Company, alleging infringement of five patents. X2Y subsequently added a sixth patent to both actions. The district court action was stayed pending resolution of the ITC proceeding. X2Y alleged that at least Intel® Core™ and Intel® Xeon® processor families infringe the asserted patents. X2Y also requested that the ITC issue permanent exclusion and cease-and-desist orders to, among other things, prohibit us from importing these microprocessors and Apple and Hewlett-Packard Company products that incorporate these microprocessors into the U.S. In the stayed district court action, X2Y seeks unspecified damages, including enhanced damages for alleged willful infringement, and injunctive relief. In June 2012, the Administrative Law Judge issued an initial determination granting X2Y’s motion to partially terminate the ITC investigation with respect to three of the asserted patents. The Administrative Law Judge held a hearing on the remaining three patents in August 2012 and issued an initial determination in December 2012. In the initial determination, the Administrative Law Judge found that Intel, Apple, and Hewlett-Packard Company have not violated Section 337 of the Tariff Act of 1930 because they have not infringed any of the asserted claims of the three patents, and ruled that the asserted claims of two of the patents were invalid. In December 2012, the parties filed petitions for review of the initial determination by the ITC. In February 2013, the ITC determined to review in part the initial determination. On review, the ITC determined to terminate the investigation with a finding of no violation. In April 2013, X2Y filed a notice of appeal with the U.S. Court of Appeals for the Federal Circuit. In July 2014, the Federal Circuit affirmed the ITC's finding that Intel's microprocessors did not infringe the X2Y patents. In September 2014, X2Y filed a petition for en banc review, which was denied by the Federal Circuit. In light of this denial by the Federal Circuit, we have concluded that the risk of loss in connection with this matter, if any, is not material to Intel. We continue to dispute the remaining claims and intend to vigorously defend against them.

Operating_Segments_and_Geograp

Operating Segments and Geographic Information	12 Months Ended
	Dec. 27, 2014
Segment Reporting [Abstract]
Operating Segments and Geographic Information [Text Block]	Note 26: Operating Segments and Geographic Information
	Our operating segments in effect as of December 27, 2014 include:
	•    PC Client Group		•    All other
	•    Data Center Group		•    Non-Volatile Memory Solutions Group
	•    Internet of Things Group		•    Netbook Group
	•    Mobile and Communications Group		•    New Devices Group
	•    Software and services operating segments
	•    McAfee
	•    Software and Services Group
	In the first three months of 2014, we formed the Internet of Things Group, which includes platforms and software optimized for the Internet of Things market segment. Additionally, we changed our organizational structure to align with our critical objectives, which changed information that our Chief Operating Decision Maker (CODM) reviews for purposes of allocating resources and assessing performance. After the reorganization, we have nine operating segments: PC Client Group (PCCG), Data Center Group (DCG), Internet of Things Group (IOTG), Mobile and Communication Group (MCG), McAfee, Software and Services Group, Non-Volatile Memory Solutions Group, Netbook Group, and New Devices Group. All prior-period amounts have been adjusted retrospectively to reflect these operating segment changes, as well as other minor reorganizations.
	The CODM is our CEO. The CODM allocates resources to and assesses the performance of each operating segment using information about its revenue and operating income (loss).
	We manage our business activities primarily based on a product segmentation basis. PCCG, DCG, and MCG are our reportable operating segments. IOTG and the aggregated "software and services operating segments," as shown in the preceding operating segment list, do not meet the quantitative thresholds to qualify as reportable operating segments; however, we have elected to disclose the results of these non-reportable operating segments. Our Non-Volatile Memory Solutions Group, Netbook Group, and New Devices Group operating segments do not meet the quantitative thresholds to qualify as reportable segments and their combined results are included within the "all other" category.
	In November 2014, we announced the implementation of a new operating structure. Our new structure reflects our strategy to address all aspects of the client computing market segment and utilize our intellectual property to offer compelling solutions. The new operating structure ensures that we are able to respond to market demand, while reducing costs through efficiencies and products targeted for the client computing market segment. As a result of the implementation of our new operating structure, all prior-period amounts will be adjusted retrospectively to reflect the new organizational structure expected to become effective in the first quarter of 2015.
	Revenue for our reportable and aggregated non-reportable operating segments is primarily related to the following product lines:
	•	PC Client Group. Includes platforms designed for the notebook (including Ultrabook™ devices), 2 in 1 systems, the desktop (including all-in-ones and high-end enthusiast PCs), and tablets; wireless and wired connectivity products; as well as home gateway and set-top box components.
	•	Data Center Group. Includes server, network, and storage platforms designed for the enterprise, cloud, communications infrastructure, and technical computing segments.
	•	Internet of Things Group. Includes platforms designed for embedded market segments, including retail, transportation, industrial, and buildings and home, along with a broad range of other market segments.
	•	Mobile and Communications Group. Includes platforms designed for the tablet and smartphone market segments; and mobile communications components such as baseband processors, radio frequency transceivers, Wi-Fi, Bluetooth® technology, global navigation satellite systems, and power management chips.
	•	Software and services operating segments. Includes software products for endpoint security, network and content security, risk and compliance, and consumer and mobile security from our McAfee business, and software products and services that promote Intel architecture as the platform of choice for software development.
	We have sales and marketing, manufacturing, engineering, finance, and administration groups. Expenses for these groups are generally allocated to the operating segments, and the expenses are included in the following operating results.
	The "all other" category includes revenue, expenses, and charges such as:
	•	results of operations from our Non-Volatile Memory Solutions Group, Netbook Group, and New Devices Group;
	•	amounts included within restructuring and asset impairment charges;
	•	a portion of profit-dependent compensation and other expenses not allocated to the operating segments;
	•	divested businesses for which discrete operating results are not regularly reviewed by our CODM;
	•	results of operations of start-up businesses that support our initiatives, including our foundry business; and
	•	acquisition-related costs, including amortization and any impairment of acquisition-related intangibles and goodwill.
	The CODM does not evaluate operating segments using discrete asset information. Based on the interchangeable nature of our manufacturing and assembly and test assets, most of the related depreciation expense is not directly identifiable within our operating segments, as it is included in overhead cost pools and subsequently absorbed into inventory as each product passes through our manufacturing process. As our products are then sold across multiple operating segments, it is impracticable to determine the total depreciation expense included as a component of each operating segment’s operating income (loss) results. Operating segments do not record inter-segment revenue. We do not allocate gains and losses from equity investments, interest and other income, or taxes to operating segments. Although the CODM uses operating income to evaluate the segments, operating costs included in one segment may benefit other segments. Except for these differences, the accounting policies for segment reporting are the same as for Intel as a whole.
	Net revenue and operating income (loss) for each period were as follows:
	(In Millions)		2014			2013			2012
	Net revenue:
	PC Client Group		$	34,669		$	33,270		$	34,688
	Data Center Group		14,387			12,161			11,219
	Internet of Things Group		2,142			1,801			1,600
	Mobile and Communications Group		202			1,375			1,791
	Software and services operating segments		2,216			2,190			2,072
	All other		2,254			1,911			1,971
	Total net revenue		55,870			52,708			53,341
	Operating income (loss):
	PC Client Group		14,635			11,751			13,008
	Data Center Group		7,279			5,569			5,231
	Internet of Things Group		616			550			278
	Mobile and Communications Group		(4,206		)	(3,148		)	(1,776		)
	Software and services operating segments		55			24			12
	All other		(3,032		)	(2,455		)	(2,115		)
	Total operating income		$	15,347		$	12,291		$	14,638
	In 2014, Hewlett-Packard Company accounted for 18% of our net revenue (17% in 2013 and 18% in 2012), Dell Inc. accounted for 16% of our net revenue (15% in 2013 and 14% in 2012), and Lenovo Group Limited accounted for 12% of our net revenue (12% in 2013 and 11% in 2012). The majority of the revenue from these customers was from the sale of platforms and other components by the PCCG and DCG operating segments.
	A substantial majority of our revenue in the PCCG and DCG operating segments is generated from the sale of platforms.
	Net revenue by country for the three years ended December 27, 2014 is based on the billing location of the customer. Revenue from unaffiliated customers for each period was as follows:
	(In Millions)		2014			2013			2012
	Singapore		$	11,573		$	10,997		$	12,622
	China (including Hong Kong)		11,197			9,890			8,299
	United States		9,828			9,091			8,348
	Taiwan		8,955			8,888			9,327
	Japan		2,776			3,725			4,303
	Other countries		11,541			10,117			10,442
	Total net revenue		$	55,870		$	52,708		$	53,341
	Revenue from unaffiliated customers outside the U.S. totaled $46.0 billion in 2014 ($43.6 billion in 2013 and $45.0 billion in 2012).
	Net property, plant and equipment by country at the end of each period was as follows:
	(In Millions)		Dec 27,			Dec 28,			Dec 29,
			2014			2013			2012
	United States		$	24,020		$	23,624		$	20,542
	Ireland		5,433			2,986			1,523
	Israel		1,957			2,667			3,389
Other countries		1,828			2,151			2,529
Total property, plant and equipment, net		$	33,238		$	31,428		$	27,983
Net property, plant and equipment outside the U.S. totaled $9.2 billion as of December 27, 2014 ($7.8 billion as of December 28, 2013 and $7.4 billion as of December 29, 2012).

Valuation_and_Qualifying_Accou

Valuation and Qualifying Accounts	12 Months Ended
	Dec. 27, 2014
Valuation and Qualifying Accounts [Abstract]
SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS [Text Block]	INTEL CORPORATION
	SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
	Three Years Ended December 27, 2014	Balance at Beginning of Year		Additions Charged to Expenses/		Net			Balance at
	(In Millions)			Other Accounts		(Deductions)			End of Year
						Recoveries
	Allowance for doubtful receivables
	2014	$	38	$	10	$	(10	)	$	38
	2013	$	38	$	5	$	(5	)	$	38
	2012	$	36	$	3	$	(1	)	$	38
	Valuation allowance for deferred tax assets
	2014	$	456	$	128	$	11		$	595
	2013	$	389	$	88	$	(21	)	$	456
	2012	$	373	$	77	$	(61	)	$	389
	Deductions in allowance for doubtful receivables represent uncollectible accounts written off, net of recoveries.

Accounting_Policies_Policies

Accounting Policies (Policies)	12 Months Ended
	Dec. 27, 2014
Accounting Policies [Abstract]
Use of Estimates [Policy Text Block]	Use of Estimates
	The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and judgments that affect the amounts reported in our consolidated financial statements and the accompanying notes. The accounting estimates that require our most significant, difficult, and subjective judgments include:
	•	the valuation of non-marketable equity investments and the determination of other-than-temporary impairments;
	•	the assessment of recoverability of long-lived assets (property, plant and equipment; goodwill; and identified intangibles);
	•	the recognition and measurement of current and deferred income taxes (including the measurement of uncertain tax positions);
	•	the valuation of inventory; and
	•	the recognition and measurement of loss contingencies.
	The actual results that we experience may differ materially from our estimates.
Fair Value [Policy Text Block]	Fair Value
	Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, we consider the principal or most advantageous market in which we would transact, and we consider assumptions that market participants would use when pricing the asset or liability. Our financial assets are measured and recorded at fair value, except for cost method investments, cost method loans receivable, equity method investments, grants receivable, and reverse repurchase agreements with original maturities greater than approximately three months. Substantially all of our liabilities are not measured and recorded at fair value.
	Fair Value Hierarchy
	The three levels of inputs that may be used to measure fair value are as follows:
	Level 1. Quoted prices in active markets for identical assets or liabilities.
	Level 2. Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in less active markets, or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities. Level 2 inputs also include non-binding market consensus prices that can be corroborated with observable market data, as well as quoted prices that were adjusted for security-specific restrictions.
	Level 3. Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. Level 3 inputs also include non-binding market consensus prices or non-binding broker quotes that we were unable to corroborate with observable market data.
	For further discussion of fair value, see "Note 4: Fair Value" and "Note 16: Retirement Benefit Plans."
Cash Equivalents [Policy Text Block]	Cash Equivalents
	We consider all highly liquid debt investments with original maturities from the date of purchase of approximately three months or less as cash equivalents. Cash equivalents can include investments such as corporate debt, financial institution instruments, government debt, and reverse repurchase agreements classified as cash equivalents. See "Note 4: Fair Value" for the instruments held as cash equivalents.
Trading Assets [Policy Text Block]	Trading Assets
	Marketable debt instruments are generally designated as trading assets when a market risk is economically hedged at inception with a related derivative instrument, or when the marketable debt instrument itself is used to economically hedge foreign exchange rate risk from remeasurement. Investments designated as trading assets are reported at fair value. The gains or losses of these investments arising from changes in fair value due to interest rate and currency market fluctuations and credit market volatility, largely offset by losses or gains on the related derivative instruments and balance sheet remeasurement, are recorded in interest and other, net. We also designate certain floating-rate securitized financial instruments, primarily asset-backed securities, as trading assets.
Available-for-Sale Investments [Policy Text Block]	Available-for-Sale Investments
	We consider all liquid available-for-sale debt instruments with original maturities from the date of purchase of approximately three months or less to be cash and cash equivalents. Available-for-sale debt instruments with original maturities at the date of purchase greater than approximately three months and remaining maturities of less than one year are classified as short-term investments. Available-for-sale debt instruments with remaining maturities beyond one year are classified as other long-term investments.
	Investments that we designate as available-for-sale are reported at fair value, with unrealized gains and losses, net of tax, recorded in accumulated other comprehensive income (loss), except as noted in the "Other-Than-Temporary Impairment" section that follows. We determine the cost of the investment sold based on an average cost basis at the individual security level. Our available-for-sale investments include:
	•	Marketable debt instruments when the interest rate and foreign currency risks are not hedged at the inception of the investment or when our criteria for designation as trading assets are not met. We generally hold these debt instruments to generate a return commensurate with the U.S.-dollar three-month LIBOR. We record the interest income and realized gains and losses on the sale of these instruments in interest and other, net.
	•	Marketable equity securities when there is no plan to sell or hedge the investment at the time of original classification. We acquire these equity investments to promote business and strategic objectives. To the extent that these investments continue to have strategic value, we typically do not attempt to reduce or eliminate the equity market risks through hedging activities. We record the realized gains or losses on the sale or exchange of marketable equity securities in gains (losses) on equity investments, net.
Non-Marketable and Other Equity Investments [Policy Text Block]	Non-Marketable and Other Equity Investments
	Our non-marketable equity and other equity investments are included in other long-term assets. We account for non-marketable equity and other equity investments for which we do not have control over the investee as:
	•	Equity method investments when we have the ability to exercise significant influence, but not control, over the investee. Equity method investments include marketable and non-marketable investments. Our proportionate share of the income or loss is recognized on a one-quarter lag and is recorded in gains (losses) on equity investments, net.
	•	Non-marketable cost method investments when the equity method does not apply.
	We record the realized gains or losses on the sale of equity method and non-marketable cost method investments in gains (losses) on equity investments, net.
Other-Than-Temporary Impairment [Policy Text Block]	Other-Than-Temporary Impairment
	Our available-for-sale investments and non-marketable and other equity investments are subject to a periodic impairment review. Investments are considered impaired when the fair value is below the investment’s adjusted cost basis. Impairments affect earnings as follows:
	•	Marketable debt instruments when the fair value is below amortized cost and we intend to sell the instrument, or when it is more likely than not that we will be required to sell the instrument before recovery of its amortized cost basis, or when we do not expect to recover the entire amortized cost basis of the instrument (that is, a credit loss exists). When we do not expect to recover the entire amortized cost basis of the instrument, we separate other-than-temporary impairments into amounts representing credit losses, which are recognized in interest and other, net, and amounts related to all other factors, which are recognized in other comprehensive income (loss).
	•	Marketable equity securities based on the specific facts and circumstances present at the time of assessment, which include the consideration of general market conditions, the duration and extent to which the fair value is below cost, and our ability and intent to hold the investment for a sufficient period of time to allow for recovery of value in the foreseeable future. We also consider specific adverse conditions related to the financial health of, and the business outlook for, the investee, which may include industry and sector performance, changes in technology, operational and financing cash flow factors, and changes in the investee’s credit rating. We record other-than-temporary impairments on marketable equity securities and marketable equity method investments in gains (losses) on equity investments, net.
	•	Non-marketable equity investments based on our assessment of the severity and duration of the impairment, and qualitative and quantitative analysis, including:
	•	the investee’s revenue and earnings trends relative to pre-defined milestones and overall business prospects;
	•	the technological feasibility of the investee’s products and technologies;
	•	the general market conditions in the investee’s industry or geographic area, including adverse regulatory or economic changes;
	•	the management and governance structure of the investee;
	•	factors related to the investee’s ability to remain in business, such as the investee’s liquidity and debt ratios, and the rate at which the investee is using its cash; and
	•	the investee’s receipt of additional funding at a lower valuation.
	We record other-than-temporary impairments for non-marketable cost method investments and equity method investments in gains (losses) on equity investments, net.
Derivative Financial Instruments [Policy Text Block]	Derivative Financial Instruments
	Our primary objective for holding derivative financial instruments is to manage currency exchange rate risk and interest rate risk, and, to a lesser extent, equity market risk, commodity price risk, and credit risk. When possible, we enter into master netting arrangements with counterparties to mitigate credit risk in derivative transactions. A master netting arrangement may allow counterparties to net settle amounts owed to each other as a result of multiple, separate derivative transactions. Generally, our master netting agreements allow for net settlement in case of certain triggering events such as bankruptcy or default of one of the counterparties to the transaction. We may also elect to exchange cash collateral with certain of our counterparties on a regular basis. For presentation on our consolidated balance sheets, we do not offset fair value amounts recognized for derivative instruments under master netting arrangements. Our derivative financial instruments are recorded at fair value and are included in other current assets, other long-term assets, other accrued liabilities, or other long-term liabilities.
	Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as a cash flow hedge. A designated hedge with exposure to variability in the functional currency equivalent of the future foreign currency cash flows of a forecasted transaction is one example of a cash flow hedge. The criteria for designating a derivative as a cash flow hedge include the assessment of the instrument’s effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction, and the assessment of the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss) and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedged transaction. Derivatives that we designate as cash flow hedges are classified in the consolidated statements of cash flows in the same section as the underlying item, primarily within cash flows from operating activities.
	We recognize gains and losses from changes in fair value of derivatives that are not designated as hedges for accounting purposes in the line item on the consolidated statements of income most closely associated with the related exposures, primarily in interest and other, net and gains (losses) on equity investments, net. As part of our strategic investment program, we also acquire equity derivative instruments, such as equity conversion rights associated with debt instruments, that we do not designate as hedging instruments. We recognize the gains or losses from changes in fair value of these equity derivative instruments in gains (losses) on equity investments, net. Realized gains and losses from derivatives not designated as hedges are classified in the consolidated statements of cash flows within cash flows from operating activities or investing activities, depending on the activity the exposure is most closely associated with.
	Measurement of Effectiveness
	•	Effectiveness for forwards is generally measured by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the fair value of the forecasted cash flows of the hedged item. For currency forward contracts used in cash flow hedging strategies related to capital purchases, forward points are excluded, and effectiveness is measured using spot rates to value both the hedge contract and the hedged item. For currency forward contracts used in cash flow hedging strategies related to operating expenditures, forward points are included, and effectiveness is measured using forward rates to value both the hedge contract and the hedged item.
	•	Effectiveness for options is generally measured by comparing the cumulative change in the intrinsic value of the hedge contract with the cumulative change in the intrinsic value of an option instrument representing the hedged risks in the hedged item. Time value is excluded and effectiveness is measured using spot rates to value both the hedge contract and the hedged item.
	•	Effectiveness for interest rate swaps and commodity swaps is generally measured by comparing the cumulative change in fair value of the swap with the cumulative change in the fair value of the hedged item.
	If a cash flow hedge is discontinued because it is probable that the original hedged transaction will not occur as previously anticipated, the cumulative unrealized gain or loss on the related derivative is reclassified from accumulated other comprehensive income (loss) into earnings. Subsequent gains or losses on the related derivative instrument are recognized in interest and other, net in each period until the instrument matures, is terminated, is re-designated as a qualified cash flow hedge, or is sold. Ineffective portions of cash flow hedges, as well as amounts excluded from the assessment of effectiveness, are recognized in earnings in interest and other, net. For further discussion of our derivative instruments and risk management programs, see "Note 6: Derivative Financial Instruments."
Securities Lending [Policy Text Block]	Securities Lending
	We may enter into securities lending agreements with financial institutions, generally to facilitate hedging and certain investment and financing transactions. Selected securities may be loaned, secured by collateral in the form of cash or securities. The loaned securities continue to be carried as investment assets on our consolidated balance sheets. For lending agreements collateralized by cash and cash equivalents, collateral is recorded as an asset with a corresponding liability. For lending agreements collateralized by other securities, we do not record the collateral as an asset or a liability, unless the collateral is repledged.
Loans Receivable [Policy Text Block]	Loans Receivable
	We make loans to third parties that are classified within other current assets or other long-term assets. We may elect the fair value option for loans when the interest rate or foreign currency exchange rate risk is economically hedged at inception with a related derivative instrument. We record the gains or losses on these loans arising from changes in fair value due to interest rate, currency, and counterparty credit changes, largely offset by losses or gains on the related derivative instruments, in interest and other, net. Loans that are denominated in U.S. dollars and have a floating-rate coupon are carried at amortized cost. We measure interest income for all loans receivable using the interest method, which is based on the effective yield of the loans rather than the stated coupon rate. For further discussion of our loans receivable, see "Note 4: Fair Value."
Inventories [Policy Text Block]	Inventories
	We compute inventory cost on a first-in, first-out basis. Costs incurred to manufacture our products are included in the valuation of inventory beginning in the quarter in which a product meets the technical criteria to qualify for sale to customers. Prior to qualification for sale, costs that do not meet the criteria for research and development (R&D) are included in cost of sales in the period incurred. Inventories at the end of each period were as follows:
	(In Millions)		Dec 27,			Dec 28,
			2014			2013
	Raw materials		$	462		$	458
	Work in process		2,375			1,998
	Finished goods		1,436			1,716
	Total inventories		$	4,273		$	4,172
Property, Plant and Equipment [Policy Text Block]	Property, Plant and Equipment
	Property, plant and equipment, net at the end of each period were as follows:
	(In Millions)		Dec 27,			Dec 28,
			2014			2013
	Land and buildings		$	22,989		$	21,098
	Machinery and equipment		44,441			40,540
	Construction in progress		12,279			11,778
	Total property, plant and equipment, gross		79,709			73,416
	Less: accumulated depreciation		(46,471		)	(41,988		)
	Total property, plant and equipment, net		$	33,238		$	31,428
	We compute depreciation for financial reporting purposes using the straight-line method. Substantially all of our depreciable property, plant and equipment assets are depreciated over the following estimated useful lives: machinery and equipment, 2 to 4 years; buildings, 10 to 25 years.
	We capitalize a majority of interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and amortized over the estimated useful lives of the assets. We record capital-related government grants earned as a reduction to property, plant and equipment.
Goodwill [Policy Text Block]	Goodwill
	We record goodwill when the purchase price of an acquisition exceeds the fair value of the net tangible and identified intangible assets acquired. We assign the goodwill to our reporting units based on the relative expected fair value provided by the acquisition. We perform an annual impairment assessment in the fourth quarter of each year, or more frequently if indicators of potential impairment exist, which includes evaluating qualitative and quantitative factors to assess the likelihood of an impairment of a reporting unit’s goodwill. We perform impairment tests using a fair value approach when necessary. The reporting unit’s carrying value used in an impairment test represents the assignment of various assets and liabilities, excluding certain corporate assets and liabilities, such as cash, investments, and debt. For further discussion of goodwill, see "Note 10: Goodwill."
Identified Intangible Assets [Policy Text Block]	Identified Intangible Assets
	Licensed technology and patents are generally amortized on a straight-line basis over the periods of benefit. We amortize all acquisition-related intangible assets that are subject to amortization over their estimated useful life based on economic benefit. Acquisition-related in-process R&D assets represent the fair value of incomplete R&D projects that had not reached technological feasibility as of the date of acquisition; initially, these are classified as "other intangible assets" that are not subject to amortization. Assets related to projects that have been completed are transferred from "other intangible assets" to "acquisition-related developed technology;" these are subject to amortization, while assets related to projects that have been abandoned are impaired and expensed to R&D. In the quarter following the period in which identified intangible assets become fully amortized, we remove the fully amortized balances from the gross asset and accumulated amortization amounts.
	The estimated useful life ranges for substantially all identified intangible assets that are subject to amortization as of December 27, 2014 were as follows:
	(In Years)		Estimated
			Useful Life
	Acquisition-related developed technology		4	–	9
	Acquisition-related customer relationships		6	–	9
	Acquisition-related trade names		5	–	8
	Licensed technology and patents		5	–	17
	We perform a quarterly review of finite-lived identified intangible assets to determine whether facts and circumstances indicate that the useful life is shorter than we had originally estimated or that the carrying amount of assets may not be recoverable. If such facts and circumstances exist, we assess recoverability by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets. If an asset’s useful life is shorter than originally estimated, we accelerate the rate of amortization and amortize the remaining carrying value over the new shorter useful life. We perform an annual impairment assessment in the fourth quarter of each year for indefinite-lived intangible assets, or more frequently if indicators of potential impairment exist, to determine whether it is more likely than not that the carrying value of the assets may not be recoverable. If necessary, a quantitative impairment test is performed to compare the fair value of the indefinite-lived intangible asset with its carrying value. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets.
	For further discussion of identified intangible assets, see "Note 11: Identified Intangible Assets."
Product Warranty [Policy Text Block]	Product Warranty
	The vast majority of our products are sold with a limited warranty on product quality and a limited indemnification for customers against intellectual property rights infringement claims related to our products. The accrual and the related expense for known product warranty issues were not significant during the periods presented. Due to product testing, the short time typically between product shipment and the detection and correction of product failures, and the historical rate of payments on indemnification claims, the accrual and related expense for estimated incurred but unidentified issues were not significant during the periods presented.
Revenue Recognition [Policy Text Block]	Revenue Recognition
	We recognize net product revenue when the earnings process is complete, as evidenced by an agreement with the customer, delivery has occurred, and acceptance, if applicable, as well as fixed pricing and probable collectibility. We record pricing allowances, including discounts based on contractual arrangements with customers, when we recognize revenue as a reduction to both accounts receivable and net revenue. Because of frequent sales price reductions and rapid technology obsolescence in the industry, we defer product revenue and related costs of sales from component sales made to distributors under agreements allowing price protection or right of return until the distributors sell the merchandise. The right of return granted generally consists of a stock rotation program in which distributors are able to exchange certain products based on the number of qualified purchases made by the distributor. Under the price protection program, we give distributors credits for the difference between the original price paid and the current price that we offer. We include shipping charges billed to customers in net revenue, and include the related shipping costs in cost of sales.
	Revenue from license agreements with our McAfee, Inc. (McAfee) business generally includes service and support agreements for which the related revenue is deferred and recognized ratably over the performance period. Revenue derived from online subscription products is deferred and recognized ratably over the performance period. Professional services revenue is recognized as services are performed or, if required, upon customer acceptance. For arrangements with multiple elements, including software licenses, maintenance, and/or services, revenue is allocated across the separately identified deliverables and may be recognized or deferred. When vendor-specific objective evidence does not exist for undelivered elements such as maintenance and support, the entire arrangement fee is recognized ratably over the performance period. Direct costs, such as costs related to revenue-sharing and royalty arrangements associated with license arrangements, as well as component costs associated with product revenue and sales commissions, are deferred and amortized over the same period that the related revenue is recognized.
	We record deferred revenue offset by the related cost of sales on our consolidated balance sheets as deferred income.
Advertising [Policy Text Block]	Advertising
	Cooperative advertising programs reimburse customers for marketing activities for certain of our products, subject to defined criteria. We accrue cooperative advertising obligations and record the costs at the same time that the related revenue is recognized. We record cooperative advertising costs as marketing, general and administrative (MG&A) expenses to the extent that an advertising benefit separate from the revenue transaction can be identified and the fair value of that advertising benefit received is determinable. We record any excess in cash paid to customers over the fair value of the advertising benefit we receive as a reduction in revenue. Advertising costs, including direct marketing costs, recorded within MG&A expenses were $1.8 billion in 2014 ($1.9 billion in 2013 and $2.0 billion in 2012).
Employee Equity Incentive Plans [Policy Text Block]	Employee Equity Incentive Plans
	We have employee equity incentive plans, which are described more fully in "Note 18: Employee Equity Incentive Plans." We use the straight-line attribution method to recognize share-based compensation over the service period of the award. Upon exercise, cancellation, forfeiture, or expiration of stock options, or upon vesting or forfeiture of restricted stock units, we eliminate deferred tax assets for options and restricted stock units with multiple vesting dates for each vesting period on a first-in, first-out basis as if each vesting period were a separate award.
Income Taxes [Policy Text Block]	Income Taxes
	We compute the provision for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. We measure deferred tax assets and liabilities using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We record a valuation allowance to reduce deferred tax assets to the amount that it is believed more likely than not to be realized.
	We recognize tax benefits from uncertain tax positions only if that tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. We then measure the tax benefits recognized in the financial statements from such positions based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. We recognize interest and penalties related to unrecognized tax benefits within the provision for taxes on the consolidated statements of income. For more information about income taxes, see "Note 23: Income Taxes."

Accounting_Policies_Tables

Accounting Policies (Tables)	12 Months Ended
	Dec. 27, 2014
Accounting Policies [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventories at the end of each period were as follows:
	(In Millions)	Dec 27,			Dec 28,
		2014			2013
	Raw materials	$	462		$	458
	Work in process	2,375			1,998
	Finished goods	1,436			1,716
	Total inventories	$	4,273		$	4,172
Property, Plant and Equipment [Table Text Block]	Property, plant and equipment, net at the end of each period were as follows:
	(In Millions)	Dec 27,			Dec 28,
		2014			2013
	Land and buildings	$	22,989		$	21,098
	Machinery and equipment	44,441			40,540
	Construction in progress	12,279			11,778
	Total property, plant and equipment, gross	79,709			73,416
	Less: accumulated depreciation	(46,471		)	(41,988		)
	Total property, plant and equipment, net	$	33,238		$	31,428
Schedule Of Useful Life Ranges For Identified Intangible Assets [Table Text Block]	The estimated useful life ranges for substantially all identified intangible assets that are subject to amortization as of December 27, 2014 were as follows:
	(In Years)	Estimated
		Useful Life
	Acquisition-related developed technology	4	–	9
	Acquisition-related customer relationships	6	–	9
	Acquisition-related trade names	5	–	8
	Licensed technology and patents	5	–	17

Fair_Value_Tables

Fair Value (Tables)	12 Months Ended
	Dec. 27, 2014
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Assets and liabilities measured and recorded at fair value on a recurring basis at the end of each period were as follows:
		27-Dec-14								28-Dec-13
		Fair Value Measured and						Total		Fair Value Measured and						Total
		Recorded at Reporting Date Using								Recorded at Reporting Date Using
	(In Millions)	Level 1		Level 2		Level 3				Level 1		Level 2		Level 3
	Assets
	Cash equivalents:
	Corporate debt	$	—	$	48	$	—	$	48	$	154	$	1,920	$	—	$	2,074
	Financial institution instruments	321		1,119		—		1,440		887		1,190		—		2,077
	Government debt	—		—		—		—		—		269		—		269
	Reverse repurchase agreements	—		268		—		268		—		400		—		400
	Short-term investments:
	Corporate debt	363		412		31		806		274		1,374		19		1,667
	Financial institution instruments	149		1,050		—		1,199		194		2,895		—		3,089
	Government debt	252		173		—		425		183		1,033		—		1,216
	Trading assets:
	Asset-backed securities	—		766		58		824		—		684		4		688
	Corporate debt	2,625		339		—		2,964		2,161		628		—		2,789
	Financial institution instruments	1,146		613		—		1,759		1,188		418		—		1,606
	Government debt	1,295		2,221		—		3,516		1,625		1,733		—		3,358
	Other current assets:
	Derivative assets	—		559		2		561		48		309		—		357
	Loans receivable	—		505		—		505		—		103		—		103
	Marketable equity securities	7,097		—		—		7,097		6,221		—		—		6,221
	Other long-term investments:
	Asset-backed securities	—		2		4		6		—		—		9		9
	Corporate debt	453		728		13		1,194		228		270		27		525
	Financial institution instruments	189		319		—		508		90		402		—		492
	Government debt	75		240		—		315		259		188		—		447
	Other long-term assets:
	Derivative assets	—		35		22		57		—		7		29		36
	Loans receivable	—		216		—		216		—		702		—		702
	Total assets measured and recorded at fair value	13,965		9,613		130		23,708		13,512		14,525		88		28,125
	Liabilities
	Other accrued liabilities:
	Derivative liabilities	—		563		—		563		—		372		—		372
	Other long-term liabilities:
	Derivative liabilities	—		17		—		17		—		50		—		50
	Total liabilities measured and recorded at fair value	$	—	$	580	$	—	$	580	$	—	$	422	$	—	$	422
Financial Instruments Not Recorded At Fair Value On Recurring Basis [Table Text Block]	The carrying amounts and fair values of financial instruments not recorded at fair value on a recurring basis at the end of each period were as follows:
		December 27, 2014
		Carrying		Fair Value Measured Using						Fair Value
	(In Millions)	Amount		Level 1		Level 2		Level 3
	Grants receivable	$	676	$	—	$	679	$	—	$	679
	Loans receivable	$	250	$	—	$	250	$	—	$	250
	Non-marketable cost method investments	$	1,769	$	—	$	—	$	2,599	$	2,599
	Reverse repurchase agreements	$	450	$	—	$	450	$	—	$	450
	Short-term debt	$	1,588	$	—	$	2,145	$	—	$	2,145
	Long-term debt	$	12,107	$	11,467	$	1,309	$	—	$	12,776
	NVIDIA Corporation cross-license agreement liability	$	395	$	—	$	399	$	—	$	399
		December 28, 2013
		Carrying		Fair Value Measured Using						Fair Value
	(In Millions)	Amount		Level 1		Level 2		Level 3
	Grants receivable	$	416	$	—	$	481	$	—	$	481
	Loans receivable	$	267	$	—	$	250	$	17	$	267
	Non-marketable cost method investments	$	1,270	$	—	$	—	$	2,105	$	2,105
	Reverse repurchase agreements	$	400	$	—	$	400	$	—	$	400
	Short-term debt	$	24	$	—	$	24	$	—	$	24
	Long-term debt	$	13,165	$	10,937	$	2,601	$	—	$	13,538
	NVIDIA Corporation cross-license agreement liability	$	587	$	—	$	597	$	—	$	597

Cash_and_Investments_Tables

Cash and Investments (Tables)	12 Months Ended
	Dec. 27, 2014
Investments and Cash [Abstract]
Schedule of Total Cash and Investments [Table Text Block]	Cash and investments at the end of each period were as follows:
	(In Millions)	Dec 27,		Dec 28,
		2014		2013
	Available-for-sale investments	$	13,038	$	18,086
	Cash	805		854
	Equity method investments	1,446		1,038
	Loans receivable	971		1,072
	Non-marketable cost method investments	1,769		1,270
	Reverse repurchase agreements	718		800
	Trading assets	9,063		8,441
	Total cash and investments	$	27,810	$	31,561
Schedule of Available-for-sale Securities [Line Items]
Schedule of Available-for-sale Securities Reconciliation [Table Text Block]	Available-for-sale investments at the end of each period were as follows:
		December 27, 2014											December 28, 2013
	(In Millions)	Adjusted		Gross			Gross				Fair		Adjusted		Gross		Gross			Fair
		Cost		Unrealized			Unrealized				Value		Cost		Unrealized		Unrealized			Value
				Gains			Losses								Gains		Losses
	Asset-backed securities	$	8	$	—		$	(2	)		$	6	$	11	$	—	$	(2	)	$	9
	Corporate debt	2,040		13			(5		)		2,048		4,254		15		(3		)	4,266
	Financial institution instruments	3,146		2			(1		)		3,147		5,654		5		(1		)	5,658
	Government debt	741		—			(1		)		740		1,932		1		(1		)	1,932
	Marketable equity securities	3,318		3,779			—				7,097		3,340		2,881		—			6,221
	Total available-for-sale investments	$	9,253	$	3,794		$	(9	)		$	13,038	$	15,191	$	2,902	$	(7	)	$	18,086
Equity Method Investments [Table Text Block]	Equity method investments, classified within other long-term assets, at the end of each period were as follows:
		December 27, 2014				December 28, 2013
	(Dollars In Millions)	Carrying		Ownership		Carrying				Ownership
		Value		Percentage		Value				Percentage
	IM Flash Technologies, LLC	$	713	49	%	$	646			49	%
	Cloudera, Inc.	280		17	%	—				—	%
	Intel-GE Care Innovations, LLC	108		50	%	117				50	%
	Other equity method investments	345				275
	Total	$	1,446			$	1,038
Available-for-sale Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Investments Classified by Contractual Maturity Date [Table Text Block]	The amortized cost and fair value of available-for-sale debt investments, by contractual maturity, as of December 27, 2014 were as follows:
	(In Millions)	Cost		Fair Value
	Due in 1 year or less	$	3,490	$	3,500
	Due in 1–2 years	1,003		1,004
	Due in 2–5 years	964		962
	Instruments not due at a single maturity date	478		475
	Total	$	5,935	$	5,941

Derivative_Financial_Instrumen1

Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 27, 2014
Derivative [Line Items]
Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]	Total gross notional amounts for outstanding derivatives recorded at fair value at the end of each period were as follows:
	(In Millions)	Dec 27,				Dec 28,				Dec 29,
		2014				2013				2012
	Currency forwards	$	15,578			$	13,404			$	13,117
	Currency interest rate swaps	5,446				4,377				2,711
	Embedded debt derivatives	3,600				3,600				3,600
	Interest rate swaps	1,347				1,377				1,101
	Total return swaps	1,056				914				807
	Other	49				67				127
	Total	$	27,076			$	23,739			$	21,463
	The gross notional amounts for currency forwards and currency interest rate swaps, by currency, at the end of each period were as follows:
	(In Millions)	Dec 27,				Dec 28,				Dec 29,
		2014				2013				2012
	British pound sterling	$	410			$	549			$	308
	Chinese yuan	3,097				1,116				647
	Euro	7,486				6,874				5,994
	Indian rupee	418				303				309
	Israeli shekel	2,489				2,244				2,256
	Japanese yen	3,779				4,116				4,389
	Malaysian ringgit	902				506				442
	Swiss franc	1,289				1,189				657
	Other	1,154				884				826
	Total	$	21,024			$	17,781			$	15,828
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]	The fair value of our derivative instruments at the end of each period were as follows:
		December 27, 2014															December 28, 2013
	(In Millions)	Other				Other				Other				Other			Other			Other		Other		Other
		Current				Long-Term				Accrued				Long-Term			Current			Long-Term		Accrued		Long-Term
		Assets				Assets				Liabilities				Liabilities			Assets			Assets		Liabilities		Liabilities
	Derivatives designated as
	hedging instruments:
	Currency forwards	$	6			$	1			$	497			$	9		$	114		$	1	$	118	$	2
	Total derivatives designated as hedging instruments	6				1				497				9			114			1		118		2
	Derivatives not designated
	as hedging instruments:
	Currency forwards	207				—				44				—			66			—		63		—
	Currency interest rate swaps	344				34				7				—			124			6		163		29
	Embedded debt derivatives	—				—				4				8			—			—		—		19
	Interest rate swaps	3				—				11				—			5			—		28		—
	Total return swaps	—				—				—				—			48			—		—		—
	Other	1				22				—				—			—			29		—		—
	Total derivatives not designated as hedging instruments	555				56				66				8			243			35		254		48
	Total derivatives	$	561			$	57			$	563			$	17		$	357		$	36	$	372	$	50
Offsetting Assets And Liabilities [Table Text Block]	The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows:
		27-Dec-14
														Gross Amounts Not Offset in the Balance Sheet
	(In Millions)	Gross Amounts Recognized				Gross Amounts Offset in the Balance Sheet				Net Amounts Presented in the Balance Sheet				Financial Instruments			Cash and Non-Cash Collateral Received or Pledged			Net Amount
	Assets:
	Derivative assets subject to master netting arrangements	$	559			$	—			$	559			$	(365	)	$	(78	)	$	116
	Reverse repurchase agreements	718				—				718				—			(718		)	—
	Total assets	1,277				—				1,277				(365		)	(796		)	116
	Liabilities:
	Derivative liabilities subject to master netting arrangements	559				—				559				(365		)	(80		)	114
	Total liabilities	$	559			$	—			$	559			$	(365	)	$	(80	)	$	114
		28-Dec-13
														Gross Amounts Not Offset in the Balance Sheet
	(In Millions)	Gross Amounts Recognized				Gross Amounts Offset in the Balance Sheet				Net Amounts Presented in the Balance Sheet				Financial Instruments			Cash and Non-Cash Collateral Received or Pledged			Net Amount
	Assets:
	Derivative assets subject to master netting arrangements	$	325			$	—			$	325			$	(158	)	$	(3	)	$	164
	Reverse repurchase agreements	800				—				800				—			(800		)	—
	Total assets	1,125				—				1,125				(158		)	(803		)	164
	Liabilities:
	Derivative liabilities subject to master netting arrangements	401				—				401				(158		)	(32		)	211
	Total liabilities	$	401			$	—			$	401			$	(158	)	$	(32	)	$	211
Schedule Of Derivative Instruments In Cash Flow Hedging Relationships [Table Text Block]	The before-tax gains (losses) attributed to the effective portion of cash flow hedges that were recognized in other comprehensive income (loss) for each period were as follows:
		Gains (Losses)
		Recognized in OCI on
		Derivatives (Effective Portion)
	(In Millions)	2014				2013				2012
	Currency forwards	$	(587	)		$	(167	)		$	4
	Other	(2		)		1				9
	Total	$	(589	)		$	(166	)		$	13
Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]	The effects of derivative instruments not designated as hedging instruments on the consolidated statements of income for each period were as follows:
	(In Millions)	Location of Gains (Losses)		2014				2013				2012
		Recognized in Income on Derivatives
	Currency forwards	Interest and other, net		$	144			$	44			$	3
	Currency interest rate swaps	Interest and other, net		456				29				(71		)
	Equity options	Gains (losses) on equity investments, net		—				1				(1		)
	Interest rate swaps	Interest and other, net		(3		)		—				31
	Total return swaps	Various		68				140				77
	Other	Gains (losses) on equity investments, net		(6		)		5				(7		)
	Other	Interest and other, net		—				—				3
	Total			$	659			$	219			$	35

Goodwill_Tables

Goodwill (Tables)	12 Months Ended
	Dec. 27, 2014
Goodwill [Abstract]
Schedule of Goodwill [Table Text Block]	Goodwill activity for each period was as follows:
	(In Millions)	Dec 28,		Acquisitions		Transfers			Currency Exchange and Other			Dec 27,
		2013										2014
	PC Client Group	$	3,058	$	—	$	—		$	—		$	3,058
	Data Center Group	1,831		407		138			—			2,376
	Internet of Things Group	—		—		428			—			428
	Mobile and Communications Group	—		19		631			—			650
	Other Intel architecture operating segments	1,075		—		(1,075		)	—			—
	Software and services operating segments	4,549		41		(140		)	(214		)	4,236
	All other	—		113		18			(18		)	113
	Total	$	10,513	$	580	$	—		$	(232	)	$	10,861
	(In Millions)	Dec 29,		Acquisitions		Transfers			Currency Exchange and Other			Dec 28,
		2012										2013
	PC Client Group	$	2,962	$	62	$	34		$	—		$	3,058
	Data Center Group	1,839		14		(22		)	—			1,831
	Other Intel architecture operating segments	916		171		(12		)	—			1,075
	Software and services operating segments	3,993		504		—			52			4,549
	Total	$	9,710	$	751	$	—		$	52		$	10,513

Identified_Intangible_Assets_T

Identified Intangible Assets (Tables)	12 Months Ended
	Dec. 27, 2014
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Schedule Of Intangible Assets By Major Class [Table Text Block]	Identified intangible assets at the end of each period were as follows:
		27-Dec-14
	(In Millions)	Gross				Accumulated				Net
		Assets				Amortization
	Acquisition-related developed technology	$	3,009			$	(2,192	)		$	817
	Acquisition-related customer relationships	1,698				(1,001		)		697
	Acquisition-related trade names	61				(49		)		12
	Licensed technology and patents	3,153				(1,224		)		1,929
	Identified intangible assets subject to amortization	7,921				(4,466		)		3,455
	Acquisition-related trade names	788				—				788
	Other intangible assets	203				—				203
	Identified intangible assets not subject to amortization	991				—				991
	Total identified intangible assets	$	8,912			$	(4,466	)		$	4,446
		28-Dec-13
	(In Millions)	Gross				Accumulated				Net
		Assets				Amortization
	Acquisition-related developed technology	$	2,922			$	(1,691	)		$	1,231
	Acquisition-related customer relationships	1,760				(828		)		932
	Acquisition-related trade names	65				(44		)		21
	Licensed technology and patents	3,093				(974		)		2,119
	Identified intangible assets subject to amortization	7,840				(3,537		)		4,303
	Acquisition-related trade names	818				—				818
	Other intangible assets	29				—				29
	Identified intangible assets not subject to amortization	847				—				847
	Total identified intangible assets	$	8,687			$	(3,537	)		$	5,150
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]	As a result of our acquisitions and purchases of licensed technology and patents, identified intangible assets recorded for each period and their respective estimated weighted average useful life were as follows:
		2014						2013
		Gross				Estimated Useful Life		Gross				Estimated Useful Life
		Assets				(In Years)		Assets				(In Years)
		(In Millions)						(In Millions)
	Acquisition-related developed technology	$	175			6		$	114			5
	Acquisition-related customer relationships	$	79			9		$	60			7
	Licensed technology and patents	$	93			8		$	36			10
Finite-lived Intangible Assets Amortization Expense [Table Text Block]	Amortization expenses, with presentation location on the consolidated statements of income, for each period were as follows:
	(In Millions)	Location		2014				2013				2012
	Acquisition-related developed technology	Cost of sales		$	600			$	576			$	557
	Acquisition-related customer relationships	Amortization of acquisition-related intangibles		284				279				296
	Acquisition-related trade names	Amortization of acquisition-related intangibles		10				12				12
	Licensed technology and patents	Cost of sales		275				272				214
	Other intangible assets	Reduction of revenue		—				103				86
	Total amortization expenses			$	1,169			$	1,242			$	1,165
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Based on identified intangible assets that are subject to amortization as of December 27, 2014, we expect future amortization expense for each period to be as follows:
	(In Millions)	2015				2016				2017				2018		2019
	Acquisition-related developed technology	$	330			$	240			$	91			$	69	$	60
	Acquisition-related customer relationships	247				229				141				35		15
	Acquisition-related trade names	9				3				—				—		—
	Licensed technology and patents	263				248				210				168		167
	Total future amortization expenses	$	849			$	720			$	442			$	272	$	242

Other_LongTerm_Assets_Tables

Other Long-Term Assets (Tables)	12 Months Ended
	Dec. 27, 2014
Other Assets, Noncurrent Disclosure [Abstract]
Schedule of Other Assets, Noncurrent [Table Text Block]	Other long-term assets at the end of each period were as follows:
	(In Millions)	Dec 27,		Dec 28,
		2014		2013
	Equity method investments	$	1,446	$	1,038
	Non-marketable cost method investments	1,769		1,270
	Non-current deferred tax assets	622		434
	Loans receivable	416		952
	Pre-payments for property, plant and equipment	636		521
	Other	1,672		1,274
	Total other long-term assets	$	6,561	$	5,489

Recovered_Sheet1

Restructuring And Asset Impairment Charges (Tables)	12 Months Ended
	Dec. 27, 2014
Restructuring Costs and Asset Impairment Charges [Abstract]
Restructuring and Related Costs [Table Text Block]	Restructuring and asset impairment charges for each period were as follows:
	(In Millions)	2014			2013			2012
	Employee severance and benefit arrangements	$	265		$	201		$	—
	Asset impairments and other restructuring charges	30			39			—
	Total restructuring and asset impairment charges	$	295		$	240		$	—
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	Restructuring and asset impairment activity for each period was as follows:
	(In Millions)	Employee Severance and Benefits			Asset Impairments and Other			Total
	Accrued restructuring balance as of December 29, 2012	$	—		$	—		$	—
	Additional accruals	195			39			234
	Adjustments	6			—			6
	Cash payments	(18		)	—			(18		)
	Non-cash settlements	—			(39		)	(39		)
	Accrued restructuring balance as of December 28, 2013	183			—			183
	Additional accruals	252			31			283
	Adjustments	13			(1		)	12
	Cash payments	(327		)	(6		)	(333		)
	Non-cash settlements	—			(13		)	(13		)
	Accrued restructuring balance as of December 27, 2014	$	121		$	11		$	132

Deferred_Income_Tables

Deferred Income (Tables)	12 Months Ended
	Dec. 27, 2014
Deferred Income [Abstract]
Deferred Revenue, by Arrangement, Disclosure [Table Text Block]	Deferred income at the end of each period was as follows:
	(In Millions)	Dec 27,		Dec 28,
		2014		2013
	Deferred income on shipments of components to distributors	$	944	$	852
	Deferred income from software and services	1,261		1,244
	Current deferred income	2,205		2,096
	Non-current deferred income from software and services	483		506
	Total deferred income	$	2,688	$	2,602

Borrowings_Tables

Borrowings (Tables)	12 Months Ended
	Dec. 27, 2014
Debt Disclosure [Abstract]
Schedule of Short-term Debt [Table Text Block]	Our short-term debt at the end of each period was as follows:
	(In Millions)	Dec 27,				Dec 28,
		2014				2013
	Drafts payable	$	16			$	257
	Notes payable	—				24
	Commercial paper	500				—
	Current portion of long-term debt	1,088				—
	Short-term debt	$	1,604			$	281
Schedule of Long-term Debt Instruments [Table Text Block]	Our long-term debt at the end of each period was as follows:
	(In Millions)	Dec 27,				Dec 28,
		2014				2013
	2012 Senior notes due 2017 at 1.35%	$	2,998			$	2,997
	2012 Senior notes due 2022 at 2.70%	1,495				1,494
	2012 Senior notes due 2032 at 4.00%	744				744
	2012 Senior notes due 2042 at 4.25%	924				924
	2011 Senior notes due 2016 at 1.95%	1,499				1,499
	2011 Senior notes due 2021 at 3.30%	1,997				1,996
	2011 Senior notes due 2041 at 4.80%	1,490				1,490
	2009 Junior subordinated convertible debentures due 2039 at 3.25%	1,088				1,075
	2005 Junior subordinated convertible debentures due 2035 at 2.95%	960				946
	Total long-term debt	13,195				13,165
	Less: current portion of long-term debt	(1,088		)		—
	Long-term debt	$	12,107			$	13,165
Convertible Debentures Interest Rates [Table Text Block]
		2009			2005
		Debentures			Debentures
	Annual stated coupon interest rate	3.25	%		2.95	%
	Annual effective interest rate	7.2	%		6.45	%
Convertible Debentures Other Details [Table Text Block]
		2009 Debentures						2005 Debentures
	(In Millions, Except Per Share Amounts)	Dec 27,				Dec 28,		Dec 27,		Dec 28,
		2014				2013		2014		2013
	Outstanding principal	$	2,000			$	2,000	$	1,600	$	1,600
	Equity component (including temporary equity) carrying	$	613			$	613	$	466	$	466
	amount
	Unamortized discount	$	912			$	925	$	640	$	654
	Net debt carrying amount	$	1,088			$	1,075	$	960	$	946
	Conversion rate (shares of common stock per $1,000 principal amount of debentures)	46.06				45.57		34.95		34.6
	Effective conversion price (per share of common stock)	$	21.71			$	21.94	$	28.61	$	28.9
Schedule of Maturities of Long-term Debt [Table Text Block]	Our aggregate debt maturities based on outstanding principal as of December 27, 2014, by year payable, were as follows:
	(In Millions)
	2015	$	—
	2016	1,500
	2017	3,000
	2018	—
	2019	—
	2020 and thereafter	10,275
	Total	$	14,775

Retirement_Benefit_Plans_Table

Retirement Benefit Plans (Tables)	12 Months Ended
	Dec. 27, 2014
Defined Benefit Plan Disclosure [Line Items]
Schedule of Changes in Projected Benefit Obligations [Table Text Block]
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	2014				2013				2014			2013				2014				2013
	Beginning projected benefit obligation	$	1,137			$	1,742			$	1,695		$	1,412			$	509			$	484
	Service cost	88				119				104			78				26				27
	Interest cost	49				67				66			60				23				20
	Actuarial (gain) loss	760				(746		)		767			121				10				(56		)
	Currency exchange rate changes	—				—				(254		)	46				—				—
	Plan curtailments	(1,083		)		—				—			—				—				—
	Other	(59		)		(45		)		45			(22		)		(22		)		34
	Ending projected benefit obligation	$	892			$	1,137			$	2,423		$	1,695			$	546			$	509
Schedule of Changes in Fair Value of Plan Assets [Table Text Block]
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	2014				2013				2014			2013				2014				2013
	Beginning fair value of plan assets	$	649			$	684			$	1,005		$	838			$	395			$	191
	Actual return on plan assets	30				10				80			81				33				49
	Employer contributions	—				—				73			65				—				162
	Currency exchange rate changes	—				—				(114		)	26				—				—
	Other	(56		)		(45		)		(27		)	(5		)		(1		)		(7		)
	Ending fair value of plan assets	$	623			$	649			$	1,017		$	1,005			$	427			$	395
Schedule of Amounts Recognized in Balance Sheet [Table Text Block]	The amounts recognized on the consolidated balance sheets at the end of each period were as follows:
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	Dec 27,				Dec 28,				Dec 27,			Dec 28,				Dec 27,				Dec 28,
		2014				2013				2014			2013				2014				2013
	Other long-term assets	$	—			$	—			$	14		$	16			$	—			$	—
	Other long-term liabilities	(269		)		(488		)		(1,420		)	(706		)		(119		)		(114		)
	Accumulated other comprehensive loss (income), before tax	1				255				1,217			520				33				43
	Net amount recognized	$	(268	)		$	(233	)		$	(189	)	$	(170	)		$	(86	)		$	(71	)
Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block]	The amounts recorded in accumulated other comprehensive income (loss) before taxes at the end of each period were as follows:
		U.S. Pension Benefits								Non-U.S. Pension							U.S. Postretirement
										Benefits							Medical Benefits
	(In Millions)	Dec 27,				Dec 28,				Dec 27,			Dec 28,				Dec 27,				Dec 28,
		2014				2013				2014			2013				2014				2013
	Net prior service credit (cost)	$	—			$	—			$	(13	)	$	25			$	(48	)		$	(54	)
	Net actuarial gain (loss)	(1		)		(255		)		(1,204		)	(545		)		15				11
	Accumulated other comprehensive income (loss), before tax	$	(1	)		$	(255	)		$	(1,217	)	$	(520	)		$	(33	)		$	(43	)
Schedule of Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block]	As of December 27, 2014, the accumulated benefit obligation was $808 million for the U.S. Intel Minimum Pension Plan ($497 million as of December 28, 2013) and $1.7 billion for the non-U.S. defined-benefit pension plans ($1.3 billion as of December 28, 2013). Included in the aggregate data in the following tables are the amounts applicable to our pension plans with accumulated benefit obligations in excess of plan assets, as well as plans with projected benefit obligations in excess of plan assets. Amounts related to such plans at the end of each period were as follows:
		U.S. Pension Benefits								Non-U.S. Pension
										Benefits
	(In Millions)	Dec 27,				Dec 28,				Dec 27,			Dec 28,
		2014				2013				2014			2013
	Plans with accumulated benefit obligations in excess of plan assets:
	Accumulated benefit obligations	$	808			$	—			$	1,344		$	900
	Plan assets	$	623			$	—			$	616		$	563
	Plans with projected benefit obligations in excess of plan assets:
	Projected benefit obligations	$	892			$	1,137			$	2,361		$	1,295
	Plan assets	$	623			$	649			$	941		$	588
Schedule of Assumptions Used [Table Text Block]	Weighted average actuarial assumptions used to determine benefit obligations for the plans at the end of each period were as follows:
		U.S. Pension Benefits						Non-U.S. Pension					U.S. Postretirement
								Benefits					Medical Benefits
		Dec 27,			Dec 28,			Dec 27,			Dec 28,		Dec 27,			Dec 28,
		2014			2013			2014			2013		2014			2013
	Discount rate	3.8	%		4.8	%		2.7	%		4	%	4.1	%		4.6	%
	Rate of compensation increase	3.8	%		3.8	%		4	%		3.9	%	n/a			n/a
	Weighted average actuarial assumptions used to determine costs for the plans for each period were as follows:
		U.S. Pension Benefits									Non-U.S. Pension Benefits								U.S. Postretirement
																			Medical Benefits
		2014			2013			2012			2014		2013			2012			2014			2013		2012
	Discount rate	4.6	%		3.9	%		4.7	%		4	%	4.2	%		5	%		4.6	%		4.2	%	4.6	%
	Expected long-term rate of return on plan assets	5.4	%		4.5	%		5	%		5.7	%	5.2	%		5.9	%		7.4	%		7.7	%	3	%
	Rate of compensation increase	3.8	%		4.1	%		4.5	%		4.1	%	4.3	%		4.1	%		n/a			n/a		n/a
Schedule of Expected Benefit Payments [Table Text Block]	Estimated benefit payments over the next 10 fiscal years are as follows:
	(In Millions)	U.S. Pension				Non-U.S.				U.S.
		Benefits				Pension				Postretirement
						Benefits				Medical
										Benefits
	2015	$	55			$	66			$	14
	2016	$	54			$	26			$	16
	2017	$	58			$	31			$	19
	2018	$	64			$	35			$	21
	2019	$	64			$	40			$	24
	2020-2024	$	327			$	272			$	163
U.S. Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Schedule of Allocation of Plan Assets [Table Text Block]	U.S. Intel Minimum Pension Plan assets measured at fair value on a recurring basis consisted of the following investment categories at the end of each period:
		27-Dec-14															Dec 28,
																	2013
		Fair Value Measured at Reporting Date Using
	(In Millions)	Level 1				Level 2				Level 3			Total				Total
	Equity securities	$	56			$	291			$	—		$	347			$	220
	Fixed income	39				169				46			254				415
	Other investments	20				—				—			20				11
	Total assets measured at fair value	$	115			$	460			$	46		$	621			$	646
	Cash												2				3
	Total U.S. pension plan assets at fair value												$	623			$	649
Non-U.S. Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Schedule of Allocation of Plan Assets [Table Text Block]	Non-U.S. plan assets measured at fair value on a recurring basis consisted of the following investment categories at the end of each period:
		27-Dec-14															Dec 28,
																	2013
		Fair Value Measured at Reporting Date Using
	(In Millions)	Level 1				Level 2				Level 3			Total				Total
	Equity securities	$	447			$	59			$	15		$	521			$	361
	Fixed income	—				440				36			476				554
	Total assets measured at fair value	$	447			$	499			$	51		$	997			$	915
	Cash												20				90
	Total non-U.S. plan assets at fair value												$	1,017			$	1,005

Commitments_Tables

Commitments (Tables)	12 Months Ended
	Dec. 27, 2014
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Minimum rental commitments under all non-cancelable leases with an initial term in excess of one year were as follows as of December 27, 2014:
	(In Millions)
	2015	$	205
	2016	179
	2017	152
	2018	118
	2019	101
	2020 and thereafter	315
	Total	$	1,070

Employee_Equity_Incentive_Plan1

Employee Equity Incentive Plans (Tables)	12 Months Ended
	Dec. 27, 2014
Employee Benefits and Share-based Compensation [Abstract]
Restricted Stock Units Estimated Values And Weighted Average Assumptions [Table Text Block]	We estimate the fair value of restricted stock unit awards with time-based vesting using the value of our common stock on the date of grant, reduced by the present value of dividends expected to be paid on our shares of common stock prior to vesting. We estimate the fair value of market-based restricted stock units using a Monte Carlo simulation model on the date of grant. We based the weighted average estimated value of restricted stock unit grants, as well as the weighted average assumptions that we used in calculating the fair value, on estimates at the date of grant, for each period as follows:
			2014				2013				2012
	Estimated values		$	25.4			$	21.45			$	25.32
	Risk-free interest rate		0.5		%		0.2		%		0.3		%
	Dividend yield		3.3		%		3.8		%		3.3		%
	Volatility		23		%		25		%		26		%
Stock Options And Stock Purchase Plan Estimated Values And Weighted Average Assumptions [Table Text Block]	We use the Black-Scholes option pricing model to estimate the fair value of options granted under our equity incentive plans and rights to acquire shares of common stock granted under our stock purchase plan. We based the weighted average estimated value of employee stock option grants and rights granted under the stock purchase plan, as well as the weighted average assumptions used in calculating the fair value, on estimates at the date of grant, for each period as follows:
			Stock Options											Stock Purchase Plan
			2014				2013				2012			2014			2013				2012
	Estimated values		$	3.61			$	3.11			$	4.22		$	5.87		$	4.52			$	5.47
	Expected life (in years)		5.1				5.2				5.3			0.5			0.5				0.5
	Risk-free interest rate		1.7		%		0.8		%		1		%	0.1		%	0.1		%		0.1		%
	Dividend yield		3.6		%		3.9		%		3.3		%	3.2		%	4		%		3.3		%
	Volatility		23		%		25		%		25		%	22		%	22		%		24		%
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]	Restricted stock unit activity for each period was as follows:
			Number of			Weighted
			RSUs			Average
			(In Millions)			Grant-Date
						Fair Value
	December 31, 2011		107			$	19.18
	Granted		49.9			$	25.32
	Vested		(43.2	)		$	18.88
	Forfeited		(4.4	)		$	20.93
	29-Dec-12		109.3			$	22.03
	Granted		53.4			$	21.45
	Vested		(44.5	)		$	20.21
	Forfeited		(4.9	)		$	22.06
	28-Dec-13		113.3			$	22.47
	Granted		57.2			$	25.4
	Vested		(42.5	)		$	22.33
	Forfeited		(8.6	)		$	22.94
	27-Dec-14		119.4			$	23.89
	Expected to vest as of December 27, 2014		112.1			$	23.88
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	As of December 27, 2014, options outstanding that have vested and are expected to vest were as follows:
			Number of			Weighted				Weighted		Aggregate
			Options			Average				Average		Intrinsic
			(In Millions)			Exercise				Remaining		Value
						Price				Contractual		(In Millions)
										Term
										(In Years)
	Vested		54.7			$	20.29			2.3		$	944
	Expected to vest		21.2			$	23.74			4.8		$	293
	Total		75.9			$	21.25			3		$	1,237
Schedule of Stock Options Roll Forward [Table Text Block]	Stock option activity for each period was as follows:
			Number of			Weighted
			Options			Average
			(In Millions)			Exercise
						Price
	31-Dec-11		298.3			$	20.12
	Granted		13.5			$	27.01
	Exercised		(85.8	)		$	20.45
	Cancelled and forfeited		(3.9	)		$	21.17
	Expired		(19.3	)		$	22.45
	29-Dec-12		202.8			$	20.2
	Granted		20.1			$	22.99
	Exercised		(65.0	)		$	18.76
	Cancelled and forfeited		(3.0	)		$	22.58
	Expired		(1.9	)		$	22.56
	28-Dec-13		153			$	21.1
	Granted		0.6			$	25.34
	Exercised		(63.7	)		$	19.87
	Cancelled and forfeited		(2.7	)		$	23.7
	Expired		(9.9	)		$	27
	27-Dec-14		77.3			$	21.3
	Options exercisable as of:
	29-Dec-12		139.8			$	19.76
	28-Dec-13		111.5			$	20.25
	27-Dec-14		54.7			$	20.29
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	As of December 27, 2014, outstanding options and exercisable options information, by range of exercises prices, was as follows:
										Outstanding Options							Exercisable Options
	Range of Exercise Prices									Number of			Weighted	Weighted			Number of			Weighted
										Shares			Average	Average			Shares			Average
										(In Millions)			Remaining	Exercise			(In Millions)			Exercise
													Contractual	Price						Price
													Life
													(In Years)
	$	1.82		-	$	15				0.7			3	$	11.6		0.7			$	11.6
	$	15.01		-	$	20				32.9			1.8	$	18.27		32.9			$	18.27
	$	20.01		-	$	25				34			3.9	$	22.75		17.2			$	22.89
	$	25.01		-	$	27.42				9.7			4.3	$	27.11		3.9			$	27.21
	Total									77.3			3	$	21.3		54.7			$	20.29

Gains_Losses_on_Equity_Investm1

Gains (Losses) on Equity Investments, Net (Tables)	12 Months Ended
	Dec. 27, 2014
Equity Method Investments and Joint Ventures [Abstract]
Schedule Of Gains (Losses) On Equity Investments, Net [Table Text Block]	The components of gains (losses) on equity investments, net for each period were as follows:
	(In Millions)	2014			2013			2012
	Share of equity method investee losses, net	$	(69	)	$	(69	)	$	(81	)
	Impairments	(146		)	(123		)	(154		)
	Gains on sales, net	422			515			183
	Dividends	57			46			—
	Other, net	147			102			193
	Total gains (losses) on equity investments, net	$	411		$	471		$	141

Interest_and_Other_Net_Tables

Interest and Other, Net (Tables)	12 Months Ended
	Dec. 27, 2014
Interest and Other, Net [Abstract]
Interest And Other, Net [Table Text Block]	The components of interest and other, net for each period were as follows:
	(In Millions)	2014			2013			2012
	Interest income	$	141		$	104		$	97
	Interest expense	(192		)	(244		)	(90		)
	Other, net	94			(11		)	87
	Total interest and other, net	$	43		$	(151	)	$	94

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	12 Months Ended
	Dec. 27, 2014
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	We computed our basic and diluted earnings per share of common stock for each period as follows:
	(In Millions, Except Per Share Amounts)	2014		2013		2012
	Net income available to common stockholders	$	11,704	$	9,620	$	11,005
	Weighted average shares of common stock outstanding—basic	4,901		4,970		4,996
	Dilutive effect of employee equity incentive plans	75		68		100
	Dilutive effect of convertible debt	80		59		64
	Weighted average shares of common stock outstanding—diluted	5,056		5,097		5,160
	Basic earnings per share of common stock	$	2.39	$	1.94	$	2.2
	Diluted earnings per share of common stock	$	2.31	$	1.89	$	2.13

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 27, 2014
Income Tax Disclosure [Abstract]
Income Before Taxes And Provisions For Taxes [Table Text Block]	Income before taxes and the provision for taxes consisted of the following:
	(Dollars in Millions)	2014				2013				2012
	Income before taxes:
	U.S.	$	11,565			$	9,374			$	10,042
	Non-U.S.	4,236				3,237				4,831
	Total income before taxes	15,801				12,611				14,873
	Provision for taxes:
	Current:
	Federal	3,374				2,730				2,539
	State	38				68				52
	Non-U.S.	969				716				1,135
	Total current provision for taxes	4,381				3,514				3,726
	Deferred:
	Federal	(263		)		(412		)		129
	Other	(21		)		(111		)		13
	Total deferred provision for taxes	(284		)		(523		)		142
	Total provision for taxes	$	4,097			$	2,991			$	3,868
	Effective tax rate	25.9		%		23.7		%		26		%
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	The difference between the tax provision at the statutory federal income tax rate and the tax provision as a percentage of income before income taxes (effective tax rate) for each period was as follows:
		2014			2013			2012
	Statutory federal income tax rate	35	%		35	%		35	%
	Increase (reduction) in rate resulting from:
	Non-U.S. income taxed at different rates	(6.1	)		(5.8	)		(7.3	)
	Research and development tax credits	(1.7	)		(3.5	)		—
	Domestic manufacturing deduction benefit	(2.1	)		(2.1	)		(2.1	)
	Other	0.8			0.1			0.4
	Effective tax rate	25.9	%		23.7	%		26	%
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Significant components of our deferred tax assets and liabilities at the end of each period were as follows:
	(In Millions)	Dec 27,				Dec 28,
		2014				2013
	Deferred tax assets:
	Accrued compensation and other benefits	$	982			$	1,047
	Share-based compensation	438				564
	Deferred income	691				672
	Inventory	339				733
	State credits and net operating losses	519				378
	Other, net	715				654
	Gross deferred tax assets	3,684				4,048
	Valuation allowance	(595		)		(456		)
	Total deferred tax assets	3,089				3,592
	Deferred tax liabilities:
	Property, plant and equipment	(1,171		)		(2,023		)
	Licenses and intangibles	(576		)		(687		)
	Convertible debt	(977		)		(911		)
	Unrealized gains on investments and derivatives	(1,017		)		(815		)
	Investment in non-U.S. subsidiaries	(252		)		(244		)
	Other, net	(291		)		(281		)
	Total deferred tax liabilities	(4,284		)		(4,961		)
	Net deferred tax assets (liabilities)	(1,195		)		(1,369		)
	Reported as:
	Current deferred tax assets	1,958				2,594
	Non-current deferred tax assets	622				434
	Non-current deferred tax liabilities	(3,775		)		(4,397		)
	Net deferred tax assets (liabilities)	$	(1,195	)		$	(1,369	)
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]	The aggregate changes in the balance of gross unrecognized tax benefits for each period were as follows:
	(In Millions)	2014				2013				2012
	Beginning gross unrecognized tax benefits	$	207			$	189			$	212
	Settlements and effective settlements with tax authorities and related remeasurements	(220		)		(2		)		(81		)
	Lapse of statute of limitations	—				—				(5		)
	Increases in balances related to tax positions taken during prior periods	173				21				56
	Decreases in balances related to tax positions taken during prior periods	(1		)		(9		)		(6		)
	Increases in balances related to tax positions taken during current period	418				8				13
	Ending gross unrecognized tax benefits	$	577			$	207			$	189

Other_Comprehensive_Income_Los1

Other Comprehensive Income (Loss) (Tables)	12 Months Ended
	Dec. 27, 2014
Equity [Abstract]
Components Of Other Comprehensive Income (Loss) [Table Text Block]	The components of other comprehensive income (loss) and related tax effects for each period were as follows:
		2014									2013									2012
	(In Millions)	Before			Tax			Net of			Before			Tax			Net of			Before			Tax			Net of
		Tax						Tax			Tax						Tax			Tax						Tax
	Change in unrealized holding gains (losses) on available-for-sale investments	$	1,029		$	(359	)	$	670		$	1,963		$	(687	)	$	1,276		$	909		$	(318	)	$	591
	Less: adjustment for (gains) losses on available-for-sale investments included in net income	(142		)	49			(93		)	(146		)	51			(95		)	(187		)	66			(121		)
	Less: adjustment for (gains) losses on deferred tax asset valuation allowance included in net income	—			(41		)	(41		)	—			(26		)	(26		)	—			(11		)	(11		)
	Change in unrealized holding gains (losses) on derivatives	(589		)	160			(429		)	(166		)	76			(90		)	12			8			20
	Less: adjustment for (gains) losses on derivatives included in net income	13			(11		)	2			30			(29		)	1			78			(13		)	65
	Change in net prior service costs	(42		)	5			(37		)	17			(2		)	15			(4		)	1			(3		)
	Less: adjustment for amortization of net prior service costs	6			(2		)	4			4			(1		)	3			5			(2		)	3
	Change in actuarial valuation	(433		)	3			(430		)	725			(275		)	450			(321		)	91			(230		)
	Less: adjustment for amortization of actuarial (gains) losses	37			(9		)	28			101			(31		)	70			90			(32		)	58
	Change in net foreign currency translation adjustment	(275		)	24			(251		)	45			(7		)	38			12			(2		)	10
	Other comprehensive income (loss)	$	(396	)	$	(181	)	$	(577	)	$	2,573		$	(931	)	$	1,642		$	594		$	(212	)	$	382
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	The changes in accumulated other comprehensive income (loss) by component and related tax effects for each period were as follows:
	(In Millions)	Unrealized Holding Gains (Losses) on Available-for-Sale Investments			Deferred Tax Asset Valuation Allowance			Unrealized Holding Gains (Losses) on Derivatives			Prior Service Credits (Costs)			Actuarial Gains (Losses)			Foreign Currency Translation Adjustment			Total
	29-Dec-12	$	701		$	93		$	93		$	(32	)	$	(1,122	)	$	(132	)	$	(399	)
	Other comprehensive income before reclassifications	1,963			—			(166		)	17			725			45			2,584
	Amounts reclassified out of accumulated other comprehensive income (loss)	(146		)	—			30			4			101			—			(11		)
	Tax effects	(636		)	(26		)	47			(3		)	(306		)	(7		)	(931		)
	Other comprehensive income (loss)	1,181			(26		)	(89		)	18			520			38			1,642
	28-Dec-13	1,882			67			4			(14		)	(602		)	(94		)	1,243
	Other comprehensive income before reclassifications	1,029			—			(589		)	(42		)	(433		)	(275		)	(310		)
	Amounts reclassified out of accumulated other comprehensive income (loss)	(142		)	—			13			6			37			—			(86		)
	Tax effects	(310		)	(41		)	149			3			(6		)	24			(181		)
	Other comprehensive income (loss)	577			(41		)	(427		)	(33		)	(402		)	(251		)	(577		)
	27-Dec-14	$	2,459		$	26		$	(423	)	$	(47	)	$	(1,004	)	$	(345	)	$	666
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]	The amounts reclassified out of accumulated other comprehensive income (loss) into the consolidated statements of income, with presentation location, for each period were as follows:
		Income Before Taxes Impact (In Millions)
	Comprehensive Income Components	2014			2013			2012			Location
	Unrealized holding gains (losses) on available-for-sale investments:
		$	10		$	8		$	(8	)	Interest and other, net
		132			138			195			Gains (losses) on equity investments, net
		142			146			187
	Unrealized holding gains (losses) on derivatives:
	Currency forwards	(31		)	(61		)	11			Cost of sales
		18			30			(63		)	Research and development
		2			—			(25		)	Marketing, general and administrative
	Other instruments	(2		)	1			(1		)	Cost of sales
		(13		)	(30		)	(78		)
	Amortization of pension and postretirement benefit components:
	Prior service credits (costs)	(6		)	(4		)	(5		)
	Actuarial gains (losses)	(37		)	(101		)	(90		)
		(43		)	(105		)	(95		)
	Total amounts reclassified out of accumulated other comprehensive income (loss)	$	86		$	11		$	14

Operating_Segments_and_Geograp1

Operating Segments and Geographic Information (Tables)	12 Months Ended
	Dec. 27, 2014
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Net revenue and operating income (loss) for each period were as follows:
	(In Millions)	2014			2013			2012
	Net revenue:
	PC Client Group	$	34,669		$	33,270		$	34,688
	Data Center Group	14,387			12,161			11,219
	Internet of Things Group	2,142			1,801			1,600
	Mobile and Communications Group	202			1,375			1,791
	Software and services operating segments	2,216			2,190			2,072
	All other	2,254			1,911			1,971
	Total net revenue	55,870			52,708			53,341
	Operating income (loss):
	PC Client Group	14,635			11,751			13,008
	Data Center Group	7,279			5,569			5,231
	Internet of Things Group	616			550			278
	Mobile and Communications Group	(4,206		)	(3,148		)	(1,776		)
	Software and services operating segments	55			24			12
	All other	(3,032		)	(2,455		)	(2,115		)
	Total operating income	$	15,347		$	12,291		$	14,638
Revenue from External Customers by Geographic Areas [Table Text Block]	Net revenue by country for the three years ended December 27, 2014 is based on the billing location of the customer. Revenue from unaffiliated customers for each period was as follows:
	(In Millions)	2014			2013			2012
	Singapore	$	11,573		$	10,997		$	12,622
	China (including Hong Kong)	11,197			9,890			8,299
	United States	9,828			9,091			8,348
	Taiwan	8,955			8,888			9,327
	Japan	2,776			3,725			4,303
	Other countries	11,541			10,117			10,442
	Total net revenue	$	55,870		$	52,708		$	53,341
Long-lived Assets by Geographic Areas [Table Text Block]	Net property, plant and equipment by country at the end of each period was as follows:
	(In Millions)	Dec 27,			Dec 28,			Dec 29,
		2014			2013			2012
	United States	$	24,020		$	23,624		$	20,542
	Ireland	5,433			2,986			1,523
	Israel	1,957			2,667			3,389
	Other countries	1,828			2,151			2,529
	Total property, plant and equipment, net	$	33,238		$	31,428		$	27,983

Accounting_Policies_Detail

Accounting Policies (Detail) (USD $)	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Inventory Net Items Net Of Reserve Alternative [Abstract]
Raw materials	$462,000,000	$458,000,000
Work in process	2,375,000,000	1,998,000,000
Finished goods	1,436,000,000	1,716,000,000
Total Inventories	4,273,000,000	4,172,000,000
Property, Plant and Equipment [Abstract]
Property, plant and equipment, gross	79,709,000,000	73,416,000,000
Less: accumulated depreciation	-46,471,000,000	-41,988,000,000
Total property, plant and equipment, net	33,238,000,000	31,428,000,000	27,983,000,000
Advertising [Abstract]
Advertising Expense	1,800,000,000	1,900,000,000	2,000,000,000
Minimum [Member] | Acquisition-related Developed Technology [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)	4 years
Minimum [Member] | Acquisition-related Customer Relationships [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)	6 years
Minimum [Member] | Acquisition-related Trade Names [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)	5 years
Minimum [Member] | Licensed Technology and Patents [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)	5 years
Maximum [Member] | Acquisition-related Developed Technology [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)	9 years
Maximum [Member] | Acquisition-related Customer Relationships [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)	9 years
Maximum [Member] | Acquisition-related Trade Names [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)	8 years
Maximum [Member] | Licensed Technology and Patents [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)	17 years
Land and buildings [Member]
Property, Plant and Equipment [Abstract]
Property, plant and equipment, gross	22,989,000,000	21,098,000,000
Machinery and equipment [Member]
Property, Plant and Equipment [Abstract]
Property, plant and equipment, gross	44,441,000,000	40,540,000,000
Machinery and equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Useful Life (in years)	2 years
Machinery and equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Useful Life (in years)	4 years
Construction in progress [Member]
Property, Plant and Equipment [Abstract]
Property, plant and equipment, gross	$12,279,000,000	$11,778,000,000
Building [Member] | Minimum [Member]
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Useful Life (in years)	10 years
Building [Member] | Maximum [Member]
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Useful Life (in years)	25 years

Fair_Value_Detail

Fair Value (Detail) (USD $)	1 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Jan. 31, 2011	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		$9,063	$8,441
Loans Receivable, Fair Value Disclosure		721	805
Loans receivable		971	1,072
Non-marketable cost method investments		1,769	1,270
Reverse repurchase agreements		718	800
Long-term debt		12,107	13,165
NVIDIA Corporation cross-license agreement liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loss Contingency, Cross License Annual Payment Amount, 2014-2016	200
Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure, Recurring		23,708	28,125
Liabilities, Fair Value Disclosure		580	422
Fair Value, Measurements, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Non-Marketable Equity Investments, Gains (Losses)		-128	-106	-68
Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse Repurchase Agreements, Fair Value Disclosure		268	400
Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		561	357
Loans Receivable, Fair Value Disclosure		505	103
Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		57	36
Loans Receivable, Fair Value Disclosure		216	702
Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		563	372
Other Noncurrent Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		17	50
Corporate Debt [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		48	2,074
Corporate Debt [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		806	1,667
Corporate Debt [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		2,964	2,789
Corporate Debt [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		1,194	525
Financial Institution Instruments [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		1,440	2,077
Financial Institution Instruments [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		1,199	3,089
Financial Institution Instruments [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		1,759	1,606
Financial Institution Instruments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		508	492
Government Debt [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	269
Government Debt [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		425	1,216
Government Debt [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		3,516	3,358
Government Debt [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		315	447
Asset-Backed Securities [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		824	688
Asset-Backed Securities [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		6	9
Marketable Equity Securities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		7,097	6,221
Corporate Debt, Financial Institution Instruments, And Government Debt [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount		177
Fair Value, Assets, Level 2 to Level 1 Transfers, Amount		395
Level 1 [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure, Recurring		13,965	13,512
Liabilities, Fair Value Disclosure		0	0
Level 1 [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse Repurchase Agreements, Fair Value Disclosure		0	0
Level 1 [Member] | Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		0	48
Loans Receivable, Fair Value Disclosure		0	0
Level 1 [Member] | Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		0	0
Loans Receivable, Fair Value Disclosure		0	0
Level 1 [Member] | Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		0	0
Level 1 [Member] | Other Noncurrent Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		0	0
Level 1 [Member] | Corporate Debt [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	154
Level 1 [Member] | Corporate Debt [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		363	274
Level 1 [Member] | Corporate Debt [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		2,625	2,161
Level 1 [Member] | Corporate Debt [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		453	228
Level 1 [Member] | Financial Institution Instruments [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		321	887
Level 1 [Member] | Financial Institution Instruments [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		149	194
Level 1 [Member] | Financial Institution Instruments [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		1,146	1,188
Level 1 [Member] | Financial Institution Instruments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		189	90
Level 1 [Member] | Government Debt [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 1 [Member] | Government Debt [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		252	183
Level 1 [Member] | Government Debt [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		1,295	1,625
Level 1 [Member] | Government Debt [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		75	259
Level 1 [Member] | Asset-Backed Securities [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		0	0
Level 1 [Member] | Asset-Backed Securities [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 1 [Member] | Marketable Equity Securities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		7,097	6,221
Level 2 [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure, Recurring		9,613	14,525
Liabilities, Fair Value Disclosure		580	422
Level 2 [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse Repurchase Agreements, Fair Value Disclosure		268	400
Level 2 [Member] | Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		559	309
Loans Receivable, Fair Value Disclosure		505	103
Level 2 [Member] | Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		35	7
Loans Receivable, Fair Value Disclosure		216	702
Level 2 [Member] | Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		563	372
Level 2 [Member] | Other Noncurrent Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		17	50
Level 2 [Member] | Corporate Debt [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		48	1,920
Level 2 [Member] | Corporate Debt [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		412	1,374
Level 2 [Member] | Corporate Debt [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		339	628
Level 2 [Member] | Corporate Debt [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		728	270
Level 2 [Member] | Financial Institution Instruments [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		1,119	1,190
Level 2 [Member] | Financial Institution Instruments [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		1,050	2,895
Level 2 [Member] | Financial Institution Instruments [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		613	418
Level 2 [Member] | Financial Institution Instruments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		319	402
Level 2 [Member] | Government Debt [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	269
Level 2 [Member] | Government Debt [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		173	1,033
Level 2 [Member] | Government Debt [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		2,221	1,733
Level 2 [Member] | Government Debt [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		240	188
Level 2 [Member] | Asset-Backed Securities [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		766	684
Level 2 [Member] | Asset-Backed Securities [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		2	0
Level 2 [Member] | Marketable Equity Securities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 3 [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure, Recurring		130	88
Liabilities, Fair Value Disclosure		0	0
Level 3 [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse Repurchase Agreements, Fair Value Disclosure		0	0
Level 3 [Member] | Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		2	0
Loans Receivable, Fair Value Disclosure		0	0
Level 3 [Member] | Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		22	29
Loans Receivable, Fair Value Disclosure		0	0
Level 3 [Member] | Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		0	0
Level 3 [Member] | Other Noncurrent Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		0	0
Level 3 [Member] | Corporate Debt [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 3 [Member] | Corporate Debt [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		31	19
Level 3 [Member] | Corporate Debt [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		0	0
Level 3 [Member] | Corporate Debt [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		13	27
Level 3 [Member] | Financial Institution Instruments [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 3 [Member] | Financial Institution Instruments [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 3 [Member] | Financial Institution Instruments [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		0	0
Level 3 [Member] | Financial Institution Instruments [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 3 [Member] | Government Debt [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 3 [Member] | Government Debt [Member] | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 3 [Member] | Government Debt [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		0	0
Level 3 [Member] | Government Debt [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 3 [Member] | Asset-Backed Securities [Member] | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		58	4
Level 3 [Member] | Asset-Backed Securities [Member] | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		4	9
Level 3 [Member] | Marketable Equity Securities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Carrying Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Grants Receivable		676	416
Loans receivable		250	267
Non-marketable cost method investments		1,769	1,270
Reverse repurchase agreements		450	400
Short-term Debt		1,588	24
Long-term debt		12,107	13,165
Carrying Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA Corporation cross-license agreement liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes Payable		395	587
Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Grants Receivable, Fair Value Disclosure		679	481
Loans receivable		250	267
Non-Marketable Cost Method Investments, Fair Value Disclosure		2,599	2,105
Reverse repurchase agreements		450	400
Short-term Debt, Fair Value		2,145	24
Long-term debt		12,776	13,538
Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA Corporation cross-license agreement liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes Payable, Fair Value Disclosure		399	597
Fair Value [Member] | Level 1 [Member] | Not Recorded At Fair Value On Recurring Basis [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Grants Receivable, Fair Value Disclosure		0	0
Loans receivable		0	0
Non-Marketable Cost Method Investments, Fair Value Disclosure		0	0
Reverse repurchase agreements		0	0
Short-term Debt, Fair Value		0	0
Long-term debt		11,467	10,937
Fair Value [Member] | Level 1 [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA Corporation cross-license agreement liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes Payable, Fair Value Disclosure		0	0
Fair Value [Member] | Level 2 [Member] | Not Recorded At Fair Value On Recurring Basis [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Grants Receivable, Fair Value Disclosure		679	481
Loans receivable		250	250
Non-Marketable Cost Method Investments, Fair Value Disclosure		0	0
Reverse repurchase agreements		450	400
Short-term Debt, Fair Value		2,145	24
Long-term debt		1,309	2,601
Fair Value [Member] | Level 2 [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA Corporation cross-license agreement liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes Payable, Fair Value Disclosure		399	597
Fair Value [Member] | Level 3 [Member] | Not Recorded At Fair Value On Recurring Basis [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Grants Receivable, Fair Value Disclosure		0	0
Loans receivable		0	17
Non-Marketable Cost Method Investments, Fair Value Disclosure		2,599	2,105
Reverse repurchase agreements		0	0
Short-term Debt, Fair Value		0	0
Long-term debt		0	0
Fair Value [Member] | Level 3 [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA Corporation cross-license agreement liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes Payable, Fair Value Disclosure		$0	$0

Cash_and_Investment_Detail

Cash and Investment (Detail) (USD $)	Dec. 27, 2014	Dec. 28, 2013
In Millions, unless otherwise specified
Cash and Cash Equivalents [Abstract]
Available-for-sale investments	$13,038	$18,086
Cash	805	854
Equity method investments	1,446	1,038
Loans receivable	971	1,072
Non-marketable cost method investments	1,769	1,270
Reverse repurchase agreements	718	800
Trading assets	9,063	8,441
Total cash and investments	$27,810	$31,561

Cash_and_Investments_Available

Cash and Investments, Available For Sale Investments Detail (Detail) (USD $)	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Available-for-sale Securities [Abstract]
Adjusted Cost	$5,935,000,000
Adjusted Cost, Total	9,253,000,000	15,191,000,000
Gross Unrealized Gains	3,794,000,000	2,902,000,000
Gross Unrealized Losses	-9,000,000	-7,000,000
Fair Value	5,941,000,000
Fair Value, Total	13,038,000,000	18,086,000,000
Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds	1,700,000,000	1,300,000,000	3,400,000,000
Available-for-sale Securities, Gross Realized Gains	136,000,000	146,000,000	166,000,000
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities	5,000,000	14,000,000	36,000,000
Due in 1 year or less, Cost	3,490,000,000
Due in 1-2 years, Cost	1,003,000,000
Due in 2-5 years, Cost	964,000,000
Instruments not due at a single maturity date, Cost	478,000,000
Due in 1 year or less, Fair Value	3,500,000,000
Due in 1-2 years, Fair Value	1,004,000,000
Due in 2-5 years, Fair Value	962,000,000
Instruments not due at a single maturity date, Fair Value	475,000,000
ASML Holding N.V. [Member]
Available-for-sale Securities [Abstract]
Payments to Acquire Available-for-sale Securities, Equity			3,200,000,000
Cash and Cash Equivalents [Member]
Available-for-sale Securities [Abstract]
Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds	509,000,000	339,000,000	1,100,000,000
Asset-Backed Securities [Member]
Available-for-sale Securities [Abstract]
Adjusted Cost	8,000,000	11,000,000
Gross Unrealized Gains	0	0
Gross Unrealized Losses	-2,000,000	-2,000,000
Fair Value	6,000,000	9,000,000
Corporate Debt [Member]
Available-for-sale Securities [Abstract]
Adjusted Cost	2,040,000,000	4,254,000,000
Gross Unrealized Gains	13,000,000	15,000,000
Gross Unrealized Losses	-5,000,000	-3,000,000
Fair Value	2,048,000,000	4,266,000,000
Financial Institution Instruments [Member]
Available-for-sale Securities [Abstract]
Adjusted Cost	3,146,000,000	5,654,000,000
Gross Unrealized Gains	2,000,000	5,000,000
Gross Unrealized Losses	-1,000,000	-1,000,000
Fair Value	3,147,000,000	5,658,000,000
Government Debt [Member]
Available-for-sale Securities [Abstract]
Adjusted Cost	741,000,000	1,932,000,000
Gross Unrealized Gains	0	1,000,000
Gross Unrealized Losses	-1,000,000	-1,000,000
Fair Value	740,000,000	1,932,000,000
Marketable Equity Securities [Member]
Available-for-sale Securities [Abstract]
Adjusted Cost	3,318,000,000	3,340,000,000
Gross Unrealized Gains	3,779,000,000	2,881,000,000
Gross Unrealized Losses	0	0
Fair Value	$7,097,000,000	$6,221,000,000

Cash_and_Investments_Equity_Me

Cash and Investments, Equity Method and Cost Method Investments Detail (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Schedule of Equity Method Investments [Line Items]
Equity Method Investments	$1,446	$1,038
Non-marketable cost method investments	1,769	1,270
IM Flash Technologies, LLC [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investments	713	646
Equity Method Investment, Ownership Percentage	49.00%	49.00%
Related Party Transaction, Purchases from Related Party	400	380
Due to Related Parties	60	75
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital	6	45	137
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	713
Percentage Of Purchase Commitment Of Production Output And Production Related Services	49.00%
Cloudera, Inc. [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investments	280	0
Equity Method Investment, Ownership Percentage	17.00%	0.00%
Non-marketable cost method investments	454
Intel-GE Care Innovations, LLC [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investments	108	117
Equity Method Investment, Ownership Percentage	50.00%	50.00%
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	108
Other Equity Method Investments [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investments	345	275
IM Flash Technologies, LLC and IM Flash Singapore, LLP [Member]
Schedule of Equity Method Investments [Line Items]
Related Party Transaction, Purchases from Related Party			705
IM Flash Technologies, LLC and IM Flash Singapore, LLP [Member] | Micron Technology, Inc. [Member]
Schedule of Equity Method Investments [Line Items]
Proceeds From Sale Of Certain Assets Of Joint Ventures To Counterparty	0	0	605
Clearwire, LLC [Member]
Schedule of Equity Method Investments [Line Items]
Proceeds from (Payments for) Other Financing Activities		328
Equity Method Investment, Realized Gain (Loss) on Disposal		$328

Cash_and_Investments_NonMarket

Cash and Investments, Non-Marketable Cost Method Investments (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Schedule of Cost-method Investments [Line Items]
Non-marketable cost method investments	$1,769	$1,270
Cost-method Investments [Member]
Schedule of Cost-method Investments [Line Items]
Other than Temporary Impairment Losses, Investments	130	103	104
Cloudera, Inc. [Member]
Schedule of Cost-method Investments [Line Items]
Non-marketable cost method investments	$454

Cash_and_Investments_Trading_A

Cash and Investments, Trading Assets (Detail) (Debt Securities [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Debt Securities [Member]
Schedule Of Trading Securities And Other Trading Assets [Line Items]
Trading Securities, Change in Unrealized Holding Gain (Loss)	($530)	($70)	$16
Net gains (losses) on derivatives related to trading securities	$525	$86	$11

Derivative_Financial_Instrumen2

Derivative Financial Instruments (Detail)

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Dec. 27, 2014

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

Dec. 27, 2014

Dec. 28, 2013

Dec. 29, 2012

USD ($)

CNY

USD ($)

USD ($)

Other Current Assets [Member]

Other Current Assets [Member]

Other Long-Term Assets [Member]

Other Long-Term Assets [Member]

Other Accrued Liabilities [Member]

Other Accrued Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Forwards [Member]

Currency Interest Rate Swaps [Member]

Currency Interest Rate Swaps [Member]

Currency Interest Rate Swaps [Member]

Currency Interest Rate Swaps [Member]

Currency Interest Rate Swaps [Member]

Currency Interest Rate Swaps [Member]

Currency Interest Rate Swaps [Member]

Currency Interest Rate Swaps [Member]

Currency Interest Rate Swaps [Member]

Currency Interest Rate Swaps [Member]

Currency Interest Rate Swaps [Member]

Currency Interest Rate Swaps [Member]

Currency Interest Rate Swaps [Member]

Currency Interest Rate Swaps [Member]

Embedded Debt Derivatives [Member]

Embedded Debt Derivatives [Member]

Embedded Debt Derivatives [Member]

Embedded Debt Derivatives [Member]

Embedded Debt Derivatives [Member]

Embedded Debt Derivatives [Member]

Embedded Debt Derivatives [Member]

Embedded Debt Derivatives [Member]

Embedded Debt Derivatives [Member]

Embedded Debt Derivatives [Member]

Embedded Debt Derivatives [Member]

Interest Rate Swaps [Member]

Interest Rate Swaps [Member]

Interest Rate Swaps [Member]

Interest Rate Swaps [Member]

Interest Rate Swaps [Member]

Interest Rate Swaps [Member]

Interest Rate Swaps [Member]

Interest Rate Swaps [Member]

Interest Rate Swaps [Member]

Interest Rate Swaps [Member]

Interest Rate Swaps [Member]

Interest Rate Swaps [Member]

Interest Rate Swaps [Member]

Interest Rate Swaps [Member]

Total Return Swaps [Member]

Total Return Swaps [Member]

Total Return Swaps [Member]

Total Return Swaps [Member]

Total Return Swaps [Member]

Total Return Swaps [Member]

Total Return Swaps [Member]

Total Return Swaps [Member]

Total Return Swaps [Member]

Total Return Swaps [Member]

Total Return Swaps [Member]

Total Return Swaps [Member]

Total Return Swaps [Member]

Total Return Swaps [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

Other Derivative Instruments [Member]

British Pound Sterling [Member]

British Pound Sterling [Member]

British Pound Sterling [Member]

Chinese Yuan [Member]

Chinese Yuan [Member]

Chinese Yuan [Member]

Euro [Member]

Euro [Member]

Euro [Member]

Indian Rupee [Member]

Indian Rupee [Member]

Indian Rupee [Member]

Israeli Shekel [Member]

Israeli Shekel [Member]

Israeli Shekel [Member]

Japanese Yen [Member]

Japanese Yen [Member]

Japanese Yen [Member]

Malaysian Ringgit [Member]

Malaysian Ringgit [Member]

Malaysian Ringgit [Member]

Swiss Franc [Member]

Swiss Franc [Member]

Swiss Franc [Member]

Other Currencies [Member]

Other Currencies [Member]

Other Currencies [Member]

Currency Exchange Rate Derivatives [Member]

Currency Exchange Rate Derivatives [Member]

Currency Exchange Rate Derivatives [Member]

Equity Options [Member]

Equity Options [Member]

Equity Options [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Other Current Assets [Member]

Other Current Assets [Member]

Other Long-Term Assets [Member]

Other Long-Term Assets [Member]

Other Accrued Liabilities [Member]

Other Accrued Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

USD ($)

USD ($)

USD ($)

Other Current Assets [Member]

Other Current Assets [Member]

Other Long-Term Assets [Member]

Other Long-Term Assets [Member]

Other Accrued Liabilities [Member]

Other Accrued Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

USD ($)

USD ($)

USD ($)

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Tsinghua Unigroup Ltd. [Member]

USD ($)

USD ($)

USD ($)

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

USD ($)

USD ($)

USD ($)

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

USD ($)

USD ($)

USD ($)

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

USD ($)

USD ($)

USD ($)

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

USD ($)

USD ($)

USD ($)

Interest and Other, Net [Member]

Interest and Other, Net [Member]

Interest and Other, Net [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

Not Designated as Hedging Instrument [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Other Current Assets [Member]

Other Current Assets [Member]

Other Long-Term Assets [Member]

Other Long-Term Assets [Member]

Other Accrued Liabilities [Member]

Other Accrued Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Interest and Other, Net [Member]

Interest and Other, Net [Member]

Interest and Other, Net [Member]

Other Current Assets [Member]

Other Current Assets [Member]

Other Long-Term Assets [Member]

Other Long-Term Assets [Member]

Other Accrued Liabilities [Member]

Other Accrued Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

USD ($)

Interest and Other, Net [Member]

Interest and Other, Net [Member]

Interest and Other, Net [Member]

Other Current Assets [Member]

Other Current Assets [Member]

Other Long-Term Assets [Member]

Other Long-Term Assets [Member]

Other Accrued Liabilities [Member]

Other Accrued Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Current Assets [Member]

Other Current Assets [Member]

Other Long-Term Assets [Member]

Other Long-Term Assets [Member]

Other Accrued Liabilities [Member]

Other Accrued Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Interest and Other, Net [Member]

Interest and Other, Net [Member]

Interest and Other, Net [Member]

Other Current Assets [Member]

Other Current Assets [Member]

Other Long-Term Assets [Member]

Other Long-Term Assets [Member]

Other Accrued Liabilities [Member]

Other Accrued Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Various [Member]

Various [Member]

Various [Member]

Other Current Assets [Member]

Other Current Assets [Member]

Other Long-Term Assets [Member]

Other Long-Term Assets [Member]

Other Accrued Liabilities [Member]

Other Accrued Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

USD ($)

USD ($)

USD ($)

Gains (Losses) On Equity Investments, Net [Member]

Gains (Losses) On Equity Investments, Net [Member]

Gains (Losses) On Equity Investments, Net [Member]

Other Current Assets [Member]

Other Current Assets [Member]

Other Long-Term Assets [Member]

Other Long-Term Assets [Member]

Other Accrued Liabilities [Member]

Other Accrued Liabilities [Member]

Other Noncurrent Liabilities [Member]

Other Noncurrent Liabilities [Member]

Gains (Losses) On Equity Investments, Net [Member]

Gains (Losses) On Equity Investments, Net [Member]

Gains (Losses) On Equity Investments, Net [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Derivative [Line Items]

Deferred Compensation Liability, Current and Noncurrent

$1,200,000,000

$1,100,000,000

Gross Notional Amounts [Abstract]

Derivative, Notional Amount

27,076,000,000

23,739,000,000

21,463,000,000

15,578,000,000

13,404,000,000

13,117,000,000

1,500,000,000

5,446,000,000

4,377,000,000

2,711,000,000

3,600,000,000

3,600,000,000

3,600,000,000

1,347,000,000

1,377,000,000

1,101,000,000

1,056,000,000

914,000,000

807,000,000

49,000,000

67,000,000

127,000,000

410,000,000

549,000,000

308,000,000

3,097,000,000

1,116,000,000

647,000,000

7,486,000,000

6,874,000,000

5,994,000,000

418,000,000

303,000,000

309,000,000

2,489,000,000

2,244,000,000

2,256,000,000

3,779,000,000

4,116,000,000

4,389,000,000

902,000,000

506,000,000

442,000,000

1,289,000,000

1,189,000,000

657,000,000

1,154,000,000

884,000,000

826,000,000

21,024,000,000

17,781,000,000

15,828,000,000

Tsinghua Unigroup Ltd. Agreement [Abstract]

Payments to Acquire Businesses, Gross

1,500,000,000

9,000,000,000

Cost Method Investment, Ownership Percentage

20.00%

20.00%

Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]

Derivative Asset, Fair Value, Gross Asset

559,000,000

325,000,000

561,000,000

357,000,000

57,000,000

36,000,000

6,000,000

114,000,000

1,000,000

1,000,000

555,000,000

243,000,000

56,000,000

35,000,000

6,000,000

114,000,000

1,000,000

1,000,000

207,000,000

66,000,000

0

0

344,000,000

124,000,000

34,000,000

6,000,000

0

0

0

0

3,000,000

5,000,000

0

0

0

48,000,000

0

0

1,000,000

0

22,000,000

29,000,000

Derivative Liability, Fair Value, Gross Liability

559,000,000

401,000,000

563,000,000

372,000,000

17,000,000

50,000,000

497,000,000

118,000,000

9,000,000

2,000,000

66,000,000

254,000,000

8,000,000

48,000,000

497,000,000

118,000,000

9,000,000

2,000,000

44,000,000

63,000,000

0

0

7,000,000

163,000,000

0

29,000,000

4,000,000

0

8,000,000

19,000,000

11,000,000

28,000,000

0

0

0

0

0

0

0

0

0

0

Offsetting Derivative Assets [Abstract]

Derivative Assets Subject To Master Netting Arrangements, Gross Amounts Offset In The Balance Sheet

0

0

Derivative Assets Subject To Master Netting Arrangements, Net Amounts Presented In The Balance Sheet

559,000,000

325,000,000

Derivative Assets Subject To Master Netting Arrangements, Gross Amounts Not Offset In The Balance Sheet - Financial Instruments

-365,000,000

-158,000,000

Derivative Assets Subject To Master Netting Arrangements, Gross Amounts Not Offset In The Balance Sheet - Cash And Non-Cash Collateral Received Or Pledged

-78,000,000

-3,000,000

Derivative Assets Subject To Master Netting Arrangements, Net Amount

116,000,000

164,000,000

Reverse Repurchase Agreements, Gross Amounts Recognized

718,000,000

800,000,000

Reverse Repurchase Agreements, Gross Amounts Offset In The Balance Sheet

0

0

Reverse Repurchase Agreements, Net Amounts Presented In The Balance Sheet

718,000,000

800,000,000

Reverse Repurchase Agreements, Gross Amounts Not Offset In The Balance Sheet - Financial Instruments

0

0

Reverse Repurchase Agreements, Gross Amounts Not Offset In The Balance Sheet - Cash And Non-Cash Collateral Received Or Pledged

-718,000,000

-800,000,000

Reverse Repurchase Agreements, Net Amount

0

0

Total Assets, Gross Amounts Recognized

1,277,000,000

1,125,000,000

Total Assets, Gross Amounts Offset In The Balance Sheet

0

0

Total Assets, Net Amounts Presented In The Balance Sheet

1,277,000,000

1,125,000,000

Total Assets, Gross Amounts Not Offset In The Balance Sheet - Financial Instruments

-365,000,000

-158,000,000

Total Assets, Gross Amounts Not Offset In The Balance Sheet - Cash and Non-Cash Collateral Received Or Pledged

-796,000,000

-803,000,000

Total Assets, Net Amount

116,000,000

164,000,000

Offsetting Derivative Liabilities [Abstract]

Derivative Liabilities Subject To Master Netting Arrangements, Gross Amounts Recognized

0

0

Derivative Liabilities Subject To Master Netting Arrangements, Net Amounts Presented In The Balance Sheet

559,000,000

401,000,000

Derivative Liabilities Subject To Master Netting Arrangements, Gross Amounts Offset In The Balance Sheet - Financial Instruments

-365,000,000

-158,000,000

Derivative Liability, Collateral, Obligation To Reclaim Cash Or Non-Cash

-80,000,000

-32,000,000

Derivative Liabilities Subject To Master Netting Arrangements, Gross Amounts Offset In The Balance Sheet - Cash And Non-Cash Collateral Received Or Pledged

114,000,000

211,000,000

Total Liabilities, Gross Amounts Recognized

559,000,000

401,000,000

Total Liabilities, Gross Amounts Offset In The Balance Sheet

0

0

Total Liabilities, Net Amounts Presented In The Balance Sheet

559,000,000

401,000,000

Total Liabilities, Gross Amounts Not Offset In The Balance Sheet - Financial Instruments

-365,000,000

-158,000,000

Total Liabilities, Gross Amounts Not Offset In The Balance Sheet - Cash and Non-Cash Collateral Received Or Pledged

-80,000,000

-32,000,000

Total Liabilities, Net Amount

114,000,000

211,000,000

Schedule of Derivative Instruments in Cash Flow Hedging Relationships [Abstract]

Gains (Losses) Recognized in Other Comprehensive Income (Loss) on Derivatives (Effective Portion)

-589,000,000

-166,000,000

13,000,000

-587,000,000

-167,000,000

4,000,000

-2,000,000

1,000,000

9,000,000

Schedule of Derivative Instruments Not Designated as Hedging Instruments [Abstract]

Gains (Losses) Recognized in Income on Derivatives

$659,000,000

$219,000,000

$35,000,000

$144,000,000

$44,000,000

$3,000,000

$456,000,000

$29,000,000

($71,000,000)

($3,000,000)

$0

$31,000,000

$68,000,000

$140,000,000

$77,000,000

$0

$0

$3,000,000

($6,000,000)

$5,000,000

($7,000,000)

$0

$1,000,000

($1,000,000)

Concentrations_of_Credit_Risk_

Concentrations of Credit Risk (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Total Credit Exposure To Any Single Counterparty [Member]
Concentration Risk [Line Items]
Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure	750
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	46.00%	44.00%	43.00%
Accounts Receivable, Net [Member] | Accounts Receivable Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	43.00%	34.00%

Acquisitions_Detail

Acquisitions (Detail) (USD $)	12 Months Ended			3 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012	Dec. 27, 2014	Sep. 28, 2013
Series of Individually Immaterial Business Acquisitions [Member]
Acquisitions [Abstract]
Business Combinations During Period, Consideration Transferred	$963	$925	$638
Axxia Networking Business of Avago Technologies Limited [Member]
Acquisitions [Abstract]
Business Combinations During Period, Consideration Transferred				650
Stonesoft Oyj [Member]
Acquisitions [Abstract]
Business Combinations During Period, Consideration Transferred					$381

Divestitures_Detail

Divestitures (Detail) (Intel Media Assets [Member], USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 29, 2014
Intel Media Assets [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from Divestiture of Businesses	$150

Goodwill_Detail

Goodwill (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013
Goodwill [Roll Forward]
Goodwill, Beginning Balance	$10,513	$9,710
Goodwill, Acquisitions	580	751
Goodwill, Transfers	0	0
Goodwill, Currency Exchange and Other	-232	52
Goodwill, Ending Balance	10,861	10,513
Goodwill, Impaired, Accumulated Impairment Loss	719
PC Client Group [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	3,058	2,962
Goodwill, Acquisitions	0	62
Goodwill, Transfers	0	34
Goodwill, Currency Exchange and Other	0	0
Goodwill, Ending Balance	3,058	3,058
Goodwill, Impaired, Accumulated Impairment Loss	352
Data Center Group [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	1,831	1,839
Goodwill, Acquisitions	407	14
Goodwill, Transfers	138	-22
Goodwill, Currency Exchange and Other	0	0
Goodwill, Ending Balance	2,376	1,831
Goodwill, Impaired, Accumulated Impairment Loss	275
Internet of Things Group [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	0
Goodwill, Acquisitions	0
Goodwill, Transfers	428
Goodwill, Currency Exchange and Other	0
Goodwill, Ending Balance	428
Goodwill, Impaired, Accumulated Impairment Loss	79
Mobile and Communications Group [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	0
Goodwill, Acquisitions	19
Goodwill, Transfers	631
Goodwill, Currency Exchange and Other	0
Goodwill, Ending Balance	650
Goodwill, Impaired, Accumulated Impairment Loss	13
Other Intel architecture operating segments [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	1,075	916
Goodwill, Acquisitions	0	171
Goodwill, Transfers	-1,075	-12
Goodwill, Currency Exchange and Other	0	0
Goodwill, Ending Balance	0	1,075
Software and services operating segments [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	4,549	3,993
Goodwill, Acquisitions	41	504
Goodwill, Transfers	-140	0
Goodwill, Currency Exchange and Other	-214	52
Goodwill, Ending Balance	4,236	4,549
All other [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	0
Goodwill, Acquisitions	113
Goodwill, Transfers	18
Goodwill, Currency Exchange and Other	-18
Goodwill, Ending Balance	$113

Identified_Intangible_Assets_F

Identified Intangible Assets, Finite-Lived Intangible Assets (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Identified Intangible Assets By Major Class [Abstract]
Gross Assets, Finite-lived Intangible Assets	$7,921	$7,840
Accumulated Amortization	-4,466	-3,537
Net	3,455	4,303
Identified Intangible Assets, Amortization Expenses [Abstract]
Amortization of intangibles	1,169	1,242	1,165
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Future Amortization Expense, 2015	849
Future Amortization Expense, 2016	720
Future Amortization Expense, 2017	442
Future Amortization Expense, 2018	272
Future Amortization Expense, 2019	242
Acquisition-related Developed Technology [Member]
Identified Intangible Assets By Major Class [Abstract]
Gross Assets, Finite-lived Intangible Assets	3,009	2,922
Accumulated Amortization	-2,192	-1,691
Net	817	1,231
Identified Intangible Assets, Acquired During Period [Abstract]
Identified Intangible Assets Acquired During Period	175	114
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life (in years)	6 years	5 years
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Future Amortization Expense, 2015	330
Future Amortization Expense, 2016	240
Future Amortization Expense, 2017	91
Future Amortization Expense, 2018	69
Future Amortization Expense, 2019	60
Acquisition-related Customer Relationships [Member]
Identified Intangible Assets By Major Class [Abstract]
Gross Assets, Finite-lived Intangible Assets	1,698	1,760
Accumulated Amortization	-1,001	-828
Net	697	932
Identified Intangible Assets, Acquired During Period [Abstract]
Identified Intangible Assets Acquired During Period	79	60
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life (in years)	9 years	7 years
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Future Amortization Expense, 2015	247
Future Amortization Expense, 2016	229
Future Amortization Expense, 2017	141
Future Amortization Expense, 2018	35
Future Amortization Expense, 2019	15
Acquisition-related Trade Names [Member]
Identified Intangible Assets By Major Class [Abstract]
Gross Assets, Finite-lived Intangible Assets	61	65
Accumulated Amortization	-49	-44
Net	12	21
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Future Amortization Expense, 2015	9
Future Amortization Expense, 2016	3
Future Amortization Expense, 2017	0
Future Amortization Expense, 2018	0
Future Amortization Expense, 2019	0
Licensed Technology and Patents [Member]
Identified Intangible Assets By Major Class [Abstract]
Gross Assets, Finite-lived Intangible Assets	3,153	3,093
Accumulated Amortization	-1,224	-974
Net	1,929	2,119
Identified Intangible Assets, Acquired During Period [Abstract]
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life (in years)	8 years	10 years
Finite Lived Intangible Assets Purchased	93	36
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Future Amortization Expense, 2015	263
Future Amortization Expense, 2016	248
Future Amortization Expense, 2017	210
Future Amortization Expense, 2018	168
Future Amortization Expense, 2019	167
Cost of sales [Member] | Acquisition-related Developed Technology [Member]
Identified Intangible Assets, Amortization Expenses [Abstract]
Amortization of acquisition-related intangibles	600	576	557
Cost of sales [Member] | Licensed Technology and Patents [Member]
Identified Intangible Assets, Amortization Expenses [Abstract]
Amortization of intangibles	275	272	214
Amortization of acquisition-related intangibles [Member] | Acquisition-related Customer Relationships [Member]
Identified Intangible Assets, Amortization Expenses [Abstract]
Amortization of acquisition-related intangibles	284	279	296
Amortization of acquisition-related intangibles [Member] | Acquisition-related Trade Names [Member]
Identified Intangible Assets, Amortization Expenses [Abstract]
Amortization of acquisition-related intangibles	10	12	12
Reduction of revenue [Member] | Other Intangible Assets [Member]
Identified Intangible Assets, Amortization Expenses [Abstract]
Amortization of intangibles	$0	$103	$86

Identified_Intangible_Assets_I

Identified Intangible Assets, Indefinite-Lived Intangible Assets (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013
Indefinite-lived Intangible Assets [Line Items]
Intangible Assets Gross	$991	$847
Acquisition-related Trade Names [Member]
Indefinite-lived Intangible Assets [Line Items]
Gross assets, Indefinite-Lived Intangible Assets	788	818
Other Intangible Assets [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets Acquired	197
Gross assets, Indefinite-Lived Intangible Assets	$203	$29

Identified_Intangible_Assets_T1

Identified Intangible Assets, Total Intangible Assets (Detail) (USD $)	Dec. 27, 2014	Dec. 28, 2013
In Millions, unless otherwise specified
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Identified intangible assets, gross	$8,912	$8,687
Identified intangible assets, net	$4,446	$5,150

Other_LongTerm_Assets_Detail

Other Long-Term Assets (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013
Other Assets, Noncurrent Disclosure [Abstract]
Equity method investments	$1,446	$1,038
Non-marketable cost method investments	1,769	1,270
Non-current deferred tax assets	622	434
Loans receivable	416	952
Pre-payments for property, plant and equipment	636	521
Other	1,672	1,274
Total other long-term assets	6,561	5,489
Transfers From Other Long-Term Assets to Property, Plant, And Equipment Related To Prepaid Equipment	$135

Restructuring_And_Asset_Impair1

Restructuring And Asset Impairment Charges (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
	Employee
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Activities, Completion Date	26-Dec-15
Restructuring and Related Cost, Incurred Cost	$295	$240	$0
Restructuring and Related Cost, Number of Impacted Employees	3,700
Restructuring and Related Cost, Cost Incurred to Date	535
Restructuring and Related Cost, Number of Impacted Employees, Inception to Date	7,600
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	183	0
Restructuring Reserve, Additional accruals	283	234
Restructuring Reserve, Adjustments	12	6
Restructuring Reserve, Cash payments	-333	-18
Restructuring Reserve, Non-cash settlements	-13	-39
Restructuring Reserve, Ending Balance	132	183	0
Employee severance and benefit arrangements [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	265	201	0
Restructuring and Related Cost, Cost Incurred to Date	466
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	183	0
Restructuring Reserve, Additional accruals	252	195
Restructuring Reserve, Adjustments	13	6
Restructuring Reserve, Cash payments	-327	-18
Restructuring Reserve, Non-cash settlements	0	0
Restructuring Reserve, Ending Balance	121	183	0
Asset impairments and other restructuring charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	30	39	0
Restructuring and Related Cost, Cost Incurred to Date	69
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	0	0
Restructuring Reserve, Additional accruals	31	39
Restructuring Reserve, Adjustments	-1	0
Restructuring Reserve, Cash payments	-6	0
Restructuring Reserve, Non-cash settlements	-13	-39
Restructuring Reserve, Ending Balance	$11	$0	$0

Deferred_Income_Detail

Deferred Income (Detail) (USD $)	Dec. 27, 2014	Dec. 28, 2013
In Millions, unless otherwise specified
Deferred Revenue Arrangement [Line Items]
Current deferred income	$2,205	$2,096
Total deferred income	2,688	2,602
Shipments Of Components To Distributors [Member]
Deferred Revenue Arrangement [Line Items]
Current deferred income	944	852
Software And Services [Member]
Deferred Revenue Arrangement [Line Items]
Current deferred income	1,261	1,244
Non-current deferred income	$483	$506

Borrowings_Shortterm_Debt_Deta

Borrowings, Short-term Debt (Detail) (USD $)	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013
Debt Disclosure [Abstract]
Drafts payable	$16,000,000	$257,000,000
Notes payable	0	24,000,000
Commercial paper	500,000,000	0
Current portion of long-term debt	1,088,000,000	0
Short-term debt	1,604,000,000	281,000,000
Board Of Directors Maximum Borrowing Capacity Authorization	3,000,000,000
Maximum Borrowings, Commercial Paper Program	$2,400,000,000	$300,000,000

Borrowings_Longterm_Debt_Detai

Borrowings, Long-term Debt (Detail) (USD $)	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 31, 2009	Dec. 31, 2005	Dec. 29, 2012	Oct. 01, 2011
Debt Instrument [Line Items]
Total long-term debt	$13,195,000,000	$13,165,000,000
Current portion of long-term debt	-1,088,000,000	0
Long-term debt	12,107,000,000	13,165,000,000
Temporary equity	912,000,000	0
Year Payable, 2015	0
Year Payable, 2016	1,500,000,000
Year Payable, 2017	3,000,000,000
Year Payable, 2018	0
Year Payable, 2019	0
Year Payable, 2020 and thereafter	10,275,000,000
Outstanding principal	14,775,000,000
2012 Senior notes due 2017 at 1.35% [Member]
Debt Instrument [Line Items]
Net debt carrying amount	2,998,000,000	2,997,000,000
Debt Instrument, Maturity Date	15-Dec-17
Annual stated coupon interest rate	1.35%
2012 Senior notes due 2022 at 2.70% [Member]
Debt Instrument [Line Items]
Net debt carrying amount	1,495,000,000	1,494,000,000
Debt Instrument, Maturity Date	15-Dec-22
Annual stated coupon interest rate	2.70%
2012 Senior notes due 2032 at 4.00% [Member]
Debt Instrument [Line Items]
Net debt carrying amount	744,000,000	744,000,000
Debt Instrument, Maturity Date	15-Dec-32
Annual stated coupon interest rate	4.00%
2012 Senior notes due 2042 at 4.25% [Member]
Debt Instrument [Line Items]
Net debt carrying amount	924,000,000	924,000,000
Debt Instrument, Maturity Date	15-Dec-42
Annual stated coupon interest rate	4.25%
2011 Senior notes due 2016 at 1.95% [Member]
Debt Instrument [Line Items]
Net debt carrying amount	1,499,000,000	1,499,000,000
Debt Instrument, Maturity Date	1-Oct-16
Annual stated coupon interest rate	1.95%
2011 Senior notes due 2021 at 3.30% [Member]
Debt Instrument [Line Items]
Net debt carrying amount	1,997,000,000	1,996,000,000
Debt Instrument, Maturity Date	1-Oct-21
Annual stated coupon interest rate	3.30%
2011 Senior notes due 2041 at 4.80% [Member]
Debt Instrument [Line Items]
Net debt carrying amount	1,490,000,000	1,490,000,000
Debt Instrument, Maturity Date	1-Oct-41
Annual stated coupon interest rate	4.80%
2009 Junior Subordinated Convertible Debentures Due 2039 At 3.25% [Member]
Debt Instrument [Line Items]
Net debt carrying amount	1,088,000,000	1,075,000,000
Debt Instrument, Maturity Date	1-Aug-39
Current portion of long-term debt	-1,100,000,000
Debt Instrument, Face Amount			2,000,000,000
Annual stated coupon interest rate	3.25%
Annual effective interest rate	7.20%
Trading Days Period Prior To Semi Annual Interest Period, Contingent Interest	10 days
Principal Amount Per Debenture Used In Conversion Rate	1,000
Debenture Interest Period Length, Contingent Interest	6 months
Average Lowerbound Trading Price Per Debenture Prior To Semi Annual Interest Period, Contingent Interest	650
Average Upperbound Trading Price Per Debenture Prior To Semi Annual Interest Period, Contingent Interest	1,500
Minimum Percentage Of Contingent Interest That Could Accrue Per Year	0.25%
Maximum Percentage Of Contingent Interest That Could Accrue Per Year	0.50%
Embedded Derivative, Fair Value of Embedded Derivative Liability	8,000,000	10,000,000
Company Stock As Percentage Of Conversion Price, Surrender For Conversion	130.00%
Trading Days During 30 Day Period In Which Company Stock Has Been At Least 130% Of Conversion Price, Surrender for Conversion	20 days
Trading Day Period Ending On Last Day Of Preceeding Fiscal Quarter, Surrender for Conversion	30 days
Company Stock As Percentage Of Conversion Price, Redemption Of Principal	150.00%
Trading Days During 30 Day Period In Which Company Stock Has Been At Least 130% Of Conversion Price, Redemption Of Principal	20 days
Trading Day Period Prior To Notice of Redemption Date, Redemption Of Principal	30 days
Equity component carrying amount	613,000,000	613,000,000
Unamortized discount	912,000,000	925,000,000
Conversion rate (shares of common stock per $1,000 principal amount of debentures)	46.06	45.57
Effective conversion price (per share of common stock)	$21.71	$21.94
Debt Instrument, Convertible, Remaining Discount Amortization Period (in years)	25 years
Conversion Rate Adjustments, Quarterly Dividend Distributions Excess Per Share	$0.14
Outstanding principal	2,000,000,000	2,000,000,000
2005 Junior Subordinated Convertible Debentures Due 2035 At 2.95% [Member]
Debt Instrument [Line Items]
Net debt carrying amount	960,000,000	946,000,000
Debt Instrument, Maturity Date	15-Dec-35
Debt Instrument, Face Amount				1,600,000,000
Annual stated coupon interest rate	2.95%
Annual effective interest rate	6.45%
Trading Days Period Prior To Semi Annual Interest Period, Contingent Interest	10 days
Principal Amount Per Debenture Used In Conversion Rate	1,000
Debenture Interest Period Length, Contingent Interest	6 months
Average Lowerbound Trading Price Per Debenture Prior To Semi Annual Interest Period, Contingent Interest	800
Average Upperbound Trading Price Per Debenture Prior To Semi Annual Interest Period, Contingent Interest	1,300
Minimum Percentage Of Contingent Interest That Could Accrue Per Year	0.25%
Maximum Percentage Of Contingent Interest That Could Accrue Per Year	0.40%
Embedded Derivative, Fair Value of Embedded Derivative Liability	4,000,000	9,000,000
Company Stock As Percentage Of Conversion Price, Redemption Of Principal	130.00%
Trading Day Period Prior To Notice of Redemption Date, Redemption Of Principal	30 days
Trading Days During 30 Day Period In Which Company Stock Has Been At Least 150% Of Conversion Price, Redemption Of Principal	20 days
Equity component carrying amount	466,000,000	466,000,000
Unamortized discount	640,000,000	654,000,000
Conversion rate (shares of common stock per $1,000 principal amount of debentures)	34.95	34.6
Effective conversion price (per share of common stock)	$28.61	$28.90
Debt Instrument, Convertible, Remaining Discount Amortization Period (in years)	21 years
Conversion Rate Adjustments, Quarterly Dividend Distributions Excess Per Share	$0.10
Outstanding principal	1,600,000,000	1,600,000,000
2012 Senior Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount					6,200,000,000
2011 Senior Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount						$5,000,000,000

Retirement_Benefit_Plans_Detai

Retirement Benefit Plans (Detail) (USD $)	12 Months Ended				3 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012	Dec. 26, 2015	Mar. 28, 2015
Retirement Contribution Plans, Textual Detail [Abstract]
Defined Contribution Plan, Cost Recognized	$286	$298	$357
Defined Benefit Plan, Funded Status Percentage [Abstract]
Defined Benefit Plan, Funded Status Of Plan (percent)	54.00%
U.S. Pension Benefits [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Projected benefit obligation	892	1,137	1,742
Service cost	88	119
Interest cost	49	67
Actuarial (gain) loss	760	-746
Currency exchange rate changes in projected benefit obligation	0	0
Plan curtailments	-1,083	0
Other changes in projected benefit obligation	-59	-45
Fair value of plan assets	623	649	684
Actual return on plan assets	30	10
Employer contributions	0	0
Currency exchange rate changes in plan assets	0	0
Other changes in projected benefit obligation	-56	-45
Defined Benefit Plan, Amounts Recognized in Balance Sheet [Abstract]
Other long-term assets	0	0
Other long-term liabilities	-269	-488
Accumulated other comprehensive loss (income), before tax	1	255
Net amount recognized	-268	-233
Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]
Net prior service credit (cost)	0	0
Net actuarial gain (loss)	-1	-255
Accumulated Benefit Obligations [Abstract]
Defined Benefit Plan, Accumulated Benefit Obligation	808	497
Defined Benefit Plan, Plans with Benefit Obligations in Excess of Plan Assets [Abstract]
Plans with accumulated benefit obligations in excess of plan assets: Accumulated benefit obligations	808	0
Plans with accumulated benefit obligations in excess of plan assets: Plan assets	623	0
Plans with projected benefit obligations in excess of plan assets: Projected benefit obligations	892	1,137
Plans with projected benefit obligations in excess of plan assets: Plan assets	623	649
Defined Benefit Plan, Funded Status Percentage [Abstract]
Defined Benefit Plan, Funded Status Of Plan (percent)	70.00%
Defined Benefit Plan, Component Of Worldwide Pension And Postretirement Benefit Obligation (percent)	23.00%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate	3.80%	4.80%
Rate of compensation increase	3.80%	3.80%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate	4.60%	3.90%	4.70%
Expected long-term rate of return on plan assets	5.40%	4.50%	5.00%
Rate of compensation increase	3.80%	4.10%	4.50%
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]
Defined Benefit Plan, Net Periodic Benefit Cost	36	230	210
Defined Benefit Plan, Expected Future Benefit Payments, Fiscal Year Maturity [Abstract]
Estimated Benefit Payments, 2015	55
Estimated Benefit Payments, 2016	54
Estimated Benefit Payments, 2017	58
Estimated Benefit Payments, 2018	64
Estimated Benefit Payments, 2019	64
Estimated Benefit Payments, 2020-2024	327
U.S. Pension Benefits [Member] | Scenario, Forecast [Member]
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Expected long-term rate of return on plan assets				6.10%
U.S. Pension Benefits [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	347	220
Defined Benefit Plan, Target Plan Asset Allocations (percent)	55.00%
U.S. Pension Benefits [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	254	415
Defined Benefit Plan, Target Plan Asset Allocations (percent)	45.00%
U.S. Pension Benefits [Member] | Other Investments [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	20	11
U.S. Pension Benefits [Member] | Total assets measured at fair value [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	621	646
U.S. Pension Benefits [Member] | Cash [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	2	3
U.S. Pension Benefits [Member] | Level 1 [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	115
U.S. Pension Benefits [Member] | Level 1 [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	56
U.S. Pension Benefits [Member] | Level 1 [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	39
U.S. Pension Benefits [Member] | Level 1 [Member] | Other Investments [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	20
U.S. Pension Benefits [Member] | Level 2 [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	460
U.S. Pension Benefits [Member] | Level 2 [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	291
U.S. Pension Benefits [Member] | Level 2 [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	169
U.S. Pension Benefits [Member] | Level 2 [Member] | Other Investments [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	0
U.S. Pension Benefits [Member] | Level 3 [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	46
U.S. Pension Benefits [Member] | Level 3 [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	0
U.S. Pension Benefits [Member] | Level 3 [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	46
U.S. Pension Benefits [Member] | Level 3 [Member] | Other Investments [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	0
Non-U.S. Pension Benefits [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Projected benefit obligation	2,423	1,695	1,412
Service cost	104	78
Interest cost	66	60
Actuarial (gain) loss	767	121
Currency exchange rate changes in projected benefit obligation	-254	46
Plan curtailments	0	0
Other changes in projected benefit obligation	45	-22
Fair value of plan assets	1,017	1,005	838
Actual return on plan assets	80	81
Employer contributions	73	65
Currency exchange rate changes in plan assets	-114	26
Other changes in projected benefit obligation	-27	-5
Defined Benefit Plan, Percentage Of Plan Assets Invested In Qualified Insurance Companies	35.00%	38.00%
Defined Benefit Plan, Amounts Recognized in Balance Sheet [Abstract]
Other long-term assets	14	16
Other long-term liabilities	-1,420	-706
Accumulated other comprehensive loss (income), before tax	1,217	520
Net amount recognized	-189	-170
Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]
Net prior service credit (cost)	-13	25
Net actuarial gain (loss)	-1,204	-545
Accumulated Benefit Obligations [Abstract]
Defined Benefit Plan, Accumulated Benefit Obligation	1,700	1,300
Defined Benefit Plan, Plans with Benefit Obligations in Excess of Plan Assets [Abstract]
Plans with accumulated benefit obligations in excess of plan assets: Accumulated benefit obligations	1,344	900
Plans with accumulated benefit obligations in excess of plan assets: Plan assets	616	563
Plans with projected benefit obligations in excess of plan assets: Projected benefit obligations	2,361	1,295
Plans with projected benefit obligations in excess of plan assets: Plan assets	941	588
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate	2.70%	4.00%
Rate of compensation increase	4.00%	3.90%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate	4.00%	4.20%	5.00%
Expected long-term rate of return on plan assets	5.70%	5.20%	5.90%
Rate of compensation increase	4.10%	4.30%	4.10%
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]
Defined Benefit Plan, Net Periodic Benefit Cost	165	116	88
Defined Benefit Plan, Expected Future Benefit Payments, Fiscal Year Maturity [Abstract]
Estimated Benefit Payments, 2015	66
Estimated Benefit Payments, 2016	26
Estimated Benefit Payments, 2017	31
Estimated Benefit Payments, 2018	35
Estimated Benefit Payments, 2019	40
Estimated Benefit Payments, 2020-2024	272
Non-U.S. Pension Benefits [Member] | Scenario, Forecast [Member]
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Expected long-term rate of return on plan assets				5.70%
Defined Benefit Plan, Estimated Future Employer Contributions [Abstract]
Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year				69
Non-U.S. Pension Benefits [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	521	361
Non-U.S. Pension Benefits [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	476	554
Non-U.S. Pension Benefits [Member] | Total assets measured at fair value [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	997	915
Non-U.S. Pension Benefits [Member] | Cash [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	20	90
Non-U.S. Pension Benefits [Member] | Plan Assets That We Have Control Over - Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Defined Benefit Plan, Target Plan Asset Allocations (percent)	80.00%
Non-U.S. Pension Benefits [Member] | Plan Assets That We Have Control Over - Fixed Income Instruments [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Defined Benefit Plan, Target Plan Asset Allocations (percent)	20.00%
Non-U.S. Pension Benefits [Member] | Level 1 [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	447
Non-U.S. Pension Benefits [Member] | Level 1 [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	447
Non-U.S. Pension Benefits [Member] | Level 1 [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	0
Non-U.S. Pension Benefits [Member] | Level 2 [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	499
Non-U.S. Pension Benefits [Member] | Level 2 [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	59
Non-U.S. Pension Benefits [Member] | Level 2 [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	440
Non-U.S. Pension Benefits [Member] | Level 3 [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	51
Non-U.S. Pension Benefits [Member] | Level 3 [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	15
Non-U.S. Pension Benefits [Member] | Level 3 [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets	36
U.S. Postretirement Medical Benefits [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Projected benefit obligation	546	509	484
Service cost	26	27
Interest cost	23	20
Actuarial (gain) loss	10	-56
Currency exchange rate changes in projected benefit obligation	0	0
Plan curtailments	0	0
Other changes in projected benefit obligation	-22	34
Fair value of plan assets	427	395	191
Actual return on plan assets	33	49
Employer contributions	0	162
Currency exchange rate changes in plan assets	0	0
Other changes in projected benefit obligation	-1	-7
Defined Benefit Plan, Amounts Recognized in Balance Sheet [Abstract]
Other long-term assets	0	0
Other long-term liabilities	-119	-114
Accumulated other comprehensive loss (income), before tax	33	43
Net amount recognized	-86	-71
Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]
Net prior service credit (cost)	-48	-54
Net actuarial gain (loss)	15	11
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate	4.10%	4.60%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate	4.60%	4.20%	4.60%
Expected long-term rate of return on plan assets	7.40%	7.70%	3.00%
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]
Defined Benefit Plan, Net Periodic Benefit Cost	17	77	50
Defined Benefit Plan, Expected Future Benefit Payments, Fiscal Year Maturity [Abstract]
Estimated Benefit Payments, 2015	14
Estimated Benefit Payments, 2016	16
Estimated Benefit Payments, 2017	19
Estimated Benefit Payments, 2018	21
Estimated Benefit Payments, 2019	24
Estimated Benefit Payments, 2020-2024	163
U.S. Postretirement Medical Benefits [Member] | Scenario, Forecast [Member]
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Expected long-term rate of return on plan assets				7.40%
Employees At Or Above A Specific Grade Level And Generally All Highly Compensated Employees [Member] | U.S. Pension Benefits [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Plan curtailments	-1,100
U.S. Intel Retirement Contribution Plan [Member]
Retirement Contribution Plans, Textual Detail [Abstract]
Retirement Contribution Plan, Equity Securities (percent)	84.00%
Retirement Contribution Plan, Fixed-Income Instruments (percent)	16.00%
Qualified U.S. Retirement Contribution Plans [Member] | Subsequent Event [Member]
Retirement Contribution Plans, Textual Detail [Abstract]
Defined Contribution Plan, Employer Discretionary Contribution Amount					$277

Commitments_Detail

Commitments (Detail) (USD $)	12 Months Ended			1 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012	Oct. 31, 2010	Jan. 31, 2015
Operating Leases, Rent Expense, Net [Abstract]
Operating Leases, Rent Expense	$257,000,000	$270,000,000	$214,000,000
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
Minimum rental commitments payable, 2015	205,000,000
Minimum rental commitments payable, 2016	179,000,000
Minimum rental commitments payable, 2017	152,000,000
Minimum rental commitments payable, 2018	118,000,000
Minimum rental commitments payable, 2019	101,000,000
Minimum rental commitments payable, 2020 and thereafter	315,000,000
Minimum rental commitments payable, Total	1,070,000,000
Capital Addition Purchase Commitments [Member]
Unrecorded Unconditional Purchase Obligation [Abstract]
Unrecorded Unconditional Purchase Obligation	3,500,000,000	5,500,000,000
Other Purchase Obligations And Commitments [Member]
Unrecorded Unconditional Purchase Obligation [Abstract]
Unrecorded Unconditional Purchase Obligation	2,500,000,000	1,900,000,000
Lehman Matter [Member] | Pending Litigation [Member]
Unrecorded Unconditional Purchase Obligation [Line Items]
Loss Contingency, Damages Sought, Value				312,000,000
Subsequent Event [Member] | Lehman Matter [Member] | Pending Litigation [Member]
Unrecorded Unconditional Purchase Obligation [Line Items]
Loss Contingency, Damages Sought, Value					$129,000,000

Commitments_Long_Term_Purchase

Commitments, Long Term Purchase Obligation (Detail) (ASML Holding N.V. [Member], Research and Development Arrangement [Member])	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 27, 2014
	EUR (€)	USD ($)
Long-term Purchase Commitment [Line Items]
Long-term Purchase Commitment, Amount	€ 829
Purchase Commitment, Remaining Minimum Amount Committed	€ 562	$689

Employee_Equity_Incentive_Plan2

Employee Equity Incentive Plans (Detail) (USD $)	12 Months Ended			36 Months Ended
Share data in Millions, except Per Share data, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012	Dec. 27, 2014	Dec. 26, 2014	Dec. 31, 2011
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Market-Based Restricted Stock Units Performance Period (In Years)	3 years
Share-based Compensation	$1,148,000,000	$1,118,000,000	$1,102,000,000
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	555,000,000	385,000,000	510,000,000
Closing Price of Intel Common Stock					$37.55
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	68,000,000	186,000,000	205,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value	611,000,000	265,000,000	517,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	1-Apr-21
Participation Percentage in Stock Purchase Plan	76.00%	76.00%	72.00%	76.00%
Share-based Compensation Arrangements By Share-based Payment Award, Restricted Stock Units [Roll Forward]
Number of RSUs outstanding, ending balance	77.3			77.3
Number Of RSUs expected to vest	112.1			112.1
Stock Options Vested And Expected To Vest [Abstract]
Number of options expected to vest	21.2			21.2
Total number of options vested and expected to vest	75.9			75.9
Weighted-average exercise price for expected to vest options (in dollars per share)	$23.74			$23.74
Weighted-average exercise price for vested and expected to vest options (in dollars per share)	$21.25			$21.25
Weighted-average remaining contractual term for vested options (in years)	2 years 3 months 19 days
Weighted-average remaining contractual term for expected to vest options (in years)	4 years 9 months 22 days
Weighted-average remaining contractual term for vested and expected to vest options (in years)	3 years
Aggregate intrinsic value for vested options	944,000,000			944,000,000
Aggregate intrinsic value for expected to vest options	293,000,000			293,000,000
Total Aggregate intrinsic value for vested and expected to vest options	1,237,000,000			1,237,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of options outstanding, beginning balance	153	202.8	298.3
Number of options granted	0.6	20.1	13.5
Number of options exercised	-63.7	-65	-85.8
Number of options cancelled and forfeited	-2.7	-3	-3.9
Number of options expired	-9.9	-1.9	-19.3
Number of options outstanding, ending balance	77.3	153	202.8	77.3
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted-average exercise price of stock options (in dollars per share)	$21.30	$21.10	$20.20	$21.30		$20.12
Weighted-average exercise price for stock option grants during the year (in dollars per share)	$25.34	$22.99	$27.01
Weighted-average exercise price for stock option exercises during the year (in dollars per share)	$19.87	$18.76	$20.45
Weighted-average exercise price for stock option cancellations and forfeitures during the year (in dollars per share)	$23.70	$22.58	$21.17
Weighted-average exercise price for stock option expirations during the year (in dollars per share)	$27	$22.56	$22.45
Number of options exercisable	54.7	111.5	139.8	54.7
Weighted-average exercise price for options exercisable (in dollars per share)	$20.29	$20.25	$19.76	$20.29
Range Of Exercise Prices And Options Outstanding [Abstract]
Weighted-average remaining Contractual Life (in years), Total	3 years
$1.82-$15.00 [Member]
Range Of Exercise Prices And Options Outstanding [Abstract]
Number of outstanding options	0.7			0.7
Weighted-average remaining Contractual Life (in years)	3 years
Weighted-average exercise price for outstanding options (in dollars per share)	$11.60			$11.60
Number of exercisable options	0.7			0.7
Weighted-average exercise price for exercisable options (in dollars per share)	$11.60			$11.60
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit (in dollars per share)	$1.82
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit (in dollars per share)	$15
$15.01-$20.00 [Member]
Range Of Exercise Prices And Options Outstanding [Abstract]
Number of outstanding options	32.9			32.9
Weighted-average remaining Contractual Life (in years)	1 year 9 months 22 days
Weighted-average exercise price for outstanding options (in dollars per share)	$18.27			$18.27
Number of exercisable options	32.9			32.9
Weighted-average exercise price for exercisable options (in dollars per share)	$18.27			$18.27
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit (in dollars per share)	$15.01
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit (in dollars per share)	$20
$20.01-$25.00 [Member]
Range Of Exercise Prices And Options Outstanding [Abstract]
Number of outstanding options	34			34
Weighted-average remaining Contractual Life (in years)	3 years 11 months
Weighted-average exercise price for outstanding options (in dollars per share)	$22.75			$22.75
Number of exercisable options	17.2			17.2
Weighted-average exercise price for exercisable options (in dollars per share)	$22.89			$22.89
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit (in dollars per share)	$20.01
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit (in dollars per share)	$25
$25.01-$27.42 [Member]
Range Of Exercise Prices And Options Outstanding [Abstract]
Number of outstanding options	9.7			9.7
Weighted-average remaining Contractual Life (in years)	4 years 3 months 19 days
Weighted-average exercise price for outstanding options (in dollars per share)	$27.11			$27.11
Number of exercisable options	3.9			3.9
Weighted-average exercise price for exercisable options (in dollars per share)	$27.21			$27.21
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit (in dollars per share)	$25.01
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit (in dollars per share)	$27.42
Minimum [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Exercise Price Of Options Exercised (In Dollars Per Share)				$1.12
Maximum [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Exercise Price Of Options Exercised (In Dollars Per Share)				$28.15
Restricted Stock Units (RSUs) [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	1,800,000,000			1,800,000,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	1 year 3 months 19 days
Share-based Compensation Arrangements By Share-based Payment Award, Restricted Stock Units [Roll Forward]
Number of RSUs outstanding, beginning balance	113.3	109.3	107
Number of RSUs granted	57.2	53.4	49.9
Number of RSUs vested	-42.5	-44.5	-43.2
Number of RSUs forfeited	-8.6	-4.9	-4.4
Number of RSUs outstanding, ending balance	119.4	113.3	109.3	119.4
Share-based Compensation Arrangements By Share-based Payment Award, Restricted Stock Units, Weighted Average Exercise Price [Roll Forward]
Weighted-average grant date fair value of RSU balance (in dollars per share)	$23.89	$22.47	$22.03	$23.89		$19.18
Weighted-average grant date fair value of granted RSUs (in dollars per share)	$25.40	$21.45	$25.32
Weighted-average grant date fair value of vested RSUs (in dollars per share)	$22.33	$20.21	$18.88
Weighted-average grant date fair value of forfeited RSUs (in dollars per share)	$22.94	$22.06	$20.93
Weighted-average grant date fair value of RSUs expected to vest (in dollars per share)	$23.88			$23.88
Restricted Stock Units, Stock Options, And Stock Purchase Plan Estimated Values And Weighted Average Assumptions [Abstract]
Risk-free interest rate	0.50%	0.20%	0.30%
Dividend yield	3.30%	3.80%	3.30%
Volatility (percent)	23.00%	25.00%	26.00%
Stock Option Awards [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	34,000,000			34,000,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	11 months
Restricted Stock Units, Stock Options, And Stock Purchase Plan Estimated Values And Weighted Average Assumptions [Abstract]
Estimated values (in dollars per share)	$3.61	$3.11	$4.22
Expected life (in years)	5 years 1 month 17 days	5 years 2 months 12 days	5 years 3 months 18 days
Risk-free interest rate	1.70%	0.80%	1.00%
Dividend yield	3.60%	3.90%	3.30%
Volatility (percent)	23.00%	25.00%	25.00%
Market Based Restricted Stock Units [Member]
Share-based Compensation Arrangements By Share-based Payment Award, Restricted Stock Units [Roll Forward]
Number of RSUs outstanding, ending balance	4			4
Market Based Restricted Stock Units [Member] | Minimum [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Vesting range (percent)	0.00%			0.00%
Market Based Restricted Stock Units [Member] | Maximum [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Vesting range (percent)	200.00%			200.00%
2006 Equity Incentive Plan [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	719			719
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	258			258
Restricted Stock or Stock Units, 2006 Plan [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	517			517
Restricted Stock or Stock Units, 2006 Plan [Member] | Restricted Stock Units (RSUs) [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value	1,100,000,000	1,000,000,000	1,200,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value Amount	949,000,000	899,000,000	816,000,000
Stock Purchase Plan [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	373			373
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	197			197
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent	85.00%
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	13,000,000			13,000,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	1 month 15 days
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period	19.4	20.5	17.4
Employee Purchases, Amount	393,000,000	369,000,000	355,000,000
Restricted Stock Units, Stock Options, And Stock Purchase Plan Estimated Values And Weighted Average Assumptions [Abstract]
Estimated values (in dollars per share)	$5.87	$4.52	$5.47
Expected life (in years)	6 months	6 months	6 months
Risk-free interest rate	0.10%	0.10%	0.10%
Dividend yield	3.20%	4.00%	3.30%
Volatility (percent)	22.00%	22.00%	24.00%
Share-based Compensation [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Other Inventory, Capitalized Costs, Gross	$39,000,000	$38,000,000	$41,000,000	$39,000,000

Common_Stock_Repurchases_Detai

Common Stock Repurchases (Detail) (USD $)	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012	Jul. 31, 2014
Common Stock Repurchases (Textuals) [Abstract]
Stock Repurchased During Period, Value	$10,792,000,000	$2,147,000,000	$4,765,000,000
Collateral Received in Association With Repurchase Of Common Stock	325,000,000
Common Stock Repurchase Program [Member]
Common Stock Repurchases (Textuals) [Abstract]
Stock Repurchase Program, Authorized Amount	65,000,000,000
Stock Repurchase Authorization Increase, Value				20,000,000,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount	12,400,000,000
Stock Repurchased During Period, Shares	332,400,000
Stock Repurchased During Period, Value	10,800,000,000
Stock Repurchased and Retired During Period, Shares		94,100,000	191,000,000
Stock Repurchased and Retired During Period, Value		2,100,000,000	4,800,000,000
Accumulated Stock Repurchased During Program, Total Shares	4,700,000,000
Accumulated Stock Repurchased During Program, Total Value	102,000,000,000
Restricted Stock Unit Withholdings [Member]
Common Stock Repurchases (Textuals) [Abstract]
Stock Repurchased and Retired During Period, Shares	12,000,000	13,100,000	12,600,000
Stock Repurchased and Retired During Period, Value	$332,000,000	$293,000,000	$345,000,000

Gains_Losses_on_Equity_Investm2

Gains (Losses) on Equity Investments, Net (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Gains (Losses) on Equity Investments, Net Detail [Abstract]
Share of equity method investee losses, net	($69)	($69)	($81)
Impairments	-146	-123	-154
Dividends	57	46	0
Other, net	147	102	193
Total gains (losses) on equity investments, net	411	471	141
Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds	1,700	1,300	3,400
Available-for-sale Securities, Gross Realized Gains	136	146	166
Clearwire Corporation [Member] | Marketable Equity Securities [Member]
Gains (Losses) on Equity Investments, Net Detail [Abstract]
Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds		142
Available-for-sale Securities, Gross Realized Gains		111
Clearwire, LLC [Member] | Equity Method Investments [Member]
Gains (Losses) on Equity Investments, Net Detail [Abstract]
Proceeds from Sale, Maturity and Collection of Investments		328
Equity Method Investment, Realized Gain (Loss) on Disposal		328
Interest In Clearwire, LLC And Shares In Clearwire Corporation [Member]
Gains (Losses) on Equity Investments, Net Detail [Abstract]
Gain (Loss) On Sale Of Combined Investment		439
Equity Investments [Member]
Gains (Losses) on Equity Investments, Net Detail [Abstract]
Gains on sales, net	$422	$515	$183

Interest_and_Other_Net_Detail

Interest and Other, Net (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Interest and Other, Net [Abstract]
Interest income	$141	$104	$97
Interest expense	-192	-244	-90
Other, net	94	-11	87
Total interest and other, net	43	-151	94
Interest Costs, Capitalized During Period	$276	$246	$240

Earnings_Per_Share_Detail

Earnings Per Share (Detail) (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Earnings Per Share [Abstract]
Net income available to common stockholders	$11,704	$9,620	$11,005
Weighted average shares of common stock outstanding-basic	4,901	4,970	4,996
Dilutive effect of employee equity incentive plans (shares)	75	68	100
Dilutive effect of convertible debt (shares)	80	59	64
Weighted average shares of common stock outstanding-diluted	5,056	5,097	5,160
Basic earnings per share of common stock	$2.39	$1.94	$2.20
Diluted earnings per share of common stock	$2.31	$1.89	$2.13
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (shares)	10	55	29

Income_Taxes_Detail

Income Taxes (Detail) (USD $)	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Income Before Taxes and Provision for Taxes [Abstract]
Income before taxes: U.S.	$11,565,000,000	$9,374,000,000	$10,042,000,000
Income before taxes: Non-U.S.	4,236,000,000	3,237,000,000	4,831,000,000
Income before taxes	15,801,000,000	12,611,000,000	14,873,000,000
Provision for taxes, Current: Federal	3,374,000,000	2,730,000,000	2,539,000,000
Provision for taxes, Current: State	38,000,000	68,000,000	52,000,000
Provision for taxes, Current: Non-U.S.	969,000,000	716,000,000	1,135,000,000
Total current provision for taxes	4,381,000,000	3,514,000,000	3,726,000,000
Provision for taxes, Deferred: Federal	-263,000,000	-412,000,000	129,000,000
Provisions For Taxes, Deferred: Other	-21,000,000	-111,000,000	13,000,000
Total deferred provision for taxes	-284,000,000	-523,000,000	142,000,000
Total Provision for taxes	4,097,000,000	2,991,000,000	3,868,000,000
Effective tax rate	25.90%	23.70%	26.00%
Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract]
Statutory federal income tax rate	35.00%	35.00%	35.00%
Increase (reduction) in rate resulting from: Non-U.S. income taxed at different rates	-6.10%	-5.80%	-7.30%
Increase (reduction) in rate resulting from: Research and Development tax credits	-1.70%	-3.50%	0.00%
Increase (reduction) in rate resulting from: Domestic manufacturing deduction benefit	-2.10%	-2.10%	-2.10%
Increase (reduction) in rate resulting from: Other	0.80%	0.10%	0.40%
Taxes, Other Textual Details [Abstract]
Income tax holiday termination date, end of range	31-Dec-23
Income Tax Holiday, Aggregate Dollar Amount	166,000,000	213,000,000	252,000,000
Income Tax Holiday, Income Tax Benefits Per Share, Diluted	$0.03	$0.04	$0.05
Income tax benefits (deficiencies) attributable to equity-based compensation transactions allocated to stockholders' equity	103,000,000	3,000,000	137,000,000
Accrued Income Taxes, Current	443,000,000	542,000,000
Long-term income taxes payable	262,000,000	188,000,000
Components of Deferred Tax Assets and Liabilities [Abstract]
Deferred tax assets, Accrued compensation and other benefits	982,000,000	1,047,000,000
Deferred tax assets, Share-based compensation	438,000,000	564,000,000
Deferred tax assets, Deferred income	691,000,000	672,000,000
Deferred tax assets, Inventory	339,000,000	733,000,000
Deferred tax assets, State credits and net operating losses	519,000,000	378,000,000
Deferred tax assets, Other, net	715,000,000	654,000,000
Gross deferred tax assets	3,684,000,000	4,048,000,000
Deferred tax assets, Valuation allowance	-595,000,000	-456,000,000
Total deferred tax assets	3,089,000,000	3,592,000,000
Deferred tax liabilities, Property, plant and equipment	-1,171,000,000	-2,023,000,000
Deferred tax liabilities, Licenses and intangibles	-576,000,000	-687,000,000
Deferred tax liabilities, Convertible debt	-977,000,000	-911,000,000
Deferred Tax Liabilities, Unrealized Gains On Investments And Derivatives	-1,017,000,000	-815,000,000
Deferred tax liabilities, Investments in non-U.S. subsidiaries	-252,000,000	-244,000,000
Deferred tax liabilities, Other, net	-291,000,000	-281,000,000
Total deferred tax liabilities	-4,284,000,000	-4,961,000,000
Net deferred tax assets (liabilities)	-1,195,000,000	-1,369,000,000
Current deferred tax assets	1,958,000,000	2,594,000,000
Non-current deferred tax assets	622,000,000	434,000,000
Non-current deferred tax liabilities	-3,775,000,000	-4,397,000,000
Valuation Allowance [Line Items]
Valuation Allowance, Amount	595,000,000	456,000,000
Deferred Tax Liability Not Recognized [Line Items]
Undistributed Earnings of Foreign Subsidiaries	23,300,000,000
Other Basis Differences For Certain Non-U.S. Subsidiaries	1,600,000,000
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Unrecognized tax benefits, Gross, Beginning Balance	207,000,000	189,000,000	212,000,000
Unrecognized tax benefits, Settlements and effective settlements with tax authorities and related remeasurements	-220,000,000	-2,000,000	-81,000,000
Unrecognized tax benefits, Lapse of statute of limitations	0	0	-5,000,000
Unrecognized tax benefits, Increases in balances related to tax positions taken during prior periods	173,000,000	21,000,000	56,000,000
Unrecognized tax benefits, Decreases in balances related to tax positions taken during prior periods	-1,000,000	-9,000,000	-6,000,000
Unrecognized tax benefits, Increases in balances related to tax positions taken during current periods	418,000,000	8,000,000	13,000,000
Unrecognized tax benefits, Gross, Ending Balance	577,000,000	207,000,000	189,000,000
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	485,000,000	81,000,000
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	21,000,000
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	44,000,000	73,000,000
Significant (Increase) Decrease in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Lower Bound	25,000,000
Significant (Increase) Decrease in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound	465,000,000
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	219,000,000
Operating Loss Carryforwards, Expiration Dates	31-Dec-34
State [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	375,000,000
Non-U.S. [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	393,000,000
Operating loss carryforwards that have a valuation allowance	291,000,000
U.S. State and Non-U.S. [Member]
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Year Which Prior Years' Tax Returns Are Generally No Longer Subject To Tax Examination (date)	31-Dec-02
U.S. Federal [Member]
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Year Which Prior Years' Tax Returns Are No Longer Subject To Tax Examination (date)	31-Dec-09
State Credit Carry Forwards [Member]
Components of Deferred Tax Assets and Liabilities [Abstract]
Deferred tax assets, Valuation allowance	-507,000,000
Valuation Allowance [Line Items]
Valuation Allowance, Amount	507,000,000
Matters Related To Our Non-U.S. Subsidiaries [Member]
Components of Deferred Tax Assets and Liabilities [Abstract]
Deferred tax assets, Valuation allowance		-88,000,000
Valuation Allowance [Line Items]
Valuation Allowance, Amount		$88,000,000

Other_Comprehensive_Income_Los2

Other Comprehensive Income (Loss), Accumulated Other Comprehensive Income (Loss) (Detail) (USD $)	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Accumulated Other Comprehensive Income (Loss) [Line Items]
Change in unrealized holding gain (loss) on available-for-sale investments, Before Tax	$1,029,000,000	$1,963,000,000	$909,000,000
Change in unrealized holding gain (loss) on available-for-sale investments, Tax	-359,000,000	-687,000,000	-318,000,000
Change in unrealized holding gain (loss) on available-for-sale investments, Net of Tax	670,000,000	1,276,000,000	591,000,000
Less: adjustment for (gain) loss on available-for-sale investments included in net income, Before Tax	-142,000,000	-146,000,000	-187,000,000
Less: adjustment for (gain) loss on available-for-sale investments included in net income, Tax	49,000,000	51,000,000	66,000,000
Less: adjustment for (gain) loss on available-for-sale investments included in net income, Net of Tax	-93,000,000	-95,000,000	-121,000,000
Less: adjustment for (gain) loss on deferred tax asset valuation allowance included in net income, Tax	-41,000,000	-26,000,000	-11,000,000
Less: adjustment for (gain) loss on deferred tax asset valuation allowance included in net income, Net of Tax	-41,000,000	-26,000,000	-11,000,000
Change in unrealized holding gain (loss) on derivatives, Before Tax	-589,000,000	-166,000,000	12,000,000
Change in unrealized holding gain (loss) on derivatives, Tax	160,000,000	76,000,000	8,000,000
Change in unrealized holding gain (loss) on derivatives, Net of Tax	-429,000,000	-90,000,000	20,000,000
Less: adjustment for (gain) loss on derivatives included in net income, Before Tax	13,000,000	30,000,000	78,000,000
Less: adjustment for (gain) loss on derivatives included in net income, Tax	-11,000,000	-29,000,000	-13,000,000
Less: adjustment for (gain) loss on derivatives included in net income, Net of Tax	2,000,000	1,000,000	65,000,000
Change in prior service costs, Before Tax	-42,000,000	17,000,000	-4,000,000
Change in prior service costs, Tax	5,000,000	-2,000,000	1,000,000
Change in prior service costs, Net of Tax	-37,000,000	15,000,000	-3,000,000
Less: adjustment for amortization of prior service costs, Before Tax	6,000,000	4,000,000	5,000,000
Less: adjustment for amortization of prior service costs, Tax	-2,000,000	-1,000,000	-2,000,000
Less: adjustment for amortization of prior service costs, Net of Tax	4,000,000	3,000,000	3,000,000
Change in actuarial valuation, Before Tax	-433,000,000	725,000,000	-321,000,000
Change in actuarial valuation, Tax	3,000,000	-275,000,000	91,000,000
Change in actuarial valuation, Net of Tax	-430,000,000	450,000,000	-230,000,000
Less: adjustment for amortization of actuarial (gain) loss, Before Tax	37,000,000	101,000,000	90,000,000
Less: adjustment for amortization of actuarial (gain) loss, Tax	-9,000,000	-31,000,000	-32,000,000
Less: adjustment for amortization of actuarial (gain) loss, Net of Tax	28,000,000	70,000,000	58,000,000
Change in net foreign currency translation adjustment, Before Tax	-275,000,000	45,000,000	12,000,000
Change in net foreign currency translation adjustment, Tax	24,000,000	-7,000,000	-2,000,000
Change in net foreign currency translation adjustment, Net of Tax	-251,000,000	38,000,000	10,000,000
Total other comprehensive income (loss), Before Tax	-396,000,000	2,573,000,000	594,000,000
Total other comprehensive income (loss), Tax	-181,000,000	-931,000,000	-212,000,000
Other comprehensive income (loss)	-577,000,000	1,642,000,000	382,000,000
Other Comprehensive Income (Loss), Pension And Other Postretirement Benefit Plans, Increase In Actuarial Loss Arising During Period, Before Tax	1,400,000,000
Other Comprehensive Income (Loss), Pension And Other Postretirement Benefit Plans, Decrease In Actuarial Loss Arising During Period, Before Tax	1,000,000,000
Accumulated Other Comprehensive Income (Loss), Net of Tax	666,000,000	1,243,000,000	-399,000,000
Other Comprehensive Income (Loss), before Reclassifications, before Tax	-310,000,000	2,584,000,000
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax	-86,000,000	-11,000,000
Defined Benefit Plan, Amortization of Net Prior Service Cost (Credit)	8,000,000
Defined Benefit Plan, Amortization of Net Gains (Losses)	57,000,000
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months	-336,000,000
Unrealized holding gains (losses) on available-for-sale investments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total other comprehensive income (loss), Tax	-310,000,000	-636,000,000
Other comprehensive income (loss)	577,000,000	1,181,000,000
Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment Including Other Than Temporary Impairments, Net of Tax	2,459,000,000	1,882,000,000	701,000,000
Other Comprehensive Income (Loss), before Reclassifications, before Tax	1,029,000,000	1,963,000,000
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax	-142,000,000	-146,000,000
Deferred Tax Asset Valuation Allowance [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total other comprehensive income (loss), Tax	-41,000,000	-26,000,000
Other comprehensive income (loss)	-41,000,000	-26,000,000
Accumulated Other Comprehensive Income Loss Net Change In Deferred Tax Asset Valuation Allowance	26,000,000	67,000,000	93,000,000
Other Comprehensive Income (Loss), before Reclassifications, before Tax	0	0
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax	0	0
Unrealized holding gains (losses) on derivatives [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total other comprehensive income (loss), Tax	149,000,000	47,000,000
Other comprehensive income (loss)	-427,000,000	-89,000,000
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax	-423,000,000	4,000,000	93,000,000
Other Comprehensive Income (Loss), before Reclassifications, before Tax	-589,000,000	-166,000,000
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax	13,000,000	30,000,000
Prior service credits (costs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Less: adjustment for amortization of prior service costs, Before Tax	-6,000,000	-4,000,000	-5,000,000
Total other comprehensive income (loss), Tax	3,000,000	-3,000,000
Other comprehensive income (loss)	-33,000,000	18,000,000
Accumulated Other Comprehensive Income Loss Net Prior Service Cost Net Of Tax	-47,000,000	-14,000,000	-32,000,000
Other Comprehensive Income (Loss), before Reclassifications, before Tax	-42,000,000	17,000,000
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax	6,000,000	4,000,000
Actuarial gains (losses) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Less: adjustment for amortization of actuarial (gain) loss, Before Tax	-37,000,000	-101,000,000	-90,000,000
Total other comprehensive income (loss), Tax	-6,000,000	-306,000,000
Other comprehensive income (loss)	-402,000,000	520,000,000
Accumulated Other Comprehensive Income Loss Net Actuarial Gains Loss Net Of Tax	-1,004,000,000	-602,000,000	-1,122,000,000
Other Comprehensive Income (Loss), before Reclassifications, before Tax	-433,000,000	725,000,000
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax	37,000,000	101,000,000
Foreign Currency translation adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total other comprehensive income (loss), Tax	24,000,000	-7,000,000
Other comprehensive income (loss)	-251,000,000	38,000,000
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax	-345,000,000	-94,000,000	-132,000,000
Other Comprehensive Income (Loss), before Reclassifications, before Tax	-275,000,000	45,000,000
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax	$0	$0

Other_Comprehensive_Income_Los3

Other Comprehensive Income (Loss), Reclassification out of Accumulated Other Comprehensive Income (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Interest and other, net	$43	($151)	$94
Gains (losses) on equity investments, net	411	471	141
Income before taxes	15,801	12,611	14,873
Cost of sales	-20,261	-21,187	-20,190
Research and development	-11,537	-10,611	-10,148
Marketing, general and administrative	-8,136	-8,088	-8,057
Other Comprehensive (Income) Loss, Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax	6	4	5
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Gain (Loss), before Tax	37	101	90
Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Income before taxes	86	11	14
Unrealized holding gains (losses) on available-for-sale investments [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Interest and other, net	10	8	-8
Gains (losses) on equity investments, net	132	138	195
Income before taxes	142	146	187
Unrealized holding gains (losses) on derivatives [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Income before taxes	-13	-30	-78
Unrealized holding gains (losses) on derivatives [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | Currency Forwards [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	-31	-61	11
Research and development	18	30	-63
Marketing, general and administrative	2	0	-25
Unrealized holding gains (losses) on derivatives [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | Other Instruments [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	-2	1	-1
Prior service credits (costs) [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive (Income) Loss, Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax	-6	-4	-5
Actuarial gains (losses) [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Gain (Loss), before Tax	-37	-101	-90
Amortization of pension and postretirement benefit components [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Income before taxes	($43)	($105)	($95)

Contingencies_Detail

Contingencies (Detail)	Aug. 19, 2010	Jun. 30, 2012	31-May-09	31-May-09	Dec. 31, 2008	Oct. 31, 2010	Jan. 31, 2015
Share data in Millions, except Per Share data, unless otherwise specified	McAfee, Inc. [Member]	McAfee, Inc. [Member]	EC Fine [Member]	EC Fine [Member]	Lehman Matter [Member]	Lehman Matter [Member]	Lehman Matter [Member]
	McAfee Shareholder Litigation [Member]	McAfee Shareholder Litigation [Member]	USD ($)	EUR (€)	USD ($)	Pending Litigation [Member]	Subsequent Event [Member]
	USD ($)	Pending Litigation [Member]				USD ($)	Pending Litigation [Member]
		USD ($)					USD ($)
Loss Contingencies [Line Items]
Loss Contingency, Fine			$1,447,000,000	€ 1,060,000,000
Loss Contingency, Pre-Payment Amount For Forward-Purchase Agreement					1,000,000,000
Loss Contingency, Cash Collateral Received For Forward-Purchase Agreement					1,000,000,000
Loss Contingency, Shares Of Intel Common Stock Required To Be Delivered Under Forward-Purchase Agreement					50
Loss Contingency, Cash Collateral Foreclosed On In Forward-Purchase Agreement					1,000,000,000
Loss Contingency, Damages Sought, Value						312,000,000	129,000,000
Loss Contingency, Interest On Damages Sought, Percentage						13.50%
Loss Contingency, Range of Possible Loss, Maximum							$129,000,000
Cash Per Share of Acquiree Common Stock and Common Stock Subject to Restricted Stock Awards, Vested Restricted Stock Unit Awards, and Vested Performance Stock Unit Awards Upon Completion of Acquisition	$48
Loss Contingency, Plaintiffs Damages Expert Value Assertion of Share of Acquiree for Purposes of Assessing Damages		$62.08

Operating_Segments_and_Geograp2

Operating Segments and Geographic Information (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Schedule Of Segment Reporting Information [Abstract]
Net revenue	$55,870	$52,708	$53,341
Operating income (loss)	15,347	12,291	14,638
PC Client Group [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	34,669	33,270	34,688
Operating income (loss)	14,635	11,751	13,008
Data Center Group [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	14,387	12,161	11,219
Operating income (loss)	7,279	5,569	5,231
Internet of Things Group [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	2,142	1,801	1,600
Operating income (loss)	616	550	278
Mobile and Communications Group [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	202	1,375	1,791
Operating income (loss)	-4,206	-3,148	-1,776
Software and services operating segments [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	2,216	2,190	2,072
Operating income (loss)	55	24	12
All other [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	2,254	1,911	1,971
Operating income (loss)	($3,032)	($2,455)	($2,115)

Operating_Segments_and_Geograp3

Operating Segments and Geographic Information, Revenue by Major Customers (Detail) (Customer Concentration Risk [Member], Sales Revenue, Net [Member])	12 Months Ended
	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Revenue, Major Customer [Line Items]
Entity-Wide Revenue, Major Customer, Percentage	46.00%	44.00%	43.00%
Hewlett-Packard Company [Member]
Revenue, Major Customer [Line Items]
Entity-Wide Revenue, Major Customer, Percentage	18.00%	17.00%	18.00%
Dell Inc. [Member]
Revenue, Major Customer [Line Items]
Entity-Wide Revenue, Major Customer, Percentage	16.00%	15.00%	14.00%
Lenovo Group Limited [Member]
Revenue, Major Customer [Line Items]
Entity-Wide Revenue, Major Customer, Percentage	12.00%	12.00%	11.00%

Operating_Segments_and_Geograp4

Operating Segments and Geographic Information, Revenues from External Customers by Country (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Schedule of Revenues from External Customers, By Country [Line Items]
Net revenue	$55,870	$52,708	$53,341
Singapore [Member]
Schedule of Revenues from External Customers, By Country [Line Items]
Net revenue	11,573	10,997	12,622
China (Including Hong Kong) [Member]
Schedule of Revenues from External Customers, By Country [Line Items]
Net revenue	11,197	9,890	8,299
United States [Member]
Schedule of Revenues from External Customers, By Country [Line Items]
Net revenue	9,828	9,091	8,348
Taiwan [Member]
Schedule of Revenues from External Customers, By Country [Line Items]
Net revenue	8,955	8,888	9,327
Japan [Member]
Schedule of Revenues from External Customers, By Country [Line Items]
Net revenue	2,776	3,725	4,303
Other countries [Member]
Schedule of Revenues from External Customers, By Country [Line Items]
Net revenue	11,541	10,117	10,442
Outside the U.S. [Member]
Schedule of Revenues from External Customers, By Country [Line Items]
Net revenue	$46,000	$43,600	$45,000

Operating_Segments_and_Geograp5

Operating Segments and Geographic Information, Long-Lived Assets (Detail) (USD $)	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
In Millions, unless otherwise specified
Schedule Of Long-Lived Assets [Line Items]
Property, plant and equipment, net	$33,238	$31,428	$27,983
United States [Member]
Schedule Of Long-Lived Assets [Line Items]
Property, plant and equipment, net	24,020	23,624	20,542
Ireland [Member]
Schedule Of Long-Lived Assets [Line Items]
Property, plant and equipment, net	5,433	2,986	1,523
Israel [Member]
Schedule Of Long-Lived Assets [Line Items]
Property, plant and equipment, net	1,957	2,667	3,389
Other countries [Member]
Schedule Of Long-Lived Assets [Line Items]
Property, plant and equipment, net	1,828	2,151	2,529
Outside the U.S. [Member]
Schedule Of Long-Lived Assets [Line Items]
Property, plant and equipment, net	$9,200	$7,800	$7,400

Valuation_and_Qualifying_Accou1

Valuation and Qualifying Accounts (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 27, 2014	Dec. 28, 2013	Dec. 29, 2012
Allowance for doubtful receivables [Member]
Valuation Allowances And Reserves, Disclosure [Roll Forward]
Valuation Allowances And Reserves, Beginning Balance	$38	$38	$36
Valuation Allowances And Reserves, Additions Charged to Expenses/Other Accounts	10	5	3
Valuation Allowances And Reserves, Net (Deductions) Recoveries	-10	-5	-1
Valuation Allowances And Reserves, Ending Balance	38	38	38
Valuation allowance for deferred tax assets [Member]
Valuation Allowances And Reserves, Disclosure [Roll Forward]
Valuation Allowances And Reserves, Beginning Balance	456	389	373
Valuation Allowances And Reserves, Additions Charged to Expenses/Other Accounts	128	88	77
Valuation Allowances And Reserves, Net (Deductions) Recoveries	11	-21	-61
Valuation Allowances And Reserves, Ending Balance	$595	$456	$389